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1.1 Genomic Imprinting 
Mammalian diploid cells contain two functional equivalent copies for almost all genes. This is, 
however, not the case for X linked genes and for genes which are subject to genomic imprinting. 
Males have only one copy of X linked genes whereas females silence one of the two X 
chromosomes they possess. The expression of imprinted genes depends on their parental 
origin, e.g. for some genes only the maternal, and for other genes only the paternal allele is 
active. Thus, genomic imprinting can be described as the parental specific expression of genes. 
That the paternal and maternal genomes are not equivalent became clear in the early eighties. 
Pronuclear transplantation experiments in mice showed that replacement of the paternal 
pronucleus by a maternal one or vice versa resulted in non-viable embryos (McGrath and Solter, 
1984). Embryos containing two paternal sets of chromosomes had relatively normal placentas 
and extra-embryonic membranes but a poorly developmed embryo proper whereas embryos 
containing two sets of maternal chromosomes, showed relatively normal embryos, but poor 
placental development (Solter, 1988; Solter, 1987; Surani, 1986). These observations clearly 
demonstrated that both a paternal and a maternal genome must be present for normal 
development during which each genome makes a unique, complementary contribution to the 
embryo and placenta. 
To delineate the regions on different chromosomes with a parent-specific effect in the 
offspring, the construction of mice with uniparental disomy for different chromosomes and 
chromosomal regions has been very useful and in 1988, the first "imprinting map" for the murine 
genome was published (Beechey et al., 1988). Based on this map the total number of imprinted 
genes has been estimated between 50 and 200. Most research into the identification of 
imprinted genes and the mechanisms by which a cell recognises a gene as paternally or 
maternally derived has been performed in the mouse. A classical example of a maternal effect 
mutation in mice is the Tme locus on chromosome 17 (Johnson, 1974). Maternal, but not 
paternal, inheritance of this deletion is embryonic lethal. In 1991, Barlow et al. showed that the 
IGF2R gene mapped within the deletion interval and was expressed from the maternal allei only. 
(Barlow et al., 1991). This was the first imprinted gene identified but in the same year two other 
genes, H19 and Igf2, which are clustered on mouse chromosome 7, were both shown to be 
imprinted as well. H19 is expressed from the maternal allele whereas IGF2 is paternally 
expressed demonstrating that imprinted genes are sometimes clustered and can be either 
paternally or maternally imprinted (inactivated) (Bartolomei et al., 1991; DeChiara et al., 1991; 
Ferguson Smith et al., 1991). Until now, 24 imprinted genes have been identified in mice and 
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human (see table 1 ) and it was shown that imprinting can be restricted to certain developmental 
stages or can be tissue or promoter specific (Deltour et al., 1995; Jinno et al., 1995; Kaischeuer 
et al., 1993; DeChiara et al., 1991; Vu and Hoffman, 1994). In general, genes that are imprinted 
in mice tend to be imprinted in human as well. However, there are some exceptions to this rule, 
as will be described in chapter 3 and 5 of this thesis. 
1.2 Mechanisms in Genomic Imprinting 
After the identification of the first imprinted genes, research has been focused on the 
mechanisms involved in genomic imprinting. Multiple steps are required for the imprinting 
process. During gametogenesis, the old imprint has to be erased and a new parental specific 
mark has to be established on both alleles. The faithful propagation of the imprint during cell 
division has to be ensured and, in order to ensure parental specif gene expression, the imprint 
must either influence gene expression directly, or activate a mechanism which specifically 
activates or inactivates the corresponding allele. To meet these criteria the imprint mark has to 
be an epigenetic modification of the DNA. Until now the molecular mechanism by which a cell 
recognises a gene as paternally or maternally derived is still largely unknown and research has 
been focused on elucidating epigenetic differences between parental alleles. In this context, X 
inactivation, the process which inactivates one of the two X chromosomes in female cells, has 
been extensively studied as this process is partly subject to genomic imprinting and provides a 
good model for epigenetic differences between active and inactive DNA. 
Methylation 
To date, DNA methylation is the only known chemical modification of the DNA which is able 
to fulfill all criteria necessary for genomic imprinting. In vertebrate DNA only cytosines within a 
CpG dinucleotide can be methylated at the 5-carbon position resulting in 5-methylcytosine (5-
mC). Part of the CpG dinucleotides are clustered in so-called CpG islands surrounding the 5' 
end of many genes. In general, these CpG islands are unmethylated whereas in bulk DNA CpG 
dinucleotides are completely methylated (Antequera and Bird, 1993). In some cases, however, 
CpG islands are methylated resulting in the silencing of the corresponding genes, possibly by 
interaction with nuclear components or specific methylated DNA binding proteins such as 
MeCP1 and MeCP2 (Bird et al., 1995; Eden and Cedar, 1994; Boyes and Bird, 1992; Boyes and 
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(Villar and Pedersen, 1994, 
Riesewiik et a l , 1996) 
(Giannoukakis et a l , 1993, Ohlsson 
et a l , 1993, DeChiara et a l , 1991, 
Ferguson Smith et a l , 1991) 
(Zhang and Tycko, 1992, Zhang et 
a l , 1993, Bartolomei et al ,1991) 
(Guillemot et a l , 1995, Alders et a l , 
1997) 
(Giddmgs et a l , 1994. Haig, 1994) 
(Matsuoka et a l , 1996, Hatada et 
a l , 1996a, Hatada and Mukai, 1995) 
(Lee et a l , 1997) 
(Reed and Leff, 1994, Nakao et a l , 
1994, Cattanach et a l , 1992, Leff et 
a l , 1992) 
(Matsuura et a l , 1997, Kishmo et a l , 
1997) 
(Dittrich et a l , 1996, Wevnck et a l , 
1994) 
(Jones J in prep) (Beechey and 
Cattanach, 1997, Jong et a l , 1994) 
(Beechey and Cattanach, 1997, 
Jong et a l , 1994) 
(Sutchffeetal, 1994) 
(Sutchffe et a l , 1994) 
(MacDonald and Wevnck, 1997) 
(Kay et a l , 1993, Harrison, 1989, 
Ray et a l , 1997) 
(Kaneko Ishmo et a l , 1995, 
Riesewijk et a l , 1997, Kobayashi et 
a l , 1997) 
(Kagitani et al 1997, Dou and 
Joseph, 1996)) 
(Kuroiwa et a l , 1996, Kim et a l . 
1997) 
(Jmno et a l , 1994, Mitsuya et al, 
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(Beechey and Cattanach, 1997) 
(Williamson et a l , 1996, Wilson et 
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(Plassetal, 1996) 
(Hatada et a l , 1993, Pearsall et a l , 
1996, Hayashizaki et a l , 1994) 
(Hagiwara et a l , 1997) 
(Kaghadetal 1997) 
(Giddmgs et a l , 1994) 
Table 1, Imprinted genes in mouse and human 
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In somatic tissues, methylation patterns are clonally inherited through the strong preference 
of mammalian DNA methyltransferase (MTase) for hemimethylated DNA (Gruenbaum et a l , 
1982, Bestor and Ingram, 1983) Hence, methylation patterns are stably maintained In contrast, 
dramatic changes in the overall level of methylation are seen during early development 
Demethylation of the highly methylated zygote during the early cleavages results in a nearly 
unmethylated genome at the blastocyst stage After implantation, a wave of de novo methylation 
restores the methylation patterns of the gastrulatmg embryo to levels found in adult cells The 
primordial germ cells, however, remain unmethylated but undergo de novo methylation during 
gametogenesis which explains the high methylation levels found in zygotes (Kafri et a l , 1992, 
Monk et a l , 1987, Ariel et a l , 1994, Razm and Shemer, 1995) This implicates de novo 
methylase activity at least two stages in development, during gastrulation and during 
gametogenesis The only DNA methylase cloned to date (Dnmt) has a high affinity for 
hemimethylated DNA and therefore acts as a maintenance methylase (Bestor et a l , 1988) The 
isolation of a de novo methylase is still awaited (Lei et a l , 1996) 
All imprinted genes investigated so far in more detail contain regions which are methylated in 
a parent-of-ongin specific manner (Razm and Cedar, 1994) However, some of these 
methylation marks are acquired after fertilisation whereas a functional imprinting mark has to be 
inherited directly from the gametes Furthermore, to assure that these parentally inherited marks 
remain unaltered during development, the allele-specific methylation differences in these regions 
should be resistant to the wave of global demethylation and the de novo methylation taking 
place during embryogenesis At least three imprinted genes contain methylation marks that fulfill 
these criteria Xist and Igf2r both acquire a maternal specific methylation mark during oogenesis 
whereas H19 is specifically methylated during spermatogenesis (Stöger et a l , 1993, Tremblay et 
a l , 1995, Noms et a l , 1994, Ariel et a l , 1995) In other imprinted genes, eg Igf2, differential 
methylation arises after fertilisation and (sometimes) after silencing of the gene In these cases, 
the differential methylation is not responsible for the initial imprint recognition process but serves 
to keep the specific parental allele identifiable and/or silenced after the process of imprint 
recognition has started This resembles the situation found in X-mactivation where the 
methylation of CpG islands takes place after silencing of the corresponding genes (see below) 
Another line of evidence suggesting a key role for methylation in genomic imprinting came 
from studies in mouse embryos carrying a mutated methylase (Dnmt) gene Embryonic stem 
cells (ES) cells homozygous for a severe mutation in this gene displayed very low methylation 
levels and died upon differentiation (Li et a l , 1992) Embryos lacking a functional gene product 
did not survive past mid gestation and the expression of imprinted genes was affected H19 
became biallehcally expressed, whereas Igf2 and Igf2r became completely repressed (Li et a l , 
1993) Clearly, the maintenance of the parental specific methylation marks is required for a 
correct imprinted expression The introduction of a functional copy of the Dnmt gene in mutated 
ES cells restored global genomic methylation levels but the regions normally containing 
parentally inherited methylation differences remained unmethylated implying that either a 
specific environment or another methylase has to be present for the de novo methylation of 
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these sites Only after germlme passage these regions were remethylated according to the 
parental gender and correct imprinted expression was restored in the offspring (Tucker et a l , 
1996) 
X chromosome inactivation 
X chromosome inactivation (X inactivation) is the process by which one of the two X 
chromosomes in female cells is transcriptionally silenced to achieve dosage compensation 
between XX females and XY males In the extraembryonic lineages, which are the first cells to 
differentiate from the totipotent lineage, X inactivation is regulated by genomic imprinting and 
results in preferential inactivation of the paternal X chromosome (Takagi and Sasaki, 1975) In 
the mouse embryo proper, X inactivation starts much later, around the time of gastrulation, and 
is random with an equal chance for the maternal or the paternal X chromosome to become 
inactivated The stable transmission of the X inactivation status to all daughter cells results in a 
mosaic pattern of cells with either an active maternal or an active paternal X chromosome in 
adult female tissues There is evidence that In humans, X inactivation is regulated in a similar 
manner, with preferential inactivation of the paternal X in extraembryonic tissues and random 
inactivation in the embryo proper (Ropers et a l , 1978, Harnson, 19Θ9) 
The inactive X chromosome (Χι) is cytogenetically recognisable as the heterochromatic Ban-
body located at the border of the nucleus (Barr and Bertram, 1949) The histone molecules on Χι 
are hypoacetylated which is a characteristic for DNA in a repressed state (Jeppesen and Turner, 
1993, Keohane et a l , 1996) Moreover, Χι replicates later than its active homologue Several 
genes on Χι escape X inactivation, most notably genes located in the pseudoautosomal region 
(par) which is present on both sex chromosomes (Brown et a l , 1997, Disteche, 1995) The par 
regions on the active X (Xa) and Χι replicate early and synchronously, indicating the importance 
of early replication in gene expression On the inactive X, the CpG islands of silenced genes are 
heavily methylated, in contrast to those of active genes Methylation occurs after the initial 
silencing of the genes and is thought to be essential for proper maintenance of the inactive state 
since silenced X-lmked genes can be reactivated by demethylatmg agents such as 5 
azadeoxycytidme (Mohandas et a l , 1981) 
X inactivation requires the in as presence of the X inactivation centre (XIC/Xic) which is 
located at Xq13 in humans and at a homologous region in mice (Brown et a l , 1991b, Rastan 
and Brown, 1990) XIC is responsible for the initiation and spreading of X inactivation but not for 
its maintenance (Brown and Willard, 1994) The XIST gene (X inactive specific transcnpt), 
cloned 5 years ago, is a candidate gene for XIC as it maps to the XIC region in both human and 
mouse and is transcribed exclusively from the inactive X chromosome (Brockdorff et a l , 1991, 
Borsani et a l , 1991, Brown et a l , 1991a) The XIST gene encodes a 17 kb nuclear RNA without 
a functional open reading frame and is highly conserved between mouse and man XIST RNA 
colocalizes with the inactive X chromosome in the interphase nucleus and may play a role in 
higher level packaging of the chromatin (Clemson et a l , 1996) Xist expression precedes X-
inactivation and is necessary in as (Penny et a l , 1996) Transgenic mice carrying Xist on an 
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autosomal chromosome displayed several characteristics of X inactivation Xist loci were 
properly counted, Xist expression was induced and Xist RNA aggregated with the transgene 
chromosome Moreover, the expression of a reporter gene and several housekeeping genes 
was reduced and the transgene chromosome became late replicating and hypoacetylated (Lee 
et a l , 1996, Lee and Jaenisch, 1997, Herzing et a l , 1997) These observations demonstrate that 
neither the binding of Xist RNA nor the chromosome wide inactivation are intrinsic to the X-
chromosome and that the in as presence of the Xist gene itself is sufficient for counting, 
initiating and spreading of X inactivation 
Maternal inheritance of a deletion of the entire Xist gene resulted in normal viable and fertile 
mice whereas paternal inheritance of the same deletion was lethal in embryogenesis (Marahrens 
et a l , 1997) The earliest Xist expression starts around the 4 cell stage and is imprinted, with 
paternal specific expression, until the compacting morula stage is reached from whereon Xist 
expression becomes random (Kay et a l , 1993, Kay et a l , 1994) In embryos with two maternal 
genomes, Xist expression is delayed until the compacting morula stage whereas in androgenetic 
embryos, Xist expression starts at the 4 cell stage and is biallelic (Kay et a l , 1994) Hence 
during early development, Xist expression does not depend on the number of X chromosomes 
present but on the presence of a paternally derived, imprinted, Xist allele As cells start to 
differentiate from the totipotent state, loss of imprinted gene expression occurs and the counting 
mechanism ensures correct Xist expression depending on the X autosome ratio 
Xist expression is negatively controlled by promoter methylation (Noms et a l , 1994) A 
maternal specific methylation mark at several CpG sites at the 5' end of the gene is present in 
oocytes, but not in sperm cells, and escapes the demethylation process which takes place in the 
early embryo (Ariel et a l , 1995, Zuccotti and Monk, 1995) In male embryos homozygous for a 
severe mutation in the DNA methyl transferase gene (Dnmt), the (maternally inherited) Xist gene 
was hypomethylated and active Xist RNA associated with the only X chromosome present and 
several X linked genes were silenced (Panning and Jaenisch, 1996) These experiments 
suggest that although methylation is required for the imprinted expression of Xist, it is not 
necessary for the silencing of X-lmked genes 
Chromatin structure and replication time 
Both chromatin structure and replication time can influence gene expression Dense 
packaging of the chromatin into heterochromatm, which is condensed even during the 
interphase, is associated with gene silencing Gene inactivity is often associated with a 
decreased accessibility of the chromatin for nucleases In H19 the paternal, inactive, allele is 
more resistant to nucleases than the active maternal allele and a DNasel hypersensitive site in 
the paternal promoter region is lost (Koide et a l , 1994, Ferguson Smith et a l , 1993) Thus, 




The basic unit of chromatin packaging is the nucleosome which consist of - 200 bp of DNA 
which are wrapped twice around an octamer consisting of 4 different core historie proteins 
These histone proteins can be acetylated at lysine residues within the basic amino N-termmal 
tail domains These tails lie towards the outside of the nucleosome and hyperacetylation is 
associated with gene activity, possibly by a more open configuration of the nucleosome (Lee et 
a l , 1993, Wolffe and Pruss, 1996) Deacetylation of the histones is associated with 
heterochromatmization and gene silencing This process is evolutionary conserved in yeast and 
Drosophila, organisms that do not exhibit DNA methylation and therefore have to rely on other 
gene silencing mechanisms (Rivier and Pillus, 1994, Braunstein et a l , 1996, Hendnch and 
Willard, 1995) Recently yeast genes involved in gene silencing were shown to have acetylatmg 
activity, and a gene involved in dosage compensation in Drosophila exhibited acetylatmg activity 
as well (Reifsnyder et a l , 1996, Hilfiker et a l , 1997) 
Replication of genes occurs at a defined time interval within the cell cycle Active genes 
replicate early and inactive genes replicate late It has been suggested that transcription factors 
and proteins necessary for an open chromatin configuration are more abundant during early S 
phase and already consumed during late replication, thus providing a self regulatory mechanism 
for the repressive state of the chromatin (Riggs and Pfeifer, 1992) There are several methods to 
measure the replication time of a specific gene Fluorescence in situ hybridisation (FISH) 
analysis on interphase nuclei reveals two single hybridisation dots for cells in which the gene 
sequence has not yet replicated, and two double hybridisation dots for cells in which this region 
has already undergone replication (Selig et a l , 1992) Kitsberg et al (1993) showed that for 
imprinted genes approximately 30% of the nuclei exhibited one single hybridisation dot and one 
double hybridisation dot implying asynchronous replication For H19, IGF2, IGF2R and SNRPN 
it was always the paternal allele which replicated early, but there are also regions in the human 
genome where the maternal allele replicates early (Bickmore and Carothers, 1995, LaSalle and 
Lalande, 1995, Knoll et a l , 1994) 
FISH analysis determines replication in an indirect way whereas with BrdU incorporation 
experiments directly measure replicated DNA segments Kawame et al (1995) elegantly 
demonstrated absence of asynchronic replication for several sites within the IGF2/H19 and 
PWS/AS region For the SNRPN gene, asynchronous replication was observed in expressing 
cells, whereas in cells with low expression levels, a later replication and a lower degree of allelic 
asynchrony was observed These results indicate that the single dot / double dot pattern 
observed in the FISH experiments may reflect differences in the chromatin structure between 
the parental alleles rather than differences in replication timing Furthermore, replication timing is 
cell type specific and can depend on expression levels Treatment of cells with methylation 
inhibitors advanced the absolute replication time but did not affect the replication imprint 
whereas histone deacetylase inhibitors abolished the replication differences (Bickmore and 
Carothers, 1995) This suggest that a specific chromatin structure and differential histone 
acetylation is involved in the replication imprint 
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Clustering and imprinting centres 
Imprinted genes are not randomly distributed throughout the genome but occur in clusters At 
least two imprinted gene clusters, each containing both maternally and paternally imprinted 
genes, have been identified in the human genome The reason why imprinted genes are 
clustered remains unclear but most probably this clustering is required for the mechanism of 
imprinted gene expression and silencing 
The H19/IGF2 gene cluster resides on human chromosome 11p15 5 In total, this region 
comprises at least 6 imprinted genes, H19, HASH2, p57Wp2 and KVLQT1 are expressed from 
the maternal allele whereas IGF2 and the murine Ins gene are expressed from the paternal 
allele (Lee et a l , 1997, Zhang and Tycko, 1992, Giannoukakis et a l , 1993, Ohlsson et a l , 1993, 
Alders et a l , 1997, Hatada et a l , 1996a, Matsuoka et a l , 199Θ, Haig, 1994, Giddings et a l , 
1994) H19 and IGF2 were amongst the first imprinted genes identified and have been 
extensively studied They have a similar developmental and tissue specific expression pattern 
suggestive of a co-ordinate regulation (Lee et a l , 1990, Poirier et a l , 1991, Eversole Cire et a l , 
1995, Ohlsson et a l , 1994) In mice, H19 contains a patemal specific methylation mark in a 
region approximately 4 kb upstream from the transcription start site (Ferguson Smith et a l , 
1993, Tremblay et a l , 1995) This region is more resistant to nucleases than its maternal 
counterpart (Koide et a l , 1994, Ferguson Smith et a l , 1993) Two enhancers, necessary for the 
expression of H19 in endodermal tissues, are located 8 kb 3' of the H19 gene and do not show 
any parental specific differences Deletion of these enhancers resulted in loss of expression of 
H19 on the maternal chromosome and loss of expression of Igf2 on the paternal chromosome 
(Leighton et a l , 1995b) An enhancer competition model has been proposed in which the normal 
interaction of these enhancers with the H19 promoter is disturbed by methylation on the paternal 
allele allowing interaction with the paternal Igf2 promoter (Bartolomei et a l , 1993) This also 
explains the absence of a germhne specific methylation mark on the Igf2 gene Maternal 
inheritance of a deletion comprising the structural H19 gene and 10 kb of 5' flanking sequences 
resulted in expression of the normally silenced Igf2 allele whereas paternal inheritance had no 
effect (Leighton et a l , 1995a) The deletion of H19 also disrupted the imprinting of Ins2, which is 
expressed from the paternal allele in the visceral endoderm of the mouse yolk sac 
Another explanation for the co-ordinate expression of H19 and Igf2 could be the m cis 
requirement of H19 itself for the imprinting of genes in this cluster Both, Xist and H19 encode an 
ORF-less RNA and conservation of the primary and secondary structure of Xist and H19 argues 
for a specific function of these RNAs Similar to the role of Xist in X mactivation, H19 (RNA) 
might play a role in the imprinting of its neighbouring genes Transgenic mice carrying multiple 
copies of an H19 transgene at heterologous locations of the mouse genome displayed a correct 
imprinted methylation and expression pattern However, replacement of either the complete 
structural H19 gene or 700 bp at the 5' end of the structural gene by a luciferase reporter gene 
resulted in loss of imprinting (Pfeifer et a l , 1996) Deletions of either the 5' region involved in 
differential methylation or the 3' region containing the enhancers resulted in loss of imprinting as 
well (Elson and Bartolomei, 1997), indicating that imprinting of H19 and Igf2 relies on a complex 
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set of at least three sequence elements 
A second cluster of imprinted genes is located on chromosome 15q12 in humans and on 
chromosome 7 in mice and contains the maternally imprinted genes SNRPN, IPW, PARI, 
PAR5. NECDIN and ZNF127 and the paternally impnnted UBE3A gene (Reed and Left, 1994, 
Wevnck et a l , 1994, Sutcliffe et a l , 1994, Jong et a l , 1994, Vu and Hoffman, 1997, Rougeulle et 
a l , 1997, MacDonald and Wevnck, 1997) IPW is a non-coding RNA and the fact that genes for 
untranslated RNA's have been found in the two imprinting clusters and on the X chromosome 
implicates a specific function for these RNA's in the in cis gene silencing processes The 
SNRPN imprinting cluster is involved in two human disorders and most insight in the regulation 
of the genes in this region has been obtained through the analysis of Prader Willi and Angelman 
patients and will be discussed below 
In mice, a third imprinted gene cluster is localised on the proximal part of chromosome 17 
and contains the paternally imprinted Igf2r gene and the maternally imprinted Mas 
protooncogene (Barlow et a l , 1991, Villar and Pedersen, 1994) The Igf2r gene contains 2 
regions which exhibit parental specific methylation differences Maternal specific methylation is 
found at an mtronic CpG island and a paternal specific methylation at the promoter associated 
CpG island (Stöger et a l , 1993) Only the maternal specific methylation is inherited directly from 
the oocyte and survives the demethylation wave in the early embryo The paternal methylation 
pattern is established after fertilisation and silencing of the gene (Stöger et a l , 1993, Lerchner 
and Barlow, 1997) The human IGF2R gene maps to chromosome 6q25 and we and others 
have previously shown that, surprisingly, this gene is not subjected to genomic imprinting 
(Kalscheuer et a l , 1993, Ogawa et a l , 1993) At that time IGF2R was the only gene which was 
imprinted in mice but not in man Therefore, this observation offered an unique opportunity to 
search for structural differences between these two genes and to identify sequences that are 
important for the imprinting process Chapter 3 of this thesis gives a detailed analysis of the 
human IGF2R gene The identification of both paternal and maternal uniparental disomy patients 
(UPD, see below) for chromosome 6 ((Welch et a l , 1990, Abramowicz et a l , 1994) and chapter 
2) has facilitated the identification of parental-specific differences within the IGF2R gene 
Although not imprinted, the mtronic CpG island and its maternal specific methylation are 
conserved in human Furthermore, asynchronic replication of this gene has been reported 
(Kitsberg et a l , 1993) Xu et al suggested that IGF2R imprinting in man is a polymorphic trait 
based on their observation that 3 out of 14 fetuses studied showed complete or partial 
repression of the paternal allele (Xu et a l , 1993) To investigate this intriguing possibility, we re-
examined these 3 fetuses and demonstrated monoallehc expression for one of them A detailed 
analysis of the sequence and methylation status of this fetus, however, did not provide any 
evidence for the involvement of genomic imprinting in the silencing of the paternal allele (chapter 
4) The Mas protooncogene, the second gene in the Igf2r imprinting cluster, is expressed from 
the paternal allele in day 11 to 12 5 embryos (Villar and Pedersen, 1994) We have isolated the 
human MAS gene, demonstrated that it maps to chromosome 6q25 and that it is closely linked 
to IGF2R in humans as well Expression analysis revealed that, like IGF2R, the MAS gene is not 
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imprinted in humans (chapter 5) Since clustered imprinted genes seem to be controlled by 
regional cis acting factors we suggest that these factors might be lost or defunct in the human 
IGF2R/MAS region 
1.3 Imprinting in human diseases 
Uniparental Disomy 
Uni parental disomy (UPD) is characterised by the presence of two homologous 
chromosomes derived from one parent, and the absence of that chromosome from the other 
parent, in a normal disomic cell The analysis of UPD patients is very important for the 
identification of imprinted regions in the human genome The primary cause of UPD in humans 
is a meiotic nondisjunction event followed by trisomy or monosomy rescue (Ledbetter and Engel, 
1995) In addition, Robertsonian translocations and other structural abnormalities increase the 
risk for UPD (Robinson et a l , 1994) Depending on the mechanism and the timing of the 
nondisjunction, either isodisomy (two identical chromosomes) or heterodisomy (two different 
chromosomes from the same parent) can occur 
There are several mechanisms through which UPD can contribute to human diseases 
Effects of trisomy for a certain chromosome on fetus and placenta have been described 
Confined placental mosaicism is found in approximately 1 % of all CVS performed for advanced 
maternal age and is associated with a higher risk for abortion and intrauterine growth 
retardation (IUGR) (Desnick et a l , 1992, Wilkins Haug et a l , 1995, Wapner et a l , 1992) In 
isodisomy cases, homozygocity for recessive mutations may lead to disease Indeed, UPD in 
humans was first detected upon molecular analysis of a patient with Cystic Fibrosis who turned 
out to be isodisomic for chromosome 7 (Spence et a l , 19Θ8) UPD for chromosome 9 has been 
found in patients with cartilage-hair syndrome in the Finnish population (Suhsalo et a l , 1997) 
Since patients with mUPD9, but without this syndrome have been described, the presence of a 
homozygous recessive mutation in the Finnish patients most likely explains these findings 
Another important mechanism which can lead to abnormalities in UPD patients is the 
misexpression of imprinted genes When a chromosome harbours imprinted genes, UPD will 
result In either a double dose or non-expression of these genes which may result in a specific 
phenotype Only when UPD for a given chromosome is consistently associated with a specific 
abnormal phenotype, the possibility of recessive mutations and/or trisomy effects can be 
excluded (for review see (Ledbetter and Engel, 1995)) 
Until now there are 4 chromosomes for which such a consistent phenotype has been 
described Maternal disomy for chromosome 15 results in Angelman syndrome and paternal 
disomy for this chromosome is associated with Prader-Willi syndrome (Nicholls et a l , 1989, 
Malcolm et a l , 1991) Furthermore, paternal disomy for chromosome 11 is associated with the 
Beckwith-Wiedemann syndrome (Henry et a l , 1991) and maternal disomy for chromosome 7 is 
involved in the Silver-Russell syndrome (Preece et a l , 1997, Kotzot et a l , 1995) Finally, mUPD 
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for chromosome 14 is associated with precocious puberty and short statue (Temple et a l , 1991) 
Another imprinting effect is visible in patients with Turner Syndrome (XO) whose sole X 
chromosome can be either paternally or maternally derived Recent research revealed a 
difference in social cognition between XpO and XmO Turner patients (McGuffin and Scourfield, 
1997, Skuse et a l , 1997) For the other chromosomes an influence of UPD is either not present 
or not clear, mostly because there are not enough cases identified Based on the homology 
between mouse and man, imprinting effects might be expected for chromosome 6 The 
homologous region on mouse chromosome 17 contains at least two imprinted genes, Igf2r and 
the Mas protooncogene However, only one case of mUPD6 has been identified (see chapter 2) 
and of the 4 pUPD6 patients described to date only two have transient neonatal diabetes 
mellitus (Abramowicz et a l , 1994, Welch et a l , 1990, Temple et a l , 1995) Moreover, both 
IGF2R and the MAS protooncogene were shown not to be imprinted in humans ((Kaischeuer et 
a l , 1993) and chapter 5, this thesis) indicating that imprinting is not always conserved between 
human and mouse 
Prader-Willi syndrome and Angelman syndrome 
Angelman syndrome (AS) and Prader-Willi syndrome (PWS) are two different disorders 
resulting from a functional loss through deletion or uniparental disomy of the maternally or 
paternally derived 15q11-q13 segment, respectively In this region several imprinted genes have 
been identified and some of them exhibit a parental-specific methylation pattern which is of 
diagnostic value (Kubota et a l , 1996, Zeschnigk et a l , 1997) 
Approximately 70 % of the PWS patients have a cytogenetically visible deletion, -27 % are 
mUPD and -3 % have a maternal-specific methylation pattern but no deletion or UPD In this 
last category, the disease is caused by a defect in the resetting of the imprinting mark that 
results in maternal imprinting pattern on the paternally inherited allele (Sutcliffe et a l , 1994) 
Imprinting defects are also found in a small portion of AS patients (-2%) who have inherited a 
paternal methylation pattern on the maternal alleles The major part (-70%) of AS is caused by 
the 15q11-q13 deletion but in contrast to PWS, pUPD 15 accounts only for a small percentages 
of the AS cases (-3%), and -25 % of the patients have a normal biparental methylation pattern 
(Nicholls, 1993, Wagstaff et a l , 1992) This latter observation suggests that, a single maternally 
expressed gene might be responsible for the AS phenotype, and the recent finding that AS 
patients have mutations in the UBE3A gene supports this speculation (Matsuura et a l , 1997, 
Kishino et a l , 1997, Donion, 1997) Previously the UBE3A gene had been excluded as a 
candidate gene because of its biallelic expression in lymphoblastoid cells and its expression in 
AS patients with deletions, but the results of mutation analysis were unambigious, revealing 
frameshift, nonsense and missense mutations in non-deletion, non-UPD and non-imprinting AS 
patients More recent data indicate that this gene is maternally expressed only in specific regions 
of the brain in both mice and man (Rougelle et a l , 1997, Vu and Hoffman, 1997, Albrecht et a l , 
1997) 
Detailed investigation of PWS and AS patients with imprinting defects revealed the presence 
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of microdeletions in and upstream of SNRPN These deletions disrupt an imprinting centre (1С) 
which is necessary in as for the correct resetting of the parental imprints (Sutcliffe et a l , 1994, 
Buiting et a l , 1995, Saitoh et a l , 1996) PWS patients have deletions including at least the first 
exon of SNRPN and extending further downstream whereas the deletions of AS patients lie 
upstream of SNRPN In this upstream region, Dittrich et al (1996) detected alternative exons of 
SNRPN called BD exons The BD transcripts skip exon 1 but include SNRPN exon 2, they do 
not contain any long open reading frame and are transcribed from the paternal allele only AS 
patients lacking these BD exons have a paternal specific methylation pattern on their maternal 
alleles, hence the activity of these BD transcripts is necessary for paternal to maternal imprinting 
switching during oogenesis Analysis of a BD deletion family showed that these transcripts are 
not required for maternal to paternal switching 
In PWS patients the deletion of exon 1 of SNRPN Is involved in the maternal to paternal 
Imprint switch Dittrich et al (1996) proposed a model in which exon 1 of SNRPN is an imprint 
initiation site composed of a nucleation centre for heterochromatm assembly and disassembly 
In the female germline, the paternal BD transcript acts in cis upon this initiation site together with 
a female germline specific factor and this starts the heterochromatmization (ι e the maternal 
imprint) of this region In the male germline the maternal to paternal switch is accomplished 
through erasure of the maternal imprint starting from the initiation site, resulting in the formation 
of a euchromatic chromatin structure Deletions of SNRPN exon 1 delete the initiation site and 
so prevent euchromatimzation in the male germline This model also explains why BD deletions 
have no influence on maternal to paternal switching as this process solely depends on the 
presence, in cis, of a functional initiation site, e g SNRPN exon 1 In contrast, paternal to 
maternal switching requires both, a functional BD transcript and a functional initiation site This 
model elegantly incorporates all the known facts concerning PWS/AS imprinting but it is difficult 
to test, and it is not known whether this scheme applies to other imprinting regions as well 
Interestingly, imprinting defects have been observed in the Beckwith-Wiedemann syndrome, too 
(see below), suggesting that there might also be an imprinting centre on chromosome 11 
Beckwith-Wiedemann syndrome 
The Beckwith-Wiedemann syndrome (BWS) is a fetal overgrowth disorder associated with a 
high risk for certain childhood tumours, most commonly Wilms Tumour (WT) Most BWS cases 
are sporadic but analysis of familial cases (15%) localised the syndrome to chromosome 11p15 
(Ping et a l , 1989, Koufos et a l , 1989) Chromosomal abnormalities of the 11p15 region are 
present in a small proportion of the patients and whereas duplications are always paternally 
derived, translocations and inversions are always maternally derived (Mannens et a l , 1994) 
Moreover, mosaicism for paternal UPD for 11 p15 occurs in -20 % of the sporadic BWS patients, 
arguing for the involvement of imprinted gene(s) in the aetiology of this syndrome (Henry et a l , 
1993, Henry et a l , 1991, for review, see Weksberg and Squire, 1996) 
Multiple genes are thought to be involved in BWS, which could explain the variable presence 
and seventy of the different symptoms involved in the disease As mentioned above (see 1 2) 
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chromosome 11p15 5 contains several imprinted genes which are all candidates for BWS Most 
of the sporadic BWS cases, and also patients with non-syndromic overgrowth, express IGF2 
biallehcally (Reik et a l , 1995, Brown et a l , 1996, Morison et a l , 1996) The blallelic expression 
can be associated with silencing of H19 and the adaptation of a paternal methylation profile on 
both parental chromosomes (5-10%) resembling imprinting defects in PWS/AS However, in 
most cases normal methylation patterns are preserved and H19 expression seems unaffected 
Until now, no mutations have been found in the patients with imprinting defects The normal 
methylation patterns, monoallelic H19 expression and biallehc IGF2 expression suggest that H19 
is not the sole regulator of IGF2 imprinting The function of H19 remains unclear but it might play 
a role as a tumour suppressor gene (Hao et a l , 1993), and matemal specific loss of the 11p15 
region is observed in many of the tumours associated with BWS (see below) 
Breakpoints in BWS translocation and inversion patients are clustered in two regions on 
chromosome 11p15, BWSCR1 approximately 400 kb proximal to IGF2 and BWSCR2 proximal 
to HBBC (Mannens et a l , 1994, Mannens et a l , 1996) In familial cases with chromosomal 
rearrangements, maternal but not paternal transmission of the balanced translocation resulted in 
BWS implying that the translocation interferes with the imprint-marking process during 
oogenesis (Reeve, 1996, Norman et a l , 1992, Pueschel and Padre Mendoza, 19Θ4) In a 
BWSCR1 translocation patient maternal-specific hypomethylation was detected on the INS/IGF2 
genes (Mannens et a l , 1994) Furthermore, biallehc expression of IGF2 in another BWSCR1 
breakpoint patient was demonstrated with normal methylation patterns and normal monoallelic 
expression of H19 (Brown et a l , 1996) Recently, a potassium channel gene, KVLQT1, was 
identified within the BWSCR1 cluster (Lee et a l , 1997) KVLQT1, is involved in both a dominant 
form of a familial cardiac defect, the long QT syndrome and the Jervell and Lange-Nielsen 
cardioauditory syndrome, a recessive disease characterised by congenital bilateral deafness 
associated with a QT prolongation (Wang et a l , 1996, Neyroud et a l , 1997) Genomic imprinting 
is not involved in these syndromes and the disruption of KVLQT1 by all BWSCR1 breakpoints 
implies yet another function for this gene KVLQT1 is maternally expressed in most tissues with 
the exception of heart were biallehc expression is found There are 4 isoforms of KVLQT1 
depending on the use of alternative 5' exons Isoform 2 is most abundantly expressed in heart 
whereas isoform 1 is expressed in many tissues (Lee et a l , 1997) It is attractive to propose that 
isoform 2 is biallehcally expressed and is responsible for the LQT syndromes whereas isoform 1 
is paternally imprinted and could have a function in BWS (Mannens and Wílde, 1997, Barlow, 
1997) The two other isoforms of KVLQT1 contain no open reading frame These ORFIess 
RNAs could play a role in the establishment of the IGF2 imprint since translocations disrupting 
KVLQT1 are associated with biallehc IGF2 expression (Brown et a l , 1996) It would be of 
interest to see whether the patients with a normal karyotype, normal methylation patterns, 
biallehc IGF2 and normal H19 expression have mutations in KVLQT1 
Yet another gene in this region, p57klp2, is involved in BWS Mutations in this maternally 
expressed gene, which maps approximately 80 kb distal to BWSCR1, were identified in 2 of 9 
sporadic BWS patients (Hatada et a l , 1996b) Ρ571""2 belongs to the family of cychn-dependent 
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kinase inhibitors which are regulators of cell proliferation Recently a knockout mice for this gene 
was produced which shows several, but not all of the features also present in BWS such as 
omphalocele, skeletal abnormalities and adrenomegaly (Yan et a l , 1997, Zhang et a l , 1997) 
Clearly p57klp2 is involved in BWS but it is unlikely to be the sole determinant The lack, or 
overexpression of at least 4 different impnnted genes, IGF2. H19, KVLQT1 and p57k*2 seems to 
play a role and as yet, clear-cut phenotype-genotype correlations could not be established 
Silver-Russell syndrome 
Silver-Russell syndrome (SRS) is characterised by an intrauterine and postnatal growth 
retardation Most of the cases are sporadic, but both recessive and dominant transmission have 
been reported and until now the molecular basis of this disorder is unknown (Duncan et a l , 
1990, Al Fifi et a l , 1996, Teebi. 1992) Genetic heterogeneity appears to be involved in the SRS 
since two cases with severe SRS and a balanced translocation breakpoint in 17q25 have been 
descnbed, as well as several patients with chromosome 15 abnormalities and one patient with 
Silver-Russell syndrome-like features and an interstitial deletion of 8q11-q13 (Ramirez Dueñas 
et a l , 1992, Midro et a l , 1993, Schinzel et a l , 1994, Tamura et a l , 1993) Moreover, patients 
with mUPD7 show growth retardation (Langlois et a l , 1995, Spotila et a l , 1992, Voss et a l , 
1989) and in 1995 Kotzot et al demonstrated that mUPD7 occurs in approximately 10% of 
sporadic Silver Russell patients This was confirmed by Preece et al (1997) and Eggermann et 
al (1997) and suggests that one or more imprinted gene(s) on chromosome 7 play a role in the 
aetiology of SRS The only patient with pUPD7 identified to date, who had been ascertained 
originally because she had a recessive disorder, congenital chloride diarrhoea, is of normal 
stature (Höglund et a l , 1994) Moreover, uniparental isodisomy for paternal 7p and maternal 7q 
has been described in a patient with postnatal growth retardation (Eggerdmg et a l , 1994) These 
observations suggest that a paternally expressed gene on the long arm of chromosome 7 is 
involved in growth control 
The Paternally Expressed Gene 1, also called Mesodermal Specific Transcript, 
(PEG1/MEST) is the only imprinted gene identified on chromosome 7 (see chapter 6 and 
Kobayashi et a l , 1997) The function of this maternally imprinted gene is as yet unknown 
although amino acid homology to the α/β hydrolase family is found A maternal-specific 
methylation mark was identified involving a CpG island at the 5' end of the gene (chapter 6) 
PEG 1/MEST maps to chromosome 7q32 and the murine homologue, Peg1/Mest, is located on a 
homologous position on chromosome 6 B1 (Kaneko Ishino et a l , 1995) An imprinting effect had 
already been established for this region in mice and maternal disomy is lethal in embryogenesis 
(Beechey and Cattanach, 1997, Beechey and Cattanach, 1989) Recently a Peg1/Mest knock 
out mouse was produced and paternal inheritance of the knock-out allele resulted in viable but 
small embryos (L Lefebre and M A Surani, unpublished data, personal commutication to V 
Kalscheuer) 
The paternal specific expression, the localisation of PEG1/MEST to the long arm of 
chromosome 7 and the phenotype of the knock-out mice all point towards a role of PEG1/MEST 
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in SRS SSCP and sequence analysis, however, did not detect mutations in the coding and 
promoter region of PEG1/MEST in 49 SRS patients (chapter 7) Moreover, the parental-specific 
methylated region exhibited a normal methylation pattern with a hypomethylated paternal and a 
hypermethylated maternal allele in all patients tested These results suggest that another, yet 
unidentified, paternally expressed gene on 7q is responsible for SRS and growth retardation 
Genomic imprinting in tumongenesis 
Genomic imprinting can be either directly or indirectly involved in tumongenesis In 
paragangliomas, or glomus tumours (PGL) the involvement is a direct one Glomus tumours are 
rare, mostly benign tumours of the head and neck region In familial cases the disease shows a 
dominant pattern of inheritance, but tumours develop only upon paternal transmission of the 
PGL gene (van der Mey et a l , 1989) Linkage analysis revealed the presence of two loci on 
chromosome 11 involved in PGL, 11q13 and 11q22-q23 (Heutmk et a l , 1992, van Schothorst et 
a l , 1996, Manman et a l , 1993, Manman et a l , 1995) Most likely, the PGL gene is a tumour 
suppressor gene and the presence of two maternally imprinted genes with similar functions has 
been postulated (Manman et a l , 1995) Both active copies have to be mutated before tumor 
formation can occur, in agreement with Knudsons two hit hypothesis for tumour suppressor 
genes (Manman et a l , 1995, Knudson, 1986) Loss of the maternal copy of the 11q22-q23 
region has been described in sporadic PGL cases, suggesting the presence of a maternally 
active tumor suppressor gene (Devilee et a l , 1994) So this region seems to contain at least one 
paternally and one maternally active gene in agreement with the proposed clustering of 
imprinted genes in the human genome 
Altered expression of imprinted genes in several tumours provided evidence for a more 
indirect role of imprinted genes in tumongenesis The majority of WTs investigated lacked H19 
expression and showed an increased IGF2 expression due to either specific loss of the maternal 
11p15 region with paternal duplication or to loss of imprinting (LOI) resulting in a bipaternal 
epigenotype (Moulton et a l , 1994, Taniguchi et a l , 1995, Steenman et a l , 1994) In other 
tumours such as rhabdomyosarcoma, hepatoblastoma and lung, bladder, ovary and breast 
cancers loss of maternal 11p15 and/or LOI has been observed as well (Glassman et a l , 1996 
and references therein) In general, the methylation level in tumour cells is altered affecting not 
only imprinted gene expression but also silencing tumorsuppressor genes by promoter 
methylation Treatment of several tumour cells with a demethylatmg agent restored normal, 
imprinted expression of both H19 and IGF2 (Barletta et a l , 1997) The p57klp2 gene, located on 
chromosome 11p15 and recently shown to be paternally imprinted, is also aberrantly expressed 
in some but not all of the WTs and rhabdomyosarcomas with LOI (Kondo et a l , 1996) When 
affected, its expression is linked to the expression level of H19 but reactivation of H19 
expression through demethylatmg agents does not increase p57klp2 expression (Chung et a l , 
1996) Both H19 and P571""2 are thought to be tumour suppressor genes IGF2, on the contrary, 
is a growth promoting gene and its expression plays an important role in a oncogene-induced 
model for tumongenesis (Chnstofon et a l , 1994) In conclusion, both, LOI and the maternal loss 
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of 11p15 found in many tumours, decrease the expression of two maternally expressed putative 
tumor suppressor genes and increase the expression of a paternally expressed growth 
promoting gene Most likely the whole imprinted gene cluster on 11p15 plays a role in 
tumongenesis and the effect of the individual genes remains to be elucidated 
In all testicular cancers tested and in 1 out of 3 informative bladder cancers, biallelic 
expression of IPW, a paternally expressed non-coding RNA located in the PWS/AS region on 
chromosome 15, was found indicating that LOI is not restricted to the 11p15 region and might be 
a common phenomenon in tumongenesis (Rachmilewitz et a l , 1996) 
1.4 The scope of this thesis 
The general aim of this study was to better understand genomic imprinting and its function in 
the human genome In order to obtain more information about sequences or other features 
important for imprinted gene expression, and the involvement of these genes in human 
diseases, we identified human homologues of imprinted murine genes and performed detailed 
sequence and methylation analyses 
In chapter 1, the background of genomic imprinting and its involvement in human disorders 
is reviewed Chapter 2 describes the identification of a patient with maternal uniparental disomy 
for chromosome 6 The existence of uniparental disomy patients greatly facilitates the 
identification of regions containing imprinted genes and/or parental specific differences This 
mUPD6 patient was used in our study of the IGF2R gene which maps to chromosome 6q25 
Previously, we demonstrated that although this gene is imprinted in mice it is not imprinted in 
humans and thus provides a model system to look for regions or sequences important for 
imprinted gene expression In chapter 3 a detailed analysis of the human IGF2R gene is 
presented Similar to the murine Igf2r gene, we identified two CpG islands within the human 
IGF2R gene, one surrounding the promoter region and one in intron 2 Parental-specific 
methylation differences were identified in this second CpG island Polymorphic imprinting of the 
IGF2R gene had been suggested by Xu et al based on their observation that 3 out of 14 
informative fetuses showed complete or partial repression of the paternal IGF2R gene We have 
confirmed monoallelic IGF2R expression for one fetus To elucidate the underlying molecular 
mechanism we performed a detailed sequence and methylation analysis (chapter 4) After the 
identification of the murine Mas proto-oncogene as an imprinted gene which is closely linked to 
Igf2r we set out to isolate the human homologue and to identify its imprinting status This is 
described in chapter 5 where we show that like IGF2R the MAS gene is not imprinted in 
humans This suggests that a regional control on imprinted gene expression in the human 
IGF2R gene cluster is lost or defunct 
In order to identify new imprinted genes in the human genome we isolated the human 
homologue of Peg1/Mest, a new imprinted gene identified in the mouse by a subtraction 
hybridisation technique between parthenogenetic and normal stage-matched control embryos 
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The human PEG1/MEST gene maps to chromosome 7q32, and after the identification of an 
single base insertion/deletion polymorphism we could show that this gene is imprinted in 
humans as well (chapter 6). Again by making use of uniparental disomy patients foi 
chromosome 7 we could identify a maternal specific methylation mark at the 5' end of the 
PEG1/MEST gene. Patients with mUPD7 are affected by the Silver-Russell syndrome, a growth 
retardation disorder, indicating that an imprinted gene on chromosome 7 is involved in this 
disease. Because of its localisation to 7q32, its paternal-specific expression and the phenotype 
of a Peg 1/Mest knock-out mouse, PEG1/MEST is the candidate gene for this disorder. Chaptei 
7 deals with our search for methylation and/or sequence mutations in 49 sporadic SRS patients 
and 9 Primordial Growth Retardation (PGR) patients who were not affected by mUPD7. Mosl 
surprisingly we could not identify a mutation which suggests that yet another imprinted gene on 
chromosome 7 is involved in growth retardation and SRS. 
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H LA analysis of the family of a renal transplant patient revealed an extremely rare condition 
On repeated typings the only demonstrable HLA antigens shown in the propositus were from the 
maternal haplotype, HLA-A11,-B46,-Cw1,-DR14,-DQ1 No paternal antigens could be 
demonstrated neither by serological nor by DNA-typmg methods A paternity investigation was 
carried out to exclude the possibility of the legal father not being the biological father The results 
of this investigation showed a paternity index I = >20000 and a fatherhood probability W = > 
99 995% Karyotyping of the patient showed two normal chromosomes 6 and no other 
chromosomal abnormalities Maternal isodisomy was demonstrated from the analysis of 
polymorphic DNA markers, involving the short as well as the long arm of chromosome 6 
These data are consistent with this patient having the first uniparental maternal disomy 6 
reported (inheritance of two identical chromosome 6 haplotypes from the mother and none from 
the father) 
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Introduction 
Uniparental disomy 6 is an extremely rare condition, until now recognized only a few times It 
is defined as the inheritance of both copies of genetic material from one parent and can be 
divided according to the underlying mechanism into isodisomy and heterodisomy In isodisomy 
both copies are derived from the same chromosome and in heterodisomy one parental 
chromosome pair is present (1) 
Welch et al (2) described a case of uniparental isodisomy 6 from paternal origin, associated 
with the complete absence of the fourth component of human complement (C4) In a second 
case described by Abramowicz et al (3) the isodisomy 6 was also paternal in origin Here a 
newborn showed methylmalonic acidemia and agenesis of pancreatic beta cells causing insulin 
dependent diabetes mellitus 
Patients that are candidates for a renal transplant are typed for their HLA-A. -B, -C, -DR and -
DQ antigens Family investigations are routinely earned out in our center to confimi HLA 
antigens and establish haplotypes in the patients Over 700 family studies have been performed 
during the last ten years Irregulanties in the inheritance patterns have been shown but could 
always be attributed to a recombmational event or exclusion of paternity of the legal father In 
one of the families studied no paternal antigens could be shown in the patient despite the use of 
different typing techniques To investigate the origin of this finding the present study was 
performed and the first uniparental maternal disomy 6 was demonstrated 
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Materials and methods 
Patient 
Patient MO is a male bom in 1955 from mixed racial background The mother is of mixed 
Indonesian origin and the father is black Surinam He visited our outpatient clinic for the intake 
procedure as candidate for a cadaveric kidney graft During pregnancy his mother observed 
growth retardation compared to earlier pregnancies Blood pressure was normal, no other 
investigations were done Delivery occurred after "40 weeks of gestation His body weight 
amounted 1500 gr, the other siblings had body weights at delivery between 4 and 4 5 kg He 
was nursed at home According to his mother his physical and mental development were 
comparable to those of the other children The fact that he always remained smaller than the 
other siblings was the only difference noticed The diagnosis of sarcoidosis was made in 1979 
Because of hypercalcaemia and hepatosplenomegaly steroids were given A renal biopsy was 
performed in 1986, which showed atypical findings such as diffuse sclerosis of the glomeruli and 
signs of chronic tubulo-interstitial nephritis That same year CAPD was started because of renal 
insufficiency Physical examination only showed abnormalities compatible with the diagnosis of 
renal insufficiency No contraindications for grafting were found and he was successfully 
transplanted with a cadaveric graft in 1990 The clinical case was complicated by urinary 
leakage with secondary urinary tract infections Furthermore he developed hypercalcemia due 
to persistent hyperparathyroidism, hypertension, posttransplant erythrocytosis and hyperlipemia 
These complications could be treated successfully and at a recent outpatient visit the following 
data were obtained blood pressure 100/70 mmHg, serum creatinine 103 Mol/I, creatinine 
clearance 70 ml/mm and slight proteinuria He has three healthy children 
HLA-typing 
Family investigation of the patient was performed by H LA typing 10 family members in three 
generations (figure 1 ) 
Serological H LA typing was performed by standard microcytotoxicity assays for both class I 
and class II antigens Class I typing was routinely carried out for 21 A-, 50 B- and 10 C-locus 
antigens Class II typing detected DR1 through 1Θ, DR51-53 and DQ1 through 9 
DNA-typmg was performed using a combined low resolution high resolution PCR-SSP 
method (4) Two subsequent PCR-reactions were performed, the first determined the low 
resolution HLA-DRB1 typing ι e the serologically defined specificities DR1-16 In this first 
reaction the second exon of the DRB1 gene was also amplified The exon-2 product from the 
first reaction was used as DNA template in the second PCR reaction, which identified the 
subtypes of the different DRB1 alleles In this way 75 different DRB1 alleles can be 
distinguished 
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Paternity investigation 
Enzymatic digestion, electrophoresis and hybridization: Human genomic DNA samples of the 
parents and child 11-5 of family case MO were digested with the restriction enzyme Hinf I at a 
concentration of 10 U/:g DNA, according to the manufacturer's specifications. The separation of 
the DNA fragments was performed by 0.7% agarose gel electrophoresis. After denaturation and 
neutralization, DNA was transferred to a nylon membrane (5-9). For the detection of probe-
specific fragments, alkaline phosphatase labelled probes were used (10,11). The probes used 
for the analysis of four VNTR based DNA-polymorphisms were MS1, MS31, MS43a (Cellmark, 
UK) and YNH24 (Promega, USA). The size of the fragments detected with each probe were 
calculated by measuring the mobility relative to that of DNA fragments of known size 
(Gibco/BRL) using a digitizing tablet (12). 
Paternity was further investigated by studying eleven microsatellite markers: D1S158 (1q24-
qter), GLUT2 (3q26.2-q27), D5S392 (5p15.3), CTFR (7q31-q32), D8S201 (8pter-p23.1), 
D11S439 (11q24-q25), D11S554 (11p12-p11.2), D11S876 (11q14.1-q23.3), D12S78 (12q14.4-
qter), GABRB3 (15q11.2-q12) and D15S87 (15q25-q26.3). PCR amplification was performed 
with locus-specific primers (Genome DataBase, Isogen biosciences, The Netherlands) under the 
conditions described by Weber and May (14) in the presence of 32p-dCTP. Allelic fragments 
were separated on standard 6.6% denaturing Polyacrylamide gels. After electrophoresis, gels 
were dried and exposed to Kodak X-omat S film overnight to visualize the allelic bands. For all 
markers the segregation of alleles was consistent with I-2 being the father of II-5 (figure 2). 
The polymorphisms used are independant and located on different chromosomes. They can 
be considered as codominant systems with multiple alleles. For the calculation of paternity 
indices or likelihood ratio's the Essen-Moller version of the probability of paternity was used as a 
function of the measurement error of the fragment size (13,14). 
Genetic analysis 
Standard G-banding was performed on chromosomes from peripheral blood lymphocytes of 
the patient according to standard procedures. To confirm uniparental disomy, genomic DNA 
from the mother (1-1), the father (II-2) and from the patient (II-5) was used for the analysis of 
various polymorphic markers from chromosome 6. The analysis involved PCR amplification and 





Four different haplotypes were demonstrated for the mother (1-1 ) and the father (I-2) (figure 
1). The maternal haplotypes were HLA-A11,B46,Cw1,DR14,DQ1 and 
A203,B7x40,Cw7,DR15,DQ1. HLA-B7x40 is a very rare HLA antigen also known as DT (15) 
with no official WHO nomenclature up to now. The paternal haplotypes were HLA-
A11,B27,Cw10,DR12,DQ7 and A26,B44,C-,DR7,DQ2. All haplotypes segregated in the family. 
In the propositus II-5 only one parental HLA haplotype was detected. The patients HLA type was 
HLA A11,B46,Cw1,DR14,DQ1. HLA typing was performed on blood samples of different 
bleeding dates and typing was repeated in another laboratory to exclude the possibility of typing 
errors. None the less only antigens from the maternal haplotype were demonstrated in the 
patient. The patient was placed on the transplant waiting list with only the HLA antigens from the 
maternal haplotype. From one of the siblings (II-3) no material could be obtained and therefore 
HLA typing was not possible. 
After DNA-typing was introduced in our laboratory family MO was studied again. Typing was 
performed at the DNA level by means of the PCR-SSP method (4). The patient was typed as 
HLA-DRB1*1401, DRB3*0202. Also by the use of DNA methodology no paternal HLA 
chromosomal information could be demonstrated. The segregating maternal haplotypes are (a) 
DRB1*1401,DRB3*0202, (b) DRB1*1501,DRB5*0101, the paternal haplotypes are (c) 
DRB1*1202,DRB3*0301, (d) DRB1*0701,DRB4*0101. 
Paternity investigation 
At first the possibility was considered that the father's paternity was disputable. Paternity 
investigation was carried out using DNA polymorphisms. Based on the results of the four 
polymorphisms tested, the father (I-2) could not be excluded from paternity of the affected child 
II-5 (table 1). The size of the restriction fragments as revealed by Hinf-1 digestion and probing 
with MS1, MS31, MS43a and YNH24 is shown. The most probable inherited paternal fragments 
have been marked. 
By combining the results of the four DNA polymorphisms a paternity index >20.000 and a 
fatherhood probability W = >99.995% was obtained. Therefore the putative father is virtually 
proven the biological father of the child, provided a close relative of this man is not a possible 
father. 
Paternity was further confirmed by the analysis of eleven microsatellite markers: D1S158 
(1q24-qter), GLUT2 (3q26.2-q27), D5S392 (5p15.3), CTFR (7q31-q32), D8S201 (8pter-p23.1), 
D11S439 (11q24-q25), D11S554 (11p12-p11.2), D11S876 (11q14.1-q23.3), D12S78 (12q14.4-
qter), GABRB3 (15q11.2-q12) and D15S87 (15q25-q26.3). 
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Figure 1: Serological typing of HLA antigens in family MO 
The patient (II-5) is indicated by shading HLA class I and II antigens are given by their official 
WHO nomenclature An oblique line indicates that an individual was not tested HLA haplotypes 
are given in lower case letters The maternal haplotypes are a A11,B46,Cw1,DR14,DR52,DQ1 
andb A203,B7x40,Cw7,DR15,DR51,DQ1 
The paternal haplotypes are с A11,B27,Cw10,DR12,DR52,DQ7 
and d A26,B44,C-,DR7,DQ2. 
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Genetic analysis of chromosome 6 markers 
Cytogenetic studies of peripheral lymphocytes showed the presence of two normal 
chromosomes 6 without any sign of a microdeletion in the Major Histocompatibility Complex 
(MHC) area. DNA from the patient (11-5) and his parents (1-1 and I-2) was tested with ten 
microsatellite markers selected from various locations along the chromosome. The genotypes 
are depicted in Table 2. The data obtained with markers D6S89, D6S257 (fig 2), D6S251, 
D6S87 and D6S281 are explained by maternal isodisomy 6 in patient II-5. For the other 5 
markers the genotype of II-5 was in keeping with this phenomenon. The patient was found to be 
homozygous for all markers, whereas the mother was heterozygous for six markers. These data 
are consistent with maternal isodisomy of chromosome 6. 
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Genotypes of mother (1-1), father (I-2) and patient (II-5) were determined for ten highly 
polymorphic markers from chromosome 6. The patient was shown homozygous for all markers. 
38 
MUPD6 IN A RENAL TRANSPLANT PATIENT 
Figure 2: Marker investigation in family MO 
Examples of the use of microsatellite markers (A) to investigate paternity (D11S554) and (B) to 
demonstrate unimaternal isodisomy of chromosome 6 in patient II-5 (D6S257). 
A В 
D11S554 D6S257 









Most cases of homozygosity for a complete HLA haplotype are seen in the offspring of 
consanguineous matmgs or in children from parents carrying common HLA haplotypes The 
extreme polymorphism of the different HLA loci makes the occurrence of homozygosity for a 
complete haplotype less likely 
In this renal transplant patient we demonstrated the presence of only one HLA haplotype 
Therefore he was considered to be a HLA homozygote From segregation studies in the family it 
became clear that the haplotype was of maternal ongm and that none of the expected paternal 
antigens could be detected The parents were not related and showed clearly distinguishable 
HLA haplotypes The patient earned a common oriental HLA haplotype (A11 ,B46,Cw1 ) and 
therefore could very well be the offspring of a consanguineous mating 
To exclude the possibility that the legal father was not the biological father, a paternity 
investigation was carried out by studying 4 DNA polymorphisms However, the results of the 
paternity tests clearly showed that the putative father was virtually proven the biological father 
since the paternity index (I) was >20 000 and the fatherhood probability (W) was 99 995% 
Moreover, true paternity was corroborated by the analysis of eleven highly polymorphic CA-
repeat markers 
Another possible explanation for the lack of paternal antigens might be non-expression 
Although non-expression for HLA antigens has been described (17) this is a rare event and has 
never been reported to involve a whole haplotype In his study Lardy et al (17) showed a case in 
which no HLA product could be demonstrated by serological means However, when studying 
the genetic HLA-mformation by DNA techniques the specific allele for the expected antigen 
could be clearly demonstrated In our patient DNA typing revealed the complete absence of 
paternal HLA information 
Uniparental disomy means that an individual, showing no visible chromosomal abnormalities, 
possesses two copies of a particular pair originating from one parent The explanation for this is 
the high frequency with which non-disjunction can occur Simultaneous non-disjunctional events 
in maternal or paternal germ cells producing opposite abnormalities for the gametes involved in 
fertilization, can produce this type of abnormality Another possibility is that the individual with 
uniparental disomy was originally tnsomic and lost the copy from one parent very soon after 
fertilization Based on the number of different parental chromosomes involved, uniparental 
disomy can be divided in isodisomy or heterodisomy HLA typing together with the results of the 
analysis of various CA-repeat markers showed that our patient represents a case of isodisomy 
The fact that he is homozygous for all genetic markers tested further substantiates this finding 
Together the markers cover about 90% of the length of chromosome 6 
Cases of uniparental disomy affecting different chromosomes have been described in 
association with disease (1 ) Uniparental disomy 6 is until now only reported twice (2,3) In both 
cases the disomy was paternal in origin In our case the disomy is of maternal origin 
It is interesting to note that Hejtmancik et al (18) reported a patient with congenital 21-
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hydroxylase deficiency due to a new deletion mutation A complete deletion of the MHC without 
any cytogenetically visible deletion was mentioned Although the authors provide a different 
explanation, this case is very suggestive of maternal isodisomy (19, 20) 
Uniparental disomy can cause disease when genes on the involved chromsome are subject 
to genomic imprinting (21,22) Genomic imprinting is the phenomenon that the expression of a 
gene depends on the parental origin (23) Also, it has been shown that uniparental disomy can 
give rise to recessive diseases (24,25) Both patients reported with paternal disomy 6 showed 
recessive diseases, the first was C4 deficient and the second suffered from methylmalonic 
acidemia Apart from sarcoidosis and renal insufficiency our patient showed no differences in 
physical or mental development compared to his siblings His three children are healthy The 
only difference observed between the patient and the other sibs is the marked difference in birth 




We are grateful to family MO for their kind cooperation in providing blood and information We 
thank Edwin Manman for cntically reading the manuscript, Vera Kalscheuer and Marga 
Schepens for the analysis of the genetic markers, Christine de Die-Smulders for her advice and 
Diana van Bakel for excellent secretarial assistance 
REFERENCES 
1 Engel E Uniparental disomy revisited the first twelve years Am J Med Genet 46 670, 1993 
2 Welch TR, Beischel LS Choi E, Balaknshnan K, Bishof NA Uniparental isodisomy 6 associated 
with deficiency of the fourth component of complement J Clin Invest 86 675,1990 
3 Abramowicz MJ, Andnen M, Dupont E, Dorchy H, Parma J, Durpez L, Ledley FD, Courtens W, 
Vamos E Isodisomy of chromosome 6 in a newborn with methylmalonic acidemia and agenesis 
of pancreatic beta cells causing diabetes mellitus J Clin Invest 94 41Θ, 1994 
4 Savelkoul PHM De Bruyn-Geraets DP, Van den Berg-Loonen PM High Resolution HLA-DRB1 
SSP-typing for cadavenc donor transplantation Tissue Antigens, (In press) 1994 
5 Baird M, Balazs I, Giusti A, Miyazaki L, Nicholas L, Wexler K, Kanter E, Glassberg J, Allen F, 
Rubinstein Ρ, Sussman L Allele frequence distribution of two highly polymorphic DNA 
sequences in three ethnic groups and its application to the determination of paternity Am J Hum 
Genet 39 489, 1986 
6 Kanter E, Baird M, Shaler Ρ, Balazs I Analysis of restriction fragment length polymorphisms in 
DNA recovered from dried blood stains J Forensic Sci 31 403,1986 
7 Balazs I, Baird M, Clyne M, Meade E Human population genetic studies of five hypervanable 
DNA loci Am J Hum Genet 44 182,1989 
β Maniatis T, Fntsch EF, Sambrook J Molecular Cloning a Laboratory Manual New York, Cold 
Spnng Harbor Laboratory, Cold spnng Harbor, 1982 
9 Southern EM Detection of specific sequences among DNA fragments separated by gel 
electrophoresis J Mol Biol 98 503, 1975 
10 Dimo Simonin Ν, Brandt-Casadevall С, Guijer Η-R Evaluation and usefulness in forensic cases 
Forensic Science International 57 119, 1992 
11 Baird M, Galbreath L, Cunningham R, Castella J, Balazs I Use of chemilumlnescent labelled 
probes for forensic and paternity determination In Bär W, Fiori A, Rossi U (eds) 
Advances in Forensic Haemogenetics 5 Berlin, Heidelberg, Spnnger-Verlag, 1986 
12 Finney DJ Statistical Method in Biological Assay, 3rd edn, 
13 Charles Gnffing and Company Ltd 316,1978 
13 Essen-Möller E Die Beweiskraft der Ähnlichkeit in Vaterschaftsnachweis 
Mitt Antropol Ges 68 9, 1936 
14 Gjertson MR, Mickey DW, Hopfield J, Takenouchi T, Terasaki PI Calculation of probability of 
paternity using DNA sequences Am J Hum Genet 43 860,1988 
15 Weber JL, May PE An abundant class of human DNA polymorphisms which can be typed using 
the polymerase chain reaction Am J Hum Genet 44 388, 1989 
16 Stewart D, Lane JTL DT A new HLA-B locus antigen Chicago, Ninth Annual Meeting, Amanean 
Association for Clinical Histocompatibility Testing (Abstr), 1983 
42 
MUPD6 IN A RENAL TRANSPLANT PATIENT 
17. Lardy NM, Bakas RM, Van der Horst AR, Van Twuyver E, Bontrop RE, De Waal LP: CIS-acting 
regulatory elements abrogate allele-specific HLA class I gene expression In healthy individuals. 
Jlmmunol148 2572, 1992. 
18. Hejtrnancik JF, Black S, Harris S, Ward PA, Callaway C, Ledbetter D, Moms J, Leech SH, 
Pollack MS Congenital 21-hydroxylase deficiency as a new deletion mutation detection In a 
proband during subsequent prenatal diagnosis by HLA typing and DNA analysis. 
Hum Immunol 35.246,1992. 
19. Welch TR. Beischel LS: Letters to the Editor. Hum Immunol 37195,1993. 
20. Hejtrnancik JF, Pollack MS: Response to the Editor Hum Immunol 37.196,1993. 
21. Mascan MJ, Gottlieb W, Rogan PK, Butler MG, Waller DA, Armour JAL, Jeffreys AJ, Ladda RL, 
Nicholls RD The frequency of uniparental disomy in Prader-Willi syndrome 
New Engl J Med 326 1599,1992. 
22. Barlow DP Imprinting, a gamete's point of view.T I G 10:194,1994. 
23 Kaischeuer VM, Manman EC, Schepens MT, Render H, Ropers HH The insulin-like growth 
factor type-2 receptor gene is imprinted in the mouse but not in humans 
Nature Genet 5 74,1992. 
24. Spence JE, Perciaccante RG, Greig GM, Willard HF, Ledbetter DH, Hejtrnancik JF, Pollack MS, 
O'Bnen WE, Beaudet AL' Uniparental disomy as a mechanism for human genetic disease. 
Am J Hum Genet 42 217,1988 
25 Voss R, Ben-Simon E, Avital A, Godfrey S, Zlotogora J, Dagan J, Tikochmski Y, Hille J' 
Isodisomy of chromosome 7 in a patient with cystic fibrosis could uniparental disomy be 




Maternal-Specific Methylation of the Human IGF2R Gene 
Is Not Accompanied by Allele-Specific Transcription 
Anne M. Riesewijk, Marga T. Schepens, Thomas R. Welch, Ella M. van den Berg-Loonen, 
Edwin M. Mariman, Hans-Hilger Ropers and Vera M. Kalscheuer 
Genomics 31,158-166 (1996) 




Maternal-Specific Methylation of the Human IGF2R Gene Is Not 
Accompanied by Allele-Specific Transcription 
A N N E M. RIESEWIJK,* M A R G A T. SCHEPENS,* T H O M A S R. W E L C H . T ELLA M . V A N DEN BERG-LOONEN,* 
E D W I N M . M A R I M A N , * HANS-HILGER ROPERS,*§ A N D VERA M . KALSCHEUER§·1 
'Department of Human Genetics, University Hospital Nijmegen, Nijmegen, The Netherlands, ^Department of Pediatrics, University 
Children's Hospital, Cincinnati, Ohio 45229, tTissue Typing Laboratory, University Hospital Maastricht, Maastricht, The Netherlands, 
and %Max-Planck-lnstitut fur Molekulare Genetik, Ihnestrasse 73, D-14195 Berlin (Dahlem), Germany 
Received May 18, 1995, accepted October 25, 1995 
The human insulin-like growth factor type 2 recep­
tor gene (IGF2R) is biallelically expressed in a variety 
of fetal and adult tissues. In contrast, the imprinted 
mouse Igf2r gene is expressed exclusively from the ma­
ternally inherited chromosome. The mouse gene con­
tains two CpG islands that are methylated in a parent-
specific manner. Methylation of the CpG island in the 
promoter region occurs on the repressed paternal 
gene copy. Methylation of the CpG island in intron 2 
is specific for the active maternal allele and may repre­
sent the primary imprint. Here, we have analyzed the 
human IGF2R gene to investigate whether these motifs 
and their parent-of-origin-specific epigenetic modifi­
cation have been conserved. As in the mouse, the hu­
man IGF2R gene was found to contain two CpG is­
lands, one encompassing the transcription start site 
(CpG 1) and the other in the second intron (CpG 2). 
CpG 2 is hypermethylated on the maternal IGF2R al­
lele. In contrast to the situation in the mouse, however, 
the human CpG 1 is completely unmethylated on both 
parental chromosomes. The human and mouse in-
tronic CpG islands lack significant sequence homol­
ogy, which suggests that DNA conformation plays a 
role in allele-specific methylation. о IDM Academic P I « inc. 
INTRODUCTION 
In mammals, certain genes show parent-specific ex­
pression in the embryo and in the adult because pater­
nal and maternal genomes are differentially modified, 
or imprinted, during male and female gametogenesis. 
Aberrant imprinting of genes or the deviation of both 
homologous chromosomes from one parent (uniparen­
tal disomy) can be the cause of genetic disorders (Hall, 
1990a,b; Clarke, 1990) and may also play a role in carci­
nogenesis (Wilkins, 1988; Sapienza, 1991, 1992; Reik, 
1 To whom correspondence should be addressed Telephone. +49-
30-8413-1293 Fax +49-30-8413-1383. E-mail kalscheuer@mpimg-
berhn-dahlem mpg de 
1992; Feinberg, 1993; Mariman et al., 1995). At pres­
ent, the nature of the primary imprint and the molecu­
lar basis by which genes are recognized as paternally 
or maternally derived are still unknown. First evidence 
that methylation plays an important role in genomic 
imprinting came from the observation that many 
transgenes become hypomethylated after passage 
through the male germline and hypermethylated after 
passage through the female germline (Surani et al., 
1988). Analysis of four imprinted genes in the mouse, 
H19 (Bartolomei et al., 1993; Ferguson-Smith et al., 
1993; Brandeis et ai, 1993; Feil et al., 1994), insulin­
like growth factor II (/g/2) (Sasaki et al., 1992; Bran­
deis et al., 1993; Feil et al., 1994), Igf2 receptor 'Igf2r) 
(Stoger et al, 1993), and U2afl-rsl (SP2) (Hatada et 
al., 1995), has revealed that regions within the gene 
or adjacent to it are methylated in a parent-specific 
manner. The mouse Igf2r gene is expressed exclusively 
from the maternally inherited chromosome in fetal and 
adult tissues (Barlow et al., 1991), with the exception 
of the head and the brain, where biallelic expression 
has been observed (Villar and Pedersen, 1994). During 
preimplantation development, both maternal and pa­
ternal Igf2r alleles are expressed (Latham et al., 1994; 
Szabó and Mann, 1995), indicating that silencing of the 
paternal allele is a secondary event. Characterization 
of the mouse Igf2r gene revealed the existence of two 
distinct CpG islands that show parental-origin-specific 
methylation differences. The first CpG island that in-
cludes the promoter (region 1) is methylated on the 
repressed paternal allele, whereas the intronic CpG 
island 27 kb downstream of the promoter (region 2) 
is methylated on the expressed maternal allele. The 
paternal-specific methylation pattern of region 1 is ac-
quired after fertilization and is unchanged in the adult. 
Methylation of region 2 is inherited through the female 
gamete and is maintained during preimplantation de-
velopment (Stoger et al., 1993). Therefore, it is thought 
to represent the primary imprinting signal. On the un-
methylated paternal allele, this region may act as a 
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powerful "gene silencer" by binding an inhibitory factor 
(Stogerei al, 1993, Barlow, 1994) This model is sup­
ported by the recent finding that in the absence of DNA 
methylation, the otherwise active maternal Igf2r gene 
is repressed (Li et al, 1993) 
We (Kaischeuer et al, 1993) and others (Ogawa et 
al, 1993) have recently shown that in contrast to the 
murine gene, the human IGF2R gene is expressed from 
both parental alleles in first and second trimester fe­
tuses, although in a minority of individuals monoallehc 
expression of the maternal allele has been reported (Xu 
et al, 1993) This raises the question whether differen­
tial imprinting in humans and mice is due to methyla­
tion differences As reported here, we have isolated the 
human IGF2R gene, identified two intragenic CpG is­
lands, and found that one of these, but not the other, 
shows parent-specific methylation differences 
MATERIALS AND METHODS 
YAC characterization and cosmid mapping Screening of the ICI 
human YAC library was performed by PCR with pnmcr pairs goner 
atcd from the 5' and 3 ends of the human IGF2R cDNA sequence 
(Morgan et αι. 1987) (5' UTR 16-1 AGTCGAGCCGCGCTCACCT, 
16-2 CTGCACAGCTCGGGGAACG, 3' UTR 16 3 AATCATGGG 
CCAGAGCCTCG, 16 4 GTTGAAATCAAACAAGCCAGCCA) One 
clone was positive for both sets of primers and was further analyzed 
Yeast cultures were grown in selective synthetic medium lacking 
tryptophan and uracil High-molecular-weight yeast DNA was pre 
pared in agarose plugs using standard protocols (Mueller and Wold, 
19Θ9) For long-range restriction mapping, single and double diges 
tions were performed on the plugs with enzymes cutting infrequently 
in human DNA and analyzed by pulsed field gel electrophoresis 
DNA fragments were separated in 1 5% agarose with running condì 
tions at 150 V, 16°C for 3Θ h and transferred overnight by capillary 
blotting to GeneScreen Plus membranes To visualize the specific 
YAC fragments, the filter was hybridized sequentially with probes 
generated from YAC nght and left insert ends 5' and 3' PCR frag­
ments, and total human DNA Chimensm of the clone was excluded 
by FISH analysis on human metaphase chromosomes exactly as de 
scribed (Sunkerbuijk et al, 1993) 
To establish a cosmid library, YAC DNA was isolated according to 
Green and Olson (1990) and partially digested with Sau3A (New 
England Biolabs) Fragments were size fractionated by centrifuga 
tion through a sucrose gradient for 17 h, 22,000 rpm at 18°C Size 
fractionated DNA of 30-45 kb (0 5 ¿ig) was ligated into 1 pg of 
BamHI digested SuperCos 1 vector (Stratagene) for 16 h at 16°C 
Cosmid DNA was packaged using the Gigapack RII Gold packaging 
extract (Stratagene) Six thousand cosmid clones were screened with 
total human DNA, and 68 clones containing human DNA were grid-
ded on GeneScreen Plus membranes and used for cosmid walking 
experiments Hybridization and washing procedures were as de 
sen bed elsewhere (Sa m brook et al, 1989) End clones of the human 
YAC insert were isolated by ligation mediated PCR according to 
Mueller and Wold (1989) These probes, as well as the 5' and 3 ' PCR 
products amplified from genomic DNA, were used as starting points 
for cosmid walking and for generating the cosmid contig 
DNA sequence analysis EcoBl fragments of cosmid C12 were 
subcloned into plasmid Bluescnpt or plasmid pT7T3 From these, 
clones containing CpG 1 and CpG 2 were further subcloned and 
sequenced using T3 and T7 primers and several CpG 1- or CpG 2 
specific primers Sequencing was performed using the T7 sequencing 
kit (Pharmacia), the Taq DyeDeoxy terminator cycle sequencing kit 
(Applied Biosystems), and the Taq track sequencing kit (Promega) 
in combination with terminal transferase as described by DeShazer 
et al (1994) Homology analyses were performed using the program 
FASTA, and sequences were aligned using the programs BESTFIT 
and GAP CpG observed/expected ratios and С + G richness were 
calculated according to Gardiner Garden and Frommer ( 1987), using 
the program CpGplot 
Oligo hybridization Filters were prehybndized for at least 1 h 
at 50"C in 5x SSPE/0 3% SDS Oligonucleotides (exon 1, ATGCGA 
GCCGCGCTCACCT, exon 2, CATGGGAAGCTGTTGATACC, exon 
3, CAACAGTGAGCTGTGACCAGCA, exon 4, ACTTTGAGTGGA-
GGACCACTGC, exon 5, TGAGGAAGCATGATCTCAATCC, 3' UTR, 
AATCATGGGCCAGAGCCTCG) were phosphorylated using T4 poly­
nucleotide kinase (Gibco BRL) and [y 12PJATP and purified using 
Sephadex G50 (Pharmacia) Hybridization was for 3 h at 50°C under 
standard conditions (Sambrook et al 1989) Filters were washed 
once with 2x SSC and twice with 5x SSPE/0 Л9с SDS at 50°C 
Methylation analysis with restriction enzymes Twenty micro 
grams of genomic DNA derived from blood, liver, and placenta was 
digested with 100 U tfmdIII (Gibco BRL) according to the manufac 
turer s recommendations, extracted once with phenol/chloroform and 
once with chloroform, and precipitated with ethanol The DNAs were 
divided into two portions and digested for 3 h with 50 U of either 
Hpall or Mspl (Gibco BRL), followed by a digestion with another 50 
U of the respective enzyme The DNAs were then phenol extracted 
as described above and redigested with 50 U of Яра 11 or Mspl for 3 
h For comparison of genomic and cosmid DNA digestion patterns, 
10 pg genomic DNA and 1 pg cosmid DNA were digested with 50 or 
5 U Htndlll, respectively After phenol extraction the DNAs were 
digested with methylation sensitive enzymes íBssHII, Noti Nrul, 
Pvul, Sal I, Smal, and Xhol, Gibco BRL or New England Biolabs) as 
described above Finally the DNAs were ethanol precipitated and 
electrophoresed on a 1 to 1 5% agarose gel, transferred on a Gene-
Screen membrane and hybndized with a 4 1 kb H indili fragment 
comprising CpG 1 and a 3 kb Hindlll fragment specific for CpG 2 
Hybridization was performed at 65°C with random-primed labeled 
probes (Feinberg and Vogelstem, 1984) Filters were washed at 65*C 
with 2x SSC/0 1% SDS (15 min), l x SSC/0 1% SDS (15 mm), and 
0 l x SSC/0 1% SDS (two times, each 15 min) successively Autora-
diograms were exposed for 2 h to 2 weeks 
Bisulfite modification, PCR amplification, and sequencing Geno 
mie DNA (10 ^g) and cloned DNA (2 /ig) were first digested with 
Hindlll and then alkaline denatured in 0 3 N NaOH for 15 mm at 
37°C Treatment with sodium bisulfite was essentially as described 
by Clarke/ al (1994) Modified DNAs were desalted and concentrated 
using GencClean (BiolOl), ethanol precipitated, and resuepended in 
110 p\ lOOmMTns-HCKpHeO), ImAfEDTA An aliquot of bisul-
fite modified DNA was amplified by PCR under the following condì 
tions initial denaturation for 5 mm at 95°C, 1 mm at 94°C, 2 min 
at 63°C, and 3 mm at 72°C, for 35 cycles and then 6 mm at 72°C 
An aliquot was then ream ρ lined using one additional internal 
pnmer CpGl 16 34CCCAATCRAACCRCRCTCACCTCRAACTCC 
CRCT (944-977), 16 35 TTGTATAGTTYGGGGAAYGGGGYGGTT-
TGGGTTT (1237-1204), 16-36 CRCRATTCCRAAACCRCCRCT-
ACCRCTATCRCTAT (902-936), 16 48 AAAAAATCTAAAAAACTC 
TAACRGAACCAAAATTA (436-469), 16-49 GYGATTGTTGGGGGT 
YGTYGTTYGGGAYGGGGTYG (1043-1009» 16-50 RAACAATTA 
AAATATATTCCCACCCCCCACRAATC (494-528), 16-52 GGAATA 
AAGTAAATTGAGTTTTTGTTTTTAATTT (1609-1576), 16 51 TAA-
AACCCRCRCCCRCCCRCCRCCCRCAACRCTC (1121-1154), 16 53 
TACTCCTACTACAACTACTACTACTCRTCRCTAC (1157-1190) 
CpG 2 16-37 TTITATTTGATTGGATTTTGGATTTTGTTATGTG 
(401-435), 16 38 AAAATAACCCAACCRCACRACCACRCTAAC-
RACC (940-907), 16 39 TATTTTAGTTrYGTTTTTTAGTTTAGY-
GTTTAGG (447-480), 16-40 GAGTTTITITGGGTTTTTTGTATT 
TTTTTATGTT(1189-1222),I6 41 AAACRACAAAACATACAAAAT 
ACAAAAAAACRCRA (1549 1584), 16 42 TAYGATTTTTAGGTT 
TTTYGYGTTTTTTTAGGGAT (1226-1259) 16 37, 16 39, 16-44 
AAACTCRAAAAACCAAAAAAACRCRAAAAACTAC (1194-1161), 
16 45 TAATCTATAAATTAACACATAACTCACTATACRT (2156-
2123), 16 46 ATCTTTYGTGTGYGTTGTTGTGTTTTAYGYGTT 
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FIG. 1. The human IGF2R locus (A) A YAC containing the complete IGF2R gene (solid bar) is shown at the top The minimal cosmid 
contig encompasses six cosmids (B) Cosmid C12, which contains the 5' part of the gene including both CpG islands, is depicted in detail 
(1510-1142), 16-47 ACCATAAACTCRAAATAATAACTAATCCAA-
TCCC (2122-2089), 16 41, 16 54 GGTTTTTGATATAGAGGGGTT-
ATTTTATGTGTGA (1012-1045), 16 55 RCATAAAACACRAAA-
AATACCRAATAATACAAA (1446-1478) 
The resulting PCR fragments were phosphorylated using T4 poly­
nucleotide kinase and hgatcd into the Smal digested plasmid vector 
pT7T3 19U (Pharmacia) Individual clones were bequenced using the 
T7 sequencing kit (Pharmacia) 
RESULTS 
Isolation of a YAC Clone Containing the Human 
IGF2R Gene 
To isolate a YAC clone containing the complete hu­
man IGF2R gene, we first generated STS primers using 
the published cDNA sequence of Morgan et al (1987) 
These primers, amplifying 290 bp of the 5'-untrans-
lated region (UTR) and 324 bp οΓ the 3 ' end of the 
IGF2R gene, were used to screen the human ICI YAC 
library by PCR Three clones were isolated, one of 
which turned out to contain a human insert of 215 
kb comprising the complete IGF2R gene As expected, 
FISH analysis on human metaphase chromosomes 
showed a hybridization signal at the telomenc region 
of the long arm of chromosome 6 (6q26) (not shown) 
Single and double digestions of YAC DNA with re­
striction enzymes that cut infrequently in human DNA 
(BssHII, Noti, Sal I, Mlul, and Sfi I), followed by pulsed-
field gel electrophoresis and Southern hybridization 
with human DNA, yielded the long-range restriction 
map shown in Fig 1A In a second step, a cosmid li­
brary was established, and a complete cosmid contig 
was constructed Oligonucleotide hybridizations of 
exon 1 and the 3 ' UTR to Southern blots of EcoKl-
digested C12 and B12 cosmids enabled us to estimate 
the length of the gene as 140 kb and to determine its 
position within the YAC (Fig 1A) 
Two CpG Islands Are Present in the Human 
IGF2R Gene 
An 8 5-kb £coRI fragment containing the 5' part of 
the IGF2R gene was subcloned and partially se­
quenced Sequence analysis comprised a 1 6-kb frag­
ment centered around exon 1 and revealed the exis­
tence of a CpG island (Figs. IB and 2A) This CpG 
island, termed CpG 1, spans the putative promoter re­
gion and extends into intron 1 The size of the pro­
moter-associated CpG islands of the human and mouse 
IGF2R genes is conserved Three E-box-hke sequences 
and several Spi boxes but no TATA or CAAT boxes 
were found in the region of 700 bp immediately up­
stream to exon 1 (not shown) Sequence comparison of 
the 5' end of the human and mouse IGF2R genes re­
vealed 71% homology between positions -700 and 
+455 bp of the human gene and positions -656 and 
+346 bp of the mouse gene (Accession Nos X91875 and 
L06445) A similar degree of homology was found when 
the promoter region, exon 1, and intron 1 were ana­
lyzed separately 
Long-range restriction mapping revealed the pres­
ence of recognition sites for Л/οίΙ and BssHII in a small 
region downstream from exon 2 A 6-kb Eco RI fragment 
of cosmid С12 (Fig IB) was subcloned, and sequence 







FIG. 2. Plots showing the G + С density (broken line) and CpG content (solid line) per 100 bp for a region of 1 8 kb encompassing CpG 
1 (A) and a region of 3 kb encompassing CpG 2 (B) The data are expressed as the observed number of CpGs per 100 bp over the expected 
number of CpGs per 100 bp The diagrams display that CpG 1 and CpG 2 contain core sequences of approximately 1 and 1 3 kb, respectively, 
that are more than 70% G + С Ν, JVoíI, В, BssHII 
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firmed the presence of a second 1.3-kb-long CpG island, 
termed CpG 2 (Fig. 2B). Following successive hybrid-
izations of oligonucleotides specific for exons 1-4 to 
Southern blots of £coRI-digested С12 DNA, we were 
able to localize CpG 2 within intron 2. Comparison of 
CpG 2 and region 2 of the mouse Igßr gene with the 
program BESTFIT displayed sequence homology of 
71% for a small segment of 38 bp starting at position 
1457 in the sequenced DNA fragment, including CpG 
2 and 1002 in region 2 (Accession Nos. X91880 and 
L06446). Analysis for repetitive elements within CpG 
2 showed four different tandem, direct repeats of 36,38, 
22, and 17 bp, respectively, with an overall homology of 
>70% (Fig. 5C), as well as a number of inverted repeats 
(not shown). 
Despite the slightly different distances between CpG 
1 and CpG 2 (i.e., 27 kb in the mouse versus 40 kb in 
humans), the positions of these CpG islands within the 
gene have been conserved. 
Methylation Analysis of CpG 1 and 2 
In the mouse Igßr gene, partial methylation of CpG 
sites in regions 1 and 2 has been found by Southern blot 
analyses of genomic DNA digested with methylation-
sensitive restriction enzymes (Stöger et al., 1993). To 
investigate methylation of the human gene, a 4.1-kb 
i fmdl l l fragment comprising CpG 1 (probe 1, Fig. ЗА) 
and a 3.0-kb Hindlll fragment specific for CpG 2 (probe 
2, Fig. 4A) were used for Southern analyses of Mspl- or 
ffpall-digested human DNA isolated from peripheral 
blood. Following predigestion with Hindl l l , hybridiza­
tion of Mspl-digested control DNA with probe 1 re­
vealed fragments of 1.8 and/or 1.7 kb (due to an Mspl 
polymorphism), 0.8, and 0.4 kb (Fig. 3B, lane 1). Be­
cause of their small size, several other fragments could 
not be detected. 
In ДраІІ-digested control DNA, the same probe 
showed one prominently hybridizing fragment of 2.6 
kb (Fig. 3B, lane 2), suggesting that the two Mspl/ 
Hpall sites in intron 1, marked by M* in Fig. ЗА, are 
methylated, while other sites in this region are not. 
Fragments of 0.4 kb could be visualized only after 
longer exposure time (not shown). 
The same Southern blot was used for methylation 
analysis of CpG 2. Mspl digestion yielded bands at 2.1 
and 0.4 kb (Fig. 4, lane 1) as well as several smaller 
fragments (not shown). Ηρα I I-digested control DNA re­
sulted in a similar banding pattern, but in addition, 
one prominent fragment of 3.0 kb was present (Fig. 4, 
lane 2), indicating that all Mspl restriction sites of this 
fragment that carry CpG 2 are resistant to digestion. 
Therefore, some of the DNA appears to be completely 
methylated at all Mspl recognition sites in CpG 2. Com­
parison of the methylation pattern of DNA isolated 
from peripheral blood, liver, and placenta all gave the 
same results (not shown). As an extension of this ap­
proach, other methylation-sensitive restriction en-
H M M M M M 
probe 1 
+ Hindlll 
FIG. 3. Methylation analysis of CpG 1. (A) The 4.1-kb ЯшсШІ 
(H) hybridization probe (probe 1) is shown, including CpG 1 and 
surrounding Mspl and/or Hpall (M) sites; the asterisks refer to two 
Hpall sites. CpG 1 contains 22 Mspl sites that are not depicted here. 
The order of 0.8, 1.8, and 1.7 + 0.1 kb fragments is not exactly 
determined. (B) Southern blot analysis of control DNA, paternal, 
and maternal UPD DNA, digested with rYiíídlII and Mspl or Hpall, 
after hybridization with the 4.1-kb Hiitdlll fragment (probe 1) en-
compassing CpG 1. Weak signals at 3.0 and 2.1 kb are due to incom-
plete removal of the CpG 2 probe, which was applied first (Fig. 4). 
zymes (BssHII,Noti,Nrul,Pvul, Sail, Smal, andXhol) 
were employed to compare restriction patterns in (po-
tentially methylated) chromosomal DNA and (unmeth-
ylated) DNA from cosmids spanning CpG 1 and CpG 
2, respectively. For CpG 1, banding patterns were iden-
tical in native and cloned DNA, which indicates that 
the respective CpGs are unmethylated in the genome. 
In contrast, a BssHII and a Noti restriction site in 
CpG2 were found to be partially methylated (not 
shown). 
To study parental-allele-specific methylation in CpG 





methylated on maternal chromosomes, since in Hpall-
digested DNA from the patient with maternal UPD, 
this 3.0-kb band is the only signal present (Fig. 4B, 
lane 6). Our results clearly demonstrate that the region 
comprising CpG 2 is methylated in a parent-specific 
manner. 
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FIG. 4. Methylation analysis of CpG2. (A) The 3.0-kb Hindlll 
hybridization probe (probe 2) is shown. Vertical bars indicate Mspl/ 
Hpall recognition sites; Hindlll (H), Noti (Ν), and BssHII (B) are 
also depicted. (B) Southern blot of control, paternal, and maternal 
UPD DNA. after digestion with Hindlll and Mspl or Hpall and 
hybridization with probe 2. 
viously described patients with uniparental disomy 
(UPD), one with unipaternal disomy and the other with 
unimaternal disomy for chromosome 6 (Welch et al., 
1990; van den Berg-Loonen et al, submitted for publi­
cation). 
DNA from both patients was digested with Hindlll 
and Mspl or Hpall, and Southern blots were hybridized 
successively to probes 1 and 2. For probe 1, the same 
banding pattern as in control DNA was seen (Fig. 3B, 
lane 3), indicating that the MspllHpall sites in intron 
1 (M*) are methylated on both parental chromosomes. 
It is noteworthy that hybridization of probe 2 to Hpall-
digested paternal UPD DNA showed a 3.0-kb band that 
is much fainter than that seen in control DNA (Fig. 
4B, lane 4). This suggests that only very few paternal 
chromosomes are methylated at all MspllHpall sites 
in CpG 2. On the other hand, all of these sites must be 
CpG 1 Is Completely Unmethylated on Both Parental 
IGF2R Alleles, and CpG 2 Is Methylated in a 
Parent-Specific Manner 
Since the above findings apply only to CpGs of partic­
ular restriction sites, the genomic sequencing tech­
nique developed by Frommer et al. (1992) was em­
ployed to determine the overall degree of methylation 
in both CpG islands. In this method, sodium bisulfite 
quantitatively converts unmethylated cytosine to ura­
cil. This chemical modification is the basis for a PCR-
based assay in which only methylated cytosines yield 
positive signals in DNA sequence ladders. After chemi­
cal modification, PCR fragments were cloned and se­
quenced. Analyses were performed on DNA from nor­
mal controls, including those isolated from fetal tissues 
with proven biallelic expression and from the patients 
with paternal and maternal uniparental disomy. In ad­
dition, cloned DNA was modified and used as a control 
to assess the efficiency and fidelity of the bisulfite reac­
tion and PCR amplifications. In all cases, our results 
showed that CpG 1 is hypomethylated on both parental 
chromosomes. Of the 138 CpGs in the promoter-associ­
ated CpG island, not a single one was methylated (not 
shown). In agreement with our previous restriction en­
zyme analysis, CpG 2 was found to be modified by 
methylation in a parent-specific manner. DNA clones 
derived from maternal UPD DNA were methylated in 
most CpGs, while those derived from paternal DNA 
were hypomethylated. Methylation patterns of individ­
ual clones from (non-UPD) control DNA showed a clear 
dichotomy, i.e., either almost complete methylation or 
methylation of only a few cytosine residues. Examples 
are shown in Figs. 5A and 5B. The methylation status 
of three independent clones from paternal and mater­
nal UPD DNA is given in Fig. 5C. 
Thus, our results clearly demonstrate that CpG 1 
of the human IGF2R gene is unmethylated on both 
parental alleles and that CpG 2 is modified in a parent-
of-origin-specific manner, with the maternal locus be­
ing hypermethylated and the paternal locus being hy­
pomethylated. 
DISCUSSION 
We have previously shown that in contrast to the 
mouse, the human IGF2R gene is equally expressed 
from both paternal and maternal alleles in various tis­
sues of first and second trimester fetuses, and this has 
since been confirmed in several additional cases. Fur­
thermore, both unimaternal and unipaternal disomy 
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for the human IGF2R gene does not give rise to specific 
symptoms (Welch et al, 1990; van den Berg-Loonen et 
al., submitted for publication). Biallelic expression of 
human IGF2R in various tissues was also shown by 
Ogawa et al. (1993) and Xu et al. (1993). However, in 
lung and placenta of two fetuses, Xu et al. found that 
transcription was exclusively maternal, suggesting 
that in a small proportion of the human population 
the IGF2R gene may be monoallelically expressed. The 
expression pattern of the human IGF2R gene at earlier 
stages of development is still unknown. In the mouse, 
both maternal and paternal Igf2r alleles are expressed 
during preimplantation development (Latham et al., 
1994; Szabó and Mann, 1995), indicating that in this 
species, monoallelic expression is due to secondary in-
activation of one lgf2r gene copy. Along these lines, 
biallelic expression of the human IGF2R gene might 
result from failing repression of the paternal allele. 
There is ample evidence that parental allele-specific 
methylation plays a crucial role in genomic imprinting. 
The mouse Igf2 gene is hypermethylated on the ex-
pressed paternal allele (Sasaki et al., 1992; Brandeis 
et al., 1993; Feil et al., 1994), and this methylation is 
required for expression (Li et al., 1993). The closely 
linked and reciprocally imprinted mouse H19 gene is 
methylated specifically on the repressed paternal chro-
mosome (Bartolomei et al., 1993; Ferguson-Smith et al., 
1993; Brandeis et al., 1993; Feil et al., 1994). In addi-
tion, tissue-specific methylation, directly proportional 
to the transcriptional levels, was found (Feil et al., 
1994). Analogous to the situation in the mouse, allelic 
methylation differences are also present in the human 
IGF2 and H19 genes (Reik et al., 1994; Zhang et al., 
1993). One of the best studied imprinted genes in the 
mouse is the lgf2r gene. Two CpG-rich regions of the 
mouse lgf2r gene are modified by methylation in a par-
en t-of-origin-specific manner. Region 1, which contains 
the promoter, is methylated specifically on the re-
pressed paternal allele. Methylation takes place during 
late development, probably after transcriptional re-
pression of the gene. In the gametes and in early em-
bryos, this region is unmethylated. In contrast, a sec-
ond CpG island within intron 2 is specifically methyl-
ated on the active maternal allele. Methylation of this 
region is already present in the female gamete and 
remains unchanged during preimplantation develop-
ment and in the adult. Maternal methylation of this 
region was proposed to represent the primary im-
printing signal for the mouse Igf2r gene (Stöger et al., 
1993; Barlow, 1994). 
Here, we have shown that the human 1GF2R gene, 
too, contains CpG islands that are located at comparable 
positions. CpG 1 extends from the promoter region into 
intron 1, and CpG 2 is situated in intron 2. Sequence 
comparison of the murine and human 5' CpG islands 
displayed 73 and 78% homology for the promoter region 
and the analyzed part of intron 1, respectively. Detailed 
methylation analysis of all 138 CpGs across CpG 1 re-
FIG. 5. Methylation analysis of CpG 2 by genomic sequencing of 
individual maternal and paternal chromosomes and sequence analy-
sis for direct repeats and homology to the mouse Igf2r gene. Follow-
ing sodium-bisulfite modification of control (genomic), paternal, and 
maternal UPD DNA, nested PCR was performed. PCR products were 
cloned and sequenced. (A) An example of the segment of CpG 2 
amplified with the primer set 16-37/38 followed by 16-39/38. (B) The 
fragment amplified with the primer set 16-40/41 followed by 16-42/ 
41 (see Materials and Methods). As demonstrated by bands in the 
G-lanes, all CpGs were found to be methylated (dots and arrowheads) 
in genomic control and maternal UPD DNA, whereas in paternal 
UPD DNA most cytosine residues of CpGs are converted, indicating 
the presence of only a few methylated Cs (arrowheads). Aliquots of 
genomic control and maternal UPD DNA from the same bisulfite 
reaction were found to be completely converted at all cytosines of 
CpGs in CpG 1 (not shown). (C) Allele-specific methylation of CpG 
2, sequence analysis for direct repeats, and homology to region 2 of 
the mouse Igf2r gene. The methylation data were compiled from a 
complete analysis of three individual sodium-bisulfite-modified pa-
ternal and maternal chromosomes. CpGs unmethylated in all three 
clones are shown as open circles; one of three methylated as 1/3 
black; two of three methylated as 2/3 black; and all three methylated 
as black circles. The horizontal line represents the chromosome; the 
paternal methylation pattern is depicted above and the maternal 
pattern below this line. The nucleotides correspond to the positions 
of these fragments in the sequenced part of intron 2 (Accession No. 
X91880). Dots above the circles indicate Mspl and/or Hpall sites. 
N, Noti and B, BssHII restriction sites. The 38-bp fragment, 71% 
homologous to the mouse Igf2r gene, is shown by the black bar. 
Direct repeats with an overall homology of >107c are displayed by 
boxes, and sequence relationships within the repeats are represented 
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vealed a complete lack of methylation on both parental 
alleles. This is in marked contrast with the situation in 
the mouse, where region 1 is methylated on the repressed 
paternal allele. Therefore, our findings further substanti­
ate a relation between promoter methylation and tran­
scriptional inactivity. Apparently, promoter methylation 
does not precede the initial inactivation process (Stöger 
et al., 1993), but this modification is possibly responsible 
for maintaining the silent state. 
Sequence homology between CpG 2 and region 2 of 
the mouse Igf2r gene was found to be confined to a 
small segment of 38 bp. Thus, in contrast to the CpG 
island in the promoter region, the sequence of the in-
tronic CpG island is not conserved. Still, as in the 
mouse, the intronic CpG island of the human IGF2R 
gene is methylated in a parent-specific manner. The 
paternal allele was clearly hypomethylated, whereas 
methylation of the maternally derived allele was nearly 
complete. Thus, allele-specific methylation of CpG 2 
has been conserved between human and mouse, but in 
humans, the link between parent-specific methylation 
of CpG 2 and monoallelic expression seems to have 
been lost. Differences in chromatin structure as well 
as in the absence or presence of a irares-acting factor 
acting as a repressor by binding to the hypomethylated 
paternal CpG 2 region may account for the differential 
expression of the human and mouse IGF2R genes. 
Recently, Neumann et al. (1995) have proposed that 
tandem direct repeats embedded in CpG-rich se-
quences are another characteristic of imprinted genes. 
Indeed, analysis of CpG 2 showed the presence of a 
number of direct repeats that are specific for the human 
IGF2R gene. Thus, the human IGF2R gene resembles 
other imprinted genes as far as monoparental methyla-
tion and repeats are concerned, but it is not monoalleli-
cally expressed. 
It is increasingly clear that imprinted genes are clus-
tered in the genome. In the mouse, support for an im-
printed region on proximal chromosome 17 has come from 
the recent report that the Mas proto-oncogene, located 
less than 300 kb apart from the Igf2r gene, is imprinted 
in a developmental- and tissue-specific manner (Villar 
and Pedersen, 1994). MAS, the human homolog of the 
mouse Mas gene, is also located in the vicinity of the 
IGF2R locus on the distal long arm of chromosome 6 
(Rabin et αι., 1987). The observation that paternal (Welch 
et al., 1990) and maternal UPD 6 (van den Berg-Loonen 
et al., submitted for publication) are compatible with nor­
mal human development supports our previous finding 
that the IGF2R gene is not imprinted (Kalscheuer et al., 
1993) and raises the possibility that this holds for the 
MAS gene, too. Expression and methylation studies 
should soon clarify this point and may shed more light 
on the role of gene-specific and regional factors in the 
control of parent-specific expression. 
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We have previously shown that, in contrast to its murine homologue, the human IGF2R 
gene is not Imprinted. However, in a small number of individuals, partial or complete repression 
of the paternal allele has been observed and it has been speculated that in man, IGF2R 
imprinting is a polymorphic trait. We have confirmed monoallelic IGF2R expression in one fetus 
and Investigated whether genomic imprinting was involved in the silencing of the paternal allele. 
Two CpG rich regions, known to be important for the imprinted expression of Igf2r in mice, were 
examined for sequence and methylation changes. A17 bp deletion was identified within the ¡ntronic 
CpG island. This deletion was shown to be polymorphic and without consequence for the 
expression of the relevant IGF2R allele. Furthermore, in this fetus, methylation patterns of the 
¡ntronic and promoter CpG islands were identical to that of normal controls, including 
hypomethylation of the paternal promoter region. In mice, this region is hypermethylated on the 
paternal allele which is silenced. The absence of paternal promoter methylation indicates that 
paternal silencing in this particular fetus is by a mechanism other than parental imprinting or, 
alternatively , that promoter methylation is not necessary for IGF2R imprinting. 
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EVIDENCE AGAINST IGF2R SILENCING BY GENOMIC IMPRINTING 
Introduction 
Genomic imprinting, a process leading to the parental specific expression of genes, is 
involved in vanous genetic disorders and in tumongenesis Therefore, it Is important to identify 
genes subjected to genomic impnntmg and to reveal the mechanisms by which a cell recognises 
and silences a specific parental allele Accumulating evidence suggests that methylation is involved 
since all imprinted genes investigated so far contain regions with parental-specific methylation (1) 
and, in general, methylation of promoter regions is associated with gene silencing Most genes that 
are imprinted in the mouse are impnnted in man as well To date, the only known exceptions from 
this rule are the closely linked insulin-like growth factor type 2 receptor gene (IGF2R) and the MAS 
proto-oncogene In mice, the Mas gene and the Igf2r gene are both impnnted with paternal- and 
maternal-specific expression respectively (2,3) We have recently shown that in contrast to the 
munne gene the human MAS gene is expressed from both parental alleles in first and second 
trimester fetuses (4) Furthermore, several independent studies have shown that in man, the 
IGF2R gene is biallelically expressed (5-7) In agreement with the biallelic IGF2R expression 
observed, the promoter-associated CpG island is hypomethylated on both parental alleles in man, 
whereas in mice the paternal allele is hypermethylated (8,9) In contrast, the possibility was raised 
that in man imprinting of the IGF2R gene is a polymorphic trait (10) In several fetuses and in 50% 
of sporadic Wilms Tumours (WT) studied, the paternal IGF2R allele was found to be partially or 
completely repressed (10,11) To verify these findings and to investigate the underlying 
mechanisms we reexamined one of the fetuses with complete suppression of the paternal IGF2R 
allele and could confirm a monoallelic expression pattern Subsequently, detailed comparison of 
this fetus with controls in terms of mutation screening and methylation analysis did not show any 
obvious differences that could explain the monoallelic expresion on the basis of parental imprinting 
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CHAPTER 4 
Materials and methods 
Fetal RNA and DNA 
Isolation of fetal RNA and DNA samples was described previously (10) 
RT-PCR 
Reverse transcriptase reactions were performed exactly as previously described (5) For 
PCR amplification of the IGF2R polymorphism the primers A2 and S2 (10) were used whereas 
for the MAS polymorphism pnmerset 16-91/92 was used as previously described (4) 
Southern blotting and hybndisation's 
Genomic ONA (7цд) was digested with either HinóUÌ or EcoRI according to the 
manufacturers' recommendations, separated electrophoretically on an 0 8% agarose gel and 
transferred onto a Gene Screen plus membrane Southern hybridisation was performed under 
standard conditions o/n at 65°C with a 8 5 kb EcoRI fragment covering the promoter region of 
IGF2R (9) or a probe encompassing the second CpG island of IGF2R (probe 2 (9)) Final 
washing was performed in 0 1X SSC/0 1% SDS at 65°C for 20 mm 
SSCP and sequence analysis 
SSCP analysis was performed under standard conditions (12) Amplification for 35 cycles was 
accomplished in the presence of a^P-dCTP (>3000 Ci/mmol ICN) The products were fractionated 
on a 5% nondenatunng Polyacrylamide gel containing no, or 10% glycerol at 4°C or at RT The 
dned gels were exposed to Kodak X-ray films For sequence analysis the PCR products were 
phosphorylated using T4 polynucleotide kinase (Gibco BRL) and hgated into the Smal-digested 
plasmid vector pT7T3 (Pharmacia) 
At least seven individual clones were sequenced using the T7 sequencing kit (Pharmacia) The 
primers and PCR conditions used for SSCP and sequence analysis are listed in Table 1 
Methylation analysis 
The sodium bisulphite genomic sequencing technique of Frommer et al (13) was employed 
exactly as outlined in (9) In short, 10 цд genomic DNA was digested with Hindlll and alkaline 
denatured Treatment with sodium bisulphite was performed as described by Clark et al (1994) 
(14) Modified DNAs were desalted and concentrated using GeneClean (Bio 101), ethanol 
precipitated and resuspended in 110 μΙ 100 mM Tris-HCI (pH8 0), 1 mM EDTA Nested 
amplification was performed under the following conditions initial denaturation for 5 mm at 95°C 
followed by 35 cycles consisting of 1 mm at 94°C, 2 mm at 63°C and 3 mm at 72°C and a final 
elongation step for 6 mm at 72°C Primers sequences are given in (9) The PCR fragments were 
cloned and individual clones were sequenced as described above 
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Table 1 : Primer sequences and annealing temperatures of the overlapping primersets used for 
SSCP and sequence analysis of CpG1 (promoter associated CpG island) and CpG2 (intronlc 



































































































PCR conditions were: initial denaturation 5 min. at 98°C followed by 5 min. at 95°C in which the 
enzyme was added; 30 cycles consisting of 1 min. at 95°C, 2 min. at Ta and 2 mm. at 72°C; final 
elongation for 7 min. at 72°C. 
* For this primerset a two step PCR was applied consisting of 1 min. at 95°C and 2 min at 72°C 




Mono-allelic expression of the human IGF2R gene 
RNA from fetus 9224, which was previously shown to repress the paternal allele of the 
IGF2R gene completely (10), was reexamined under different experimental conditions in an RT-
PCR assay Complete monoallelic expression of the human IGF2R gene was observed (Fig 1) 
thereby confirming the results of Xu et al 
Figure 1 Expression analysis of the IGF2R gene of fetus 
9224 Total RNA from fetus 9224 was used as template for 
reverse transcription Amplification of cDNA and genomic 
DNA was performed in the presence of [a32P]dCTP using 
primers flanking a CAC deletion polymorphism in the 
3'UTR (10) Monoallelic maternal specific expression is 
demonstrated by the presence of the maternal allele only 
after RT-PCR (ongm of parental alleles as determined by 
Xu et al (10)) Contamination with genomic DNA was 
excluded by an RT-PCR reaction without the addition of 
reverse transcriptase (-RT) 
Southern analysis of the promoter region and an intronic CpG island 
To test for gross aberrations in the promoter region and an intronic CpG island (CpG2) 
known to be important for the imprinted expression of Igf2r in mice (8), Southern blots of EcoRI 
or H/ndlll digested DNA of fetus 9224 were hybridised with probes from the corresponding 
regions The detected banding pattern was identical to that of two control DNAs which rules out 
gross deletion or insertion in the DNA of fetus 9224 (data not shown) To exclude smaller 
aberrations including point mutations, we performed an extensive sequence and methylation 
analysis of both regions in more detail 
Sequence and methylation analysis of the IGF2R promoter region 
To identify mutations in the promoter region of fetus 9224 we performed an SSCP analysis 
with overlapping primersets covering the promoter associated CpG island No shifted bands 
were found and subsequent sequence analysis of PCR products from this region did not reveal 
any mutation Since it is known that in mice the silenced paternal allele is heavily methylated at 
the promoter region we employed the genomic sequencing technique of Frommer et al (13) to 
determine the methylation status in fetus 9224 No methylation was found for any of the 138 
CpGs present in the promoter region (Fig 2) This unmethylated pattern has also been found in 
random human controls and in patients with paternal or maternal uniparental disomy for 
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G A T C 
Figure 2: Methylation 
analysis of the promoter 
associated CpG island 
(CpG1). Following 
sodium-bisulfite 
modification of fetal 
genomic DNA nested 
PCR was performed and 
cloned PCR products 
were sequenced. Part of 
the CpG1 sequence, 
amplified with primer set 
I6-48/49 followed by I6-
49/50 (for sequences and 
PCR conditions see (9)), 
is shown. The bars 
indicate the position of 
CpG dinucleotides. As 
can be seen by the 
absence of signal in the С 
lane all CpG dinucleotides 
are unmethylated and 
therefore converted into 
TpG dinucleotides. 
A 17 bp deletion in the intronic CpG island. 
Both the human and the mouse Igf2r genes contain a second CpG island (CpG2) located in 
intron 2, which is methylated on maternally derived alleles only (8,9,15). This CpG island 
contains several direct repeats, a characteristic of CpG rich regions associated with imprinted 
genes (16). We performed an SSCP analysis using overlapping primersets covering the entire 
CpG2 island to indentify mutations in this region. With primers I6-76 and I6-67 a shifted band 
was observed and sequence analysis revealed the deletion of 17 bp exactly corresponding with 
one direct repeat unit within the differentially methylated region. RT-PCR analysis of unspliced 
nuclear RNA showed that the deletion is present on the silent paternally derived allele (Fig. 3). To 
further investigate the relevance of this deletion for the monoallelic expression of IGF2R, we 
analysed 103 unrelated individuals by PCR and denaturing Polyacrylamide gel electrophoresis. 
Three individuals carrying the same deletion were identified and in two cases we could 
demonstrate a paternal inheritance of the deletion. To study the expression pattern of the IGF2R 
gene in these individuals RT-PCR analysis on RNA isolated from lymphoblastoid cell lines was 
63 
CHAPTER 4 
performed Both individuals expressed the IGF2R gene biallelically, indicating that the deletion 
by itself does not prevent the expression of the relevant IGF2R allele (Fig 3) However, this 
deletion might still alter the maternal specific methylation of the mtronic CpG island Therefore 
we analysed the methylation pattern of CpG2 for fetus 9224 by applying the bisulphite genomic 
sequencing method Both maternal and paternal methylation patterns characterised by hyper-
and hypo-methylation, respectively, were identified The 17 bp deletion was found on the 
hypomethylated (paternal) allele (data not shown) Due to limited supply of DNA we were not 
able to analyse every CpG within this region 
Biallelic expression of the MAS proto-oncogene 
In mice, the Mas gene is imprinted with exclusive expression of the paternal allele whereas in 
humans this gene is biallelically expressed (3,4) The IGF2R and MAS genes are closely linked, 
with a distance of 65 kb in mice (17) and at most several hundred kb in humans, and it is 
suggested that they are part of an imprinting cluster which is regulated by a common cis-acting 
imprinting centre (1С) We have previously speculated that this 1С might be defunct or lost in 
humans resulting in biallelic expression of both genes (4) If in fetus 9224, the monoallelic 
expression of IGF2R results from genomic imprinting, the apparent functional 1С could influence 
the expression of the neighbouring MAS gene as well However, using the C900T polymorphism 
(4), for which fetus 9224 is heterozygous, we could demonstrate that the MAS gene is 
biallelically expressed (data not shown) 
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A CpG2 Position 1804-1870 
Figure 3: A17 bp deletion of one direct repeat unit within the differentially methylated CpG2 region. 
A) Schematic representation of the 3' part of CpG2 normally containing 4 direct repeats. The bp 
numbers mentioned refer to the position of these repeats within the published sequence, accession 
number X91880. Fetus 9224 has a deletion of 17 bp corresponding to repeat unit 3 as confirmed 
by sequence analysis. 
B) RT-PCR of the 17 bp deletion polymorphism. DNA and RNA from fetus 9224 and a 
heterozygous control individual (2780) was amplified with primer I6-66 5'->3' 
GCGCCTCCAGCTGCGCAT and I6-67 (see table 1), at 59°C. RNA from fetus 9224 contains the 
wildtype (wt) allele only. Since only the maternal IGF2R allele of fetus 9224 is expressed, the 
deletion has to be present on the silenced paternal allele. This was confirmed by methylation 
analysis which revealed the presence of the deletion on the hypomethylated (paternal) allele and 
not on the hypermethylated (maternal) allele (data not shown). RNA from control 2780 contains 




Formerly, has been suggested that imprinting of the human IGF2R gene might behave as a 
polymorphic trait (10,11) One fetus (9224, number 12 5 (10)) completely repressed the paternal 
allele resulting in monoallelic, maternal-specific expression of the IGF2R gene Using a different 
RT-PCR protocol we reanalysed RNA from this fetus and could confirm the monoallelic IGF2R 
expression described Subsequently we have analysed two regions known to be important for the 
maternal specific expression of Igf2r in mice but no indication for the involvement of genomic 
imprinting m the silencing of the paternal allele was found 
Imprinted expression of the Igf2r gene in mice is associated with the parental-specific 
methylation of two CpG islands, one surrounding the promoter region and one located in intron 2 
(CpG2) These two CpG islands and their positions are conserved within the human IGF2R gene 
In mice and humans, CpG2 is hypermethylated on the active maternal allele The promoter-
associated CpG island, however, is hypermethylated on the repressed paternal allele in mice, 
whereas in man this CpG island is hypomethylated on both parental alleles, in agreement with the 
biallelic expression found (8,9,15) Paternal-specific methylation of the promoter region in mice is 
acquired after fertilisation and silencing of the paternal allele as a consequence of genomic 
impnnting (8) If the repression of the paternal allele of fetus 9224 is the result of genomic impnntmg 
one would expect hypermethylation of the promoter region Using the sodium bisulphite genomic 
sequencing method (13) we have demonstrated that all the 138 CpGs in this region from fetus 
9224 are unmethylated This clearly shows that repression of the paternal allele is not achieved by 
methylation of the promoter region 
The maternal-specific methylation of CpG2 in the mouse is inherited directly from the oocyte 
and is believed to represent the primary imprinting signal (8) In both mice and humans, CpG2 
contains several direct repeats, which is a characteristic of parental-specific methylated CpG rich 
regions associated with imprinted genes (8,9,16) Promoter-associated CpG islands of non-
impnnted genes do not contain these direct repeats Remarkably, one repeat unit of the direct 
repeats found in CpG2, is deleted on the paternal allele in fetus 9224 It is tempting to speculate 
that this deletion renders the paternal allele inactive However, the biallelic expression of the IGF2R 
gene in two cell lines containing the same, paternally inhented, deletion, suggests that the deletion 
itself is not sufficient to induce monoallelic expression, nor does this deletion change the 
methylation status of CpG2 since methylation analysis revealed the presence of a hypomethylated 
paternal allele, containing the 17 bp deletion, and a hypermethylated maternal allele, as is normally 
found 
Examination of the two regions were imprinting signals are thought to reside, did not reveal any 
differences between fetus 9224 and non-imprinted controls Therefore, if paternal expression is due 
to genomic imprinting, the imprinting mechanism functions quite different than that in mice, and 
impnntmg signals might reside outside the areas investigated One would have to assume that 
promoter methylation is not required for monoallelic expression in the human, and that only the 
methylation impnnt at the intronic CpG island is needed However this methylation impnnt, present 
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in all humans studied, is not sufficient for monoallelic expression Furthermore, the conserved 
presence of the two CpG islands and the maternal specific methylation of the mtronic CpG island 
suggests similar mechanisms in humans and mice These discrepancies lead us to propose that 
repression of the paternal allele of fetus 9224, is not the result of genomic imprinting but is due to 
an unidentified mutation whichs renders the paternal allele inactive Gross aberrations in the 
promoter region or CpG2 could be excluded by Southern blotting and hybridisation with 
corresponding probes SSCP and sequence analysis of the promoter region did not reveal any 
mutation However, we have analysed only 1220 bp surrounding the transcription start site and the 
presence of an inactivating mutation elsewhere can not be excluded This mutation could influence 
transcription initiation, RNA stability, or lead to an abnormal early termination of transcription 
Biallelic MAS expression also argues against the possibility that monoallelic IGF2R expression is 
due to an active 1С affecting the entire impnnting domain Moreover, the lack of methylation of the 
paternal promoter-associated CpG island is not in agreement with silencing through promoter 
methylation imprinting, a potential silencing mechanism in the mouse 
Biallelic expression of the IGF2R gene in man is well documented In total 20 heterozygous 
fetuses were investigated (5,6,10,11) Of these, only two fetuses expressed the IGF2R gene 
monoallelically (10) but the studies described here failed to find an imprinting related molecular 
mechanism that would explain the silencing Thus no molecular basis for polymorphic IGF2R 
imprinting was found in the areas examined Recently, Wutz et al demonstrated that in mice, the 
second CpG island is in fact the promoter of an antisense RNA molecule This molecule is 
transcribed from the paternal allele only and deletion of the mtronic CpG island prevents the 
expression of this RNA molecule leading to loss of imprinting (18) Absence or inactivating 
mutations of this RNA in humans might explain the biallelic IGF2R expression observed At 
present, we cannot rule out the possibility that fetus 9224 has a sequence variant that permits 
expression of a functional forni of this RNA 
It has been suggested that IGF2R can function as a tumour suppressor gene and deletions of 
the IGF2R chromosomal region as well as mutations within the gene have been found in numerous 
tumours (19-22) Moreover, in 50% of informative Wilms Tumours (WT) the patemal IGF2R allele 
was partially repressed (11) It would be of interest to see whether this polymorphic, partial, 
repression is due to hypermethylation of the promoter region, and hence to genomic impnnting, or 
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Recently it was shown that the murine Μοβ gene, 
which is located less than 300 kb from the imprinted 
Igf2r gene, is also imprinted in Day 11.5 embryos with 
expression exclusively from the paternal allele. We 
have assigned the human MAS gene to chromosomal 
bands 6q25.3-q26 in close proximity to theIGF2R gene. 
In contrast to its murine homologue, the human IGF2R 
gene is not imprinted. By making use of a novel intra­
genic polymorphism, we have studied the expression 
of the MAS gene in three heterozygous human fetuses. 
In all tissues examined, including tongue, biallelic ex­
pression of the MAS gene was observed. Hence both 
MAS and the neighboring IGF2R gene are not im­
printed ІП humans. О ime Ломіешіс Ггм, Ixe 
The MAS proto-oncogene belongs to the class of GTP-
binding protein coupled receptors. Overexpression of 
MAS can induce tumor growth (18, 20). The murine 
Mas gene has been mapped to the proximal part of 
chromosome 17 (4) in the vicinity of the Igf2r gene, 
from which it is separated by less than 300 kb. Like 
Igf2r, which is active only on maternally derived chro­
mosomes (2), the Mas gene was recently shown to be 
imprinted in the mouse, in line with the observation 
that imprinted genes tend to occur in clusters. The ex­
pression of the Mas gene is confined to the paternal 
allele in Day 11 to 12.5 embryos. After Embryonic Day 
13.5 and in neonates, this paternal-specific expression 
persisted in the tongue, visceral yolk sac, heart, and 
skeletal muscle, whereas all other tissues tested 
showed relaxation of the maternal imprint resulting in 
biallelic expression (19). 
In general, genes that are subject to genomic im­
printing in mice seem to be imprinted in humans as 
well (1). The IGF2R gene is the only known exception 
to this rule; as shown by us and confirmed by others, 
this gene is biallelically expressed in first and second 
trimester fetuses (8,10). Previous studies have mapped 
the human IGF2R and MAS genes to approximately 
1 To whom correspondence should be addressed at Max-Planck-
Institut für Molekulare Genetik, Ihnestrasse 73, D-14195 Berlin 
(Dahlem), Germany Telephone' +49-30-8413-1293 Fax. +49-30-
8413-1383. E-mail kal8cheuer@mpimg-berlin-dahlem.mpg.de. 
the same region on chromosome 6q (8, 11, 12), This 
has prompted us to study the allele-specific expression 
pattern of the human MAS gene and to determine its 
physical distance from the IGF2R locus. 
To this end we screened the ICI human YAC library 
with PCR primer pairs generated from the 5' and 3 ' 
ends of the published human MAS cDNA sequence (20) 
(5'UTR 16-77 GGATCCAGAAGGGTCATTC, 16-78 
CTCAGGTTGGAACTCTTCAG; 3 ' 16-87 GCAGTAAG-
AAGAAGAGATTC, 16-88 TCATCATTAATTAGTATC-
TCATG) and isolated a YAC clone containing the MAS 
gene. FISH mapping enabled us to assign this YAC to 
6q25.3-q26, i.e., very close to the IGF2R gene, which 
has been mapped to 6q26. Moreover, FISH signals ob-
tained with YACs carrying the IGF2R gene and the 
MAS gene were partially overlapping on metaphase 
chromosomes and in 91 of 100 interphase nuclei. Since 
for cosmid probes the resolution of interphase FISH is 
approximately 50 kb (17), these findings suggest that 
in humans, too, the physical distance of the MAS gene 
and the IGF2R gene is at most several hundred kb. 
To investigate the transcriptional activity of the two 
parental copies of the human MAS gene separately, 
we searched for intragenic DNA polymorphisms using 
SSCP and sequence analysis. Amplification of genomic 
MAS fragments was performed with primers designed 
on the basis of the published cDNA sequence (20). PCR 
products of the correct size were isolated from agarose 
gels using the Qiaquick gel extraction kit (Qiagen) and 
employed as template in the sequencing reaction. Se-
quencing was performed using the Taq DyeDeoxy ter-
minator cycle sequencing kit (Applied Biosystems). 
A silent basepair substitution (C900T) was found 
with primers 16-91 CATGGATATGTCATGTGrC and 16-
92 CCATGATGACTATGTAAAGC. Of 14 first and sec-
ond trimester fetuses, 3 were found to be heterozygous 
for this polymorphism. RNAs from different tissues of 
these fetuses were tested for parental allele-specific ex-
pression. Complementary DNA was synthesized as pre-
viously described (8). To detect possible DNA contami-
nation, in each experiment half of the RNA sample was 
subjected to RT-PCR without the addition of reverse 
transcriptase. These controls were negative in all 





































Note Fl , 19th week of gestation, F4, 12th week of gestation, F5, 
12th week of gestation ND, not determined 
and sequenced. In all fetuses and tissues tested, bial-
lelic expression was found (see Table 1). In two of the 
three fetuses, MAS expression could also be tested in 
the tongue (see Fig. 1), where in mice imprinting of the 
MAS gene has been reported to persist until after birth. 
Our results show that the MAS gene is biallelically 
expressed in three informative human fetuses and that 
it is apparently not imprinted in humans. 
Genes that are imprinted in mice tend to be subject 
to imprinting in humans too. It is striking that the two 
known exceptions of this rule, IGF2R and MAS, map 
to the same chromosome region. A possible explanation 
for this finding is the assumption that the imprinting 
behavior of these genes depends on regional cis-acting 
factors that are functional in mice but defunct or lost 
in humans. 
Support for the existence of such regional control 
elements has come from the imprinted gene clusters 
on human chromosomes 11 and 15, where pairs of 
genes that are differentially imprinted are located. 
Functional loss, through deletion or uniparental dis-
omy of the paternally or maternally derived 15ql l -
ql3 segment, leads to Prader-Willi (PWS) or 
Angelman (AS) syndrome, respectively (for review see 
(9)) For both syndromes, however, patients have been 
identified with a normal biparental inheritance but 
with abnormal methylation and expression patterns, 
i.e., only maternal for PWS and only paternal for AS. In 
Beckwith-Wiedemann syndrome (BWS), too, patients 
with biparental inheritance of chromosome l lp l5 but 
paternal-specific methylation and expression patterns 
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FIG. 1. Sequence of RT-PCR products of tongue RNA of two heterozygous fetuses Sequencing was performed with pnmer 16-92 Both 
alleles are preeent in F4 and F5 DNA and RNA as shown by overlapping signals, whereas in control homozygous DNA only one allele is 
present {arrowheads) 
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have been identified These cases have been explained 
as mutations affecting imprinting control elements 
(ICEs) in the vicinity of the PWS, AS, and BWS genes 
(3,13, 14) Nothing is known so far about the molecular 
nature of these postulated ICEs, nor about their mode 
and range of action 
In mice, Igßr and Mas map to the Τ locus region on 
chromosome 17 not far from the major histocompatibil­
ity cluster (6), whereas in humans, genes from this 
region map to opposite ends of chromosome 6 (7). At 
least formally it is possible, therefore, that the evolu­
tionary rearrangement that separated these genes also 
dislocated the IGF2R and MAS genes from their ICE 
or vice versa This possibility can be tested, e g, by 
physical fine mapping of the respective evolutionary 
breakpoint On the other hand the functional need to 
imprint these two genes is clearly absent in humans, 
and biallehc expression may even be advantageous, as 
it has been shown that IGF2R can function as a tumor 
suppressor gene in liver carcinogenesis (5) If so the 
parent-specific methylation and asynchronous replica­
tion of IGF2R (15, 16) may just be an evolutionary 
remnant 
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We have isolated the human PEG1IMEST gene and 
have investigated its imprinting status and parental-
specific methylation. FISH mapping assigned the gene 
to chromosome 7q32, and homologous sequences were 
identified on the short arm of human chromosomes 3 
and 5. Through the use of a newly identified intragenic 
polymorphism, expression analysis revealed that PEGU 
MEST is monoallelically transcribed in all fetal tissues 
examined. In two informative cases, expression was 
shown to be confined to the paternally derived allele. 
In contrast to the monoallelic expression observed in 
fetal tissues, biallelic expression was evident in adult 
blood lymphocytes. Biallelic expression in blood is 
supported by the demonstration of PEG1/MEST tran-
scripts in a lymphoblastoid cell line with maternal uni-
parental disomy 7. The human PEG1/MEST gene spans 
a genomic region of approximately 13 kb. Sequence 
analysis of the 5' region of PEG1/MEST revealed the 
existence of a 620-bp-long CpG island that extends 
from the putative promoter region into intron 1. We 
demonstrate that this CpG island is methylated in a 
parent-of-origin-specific manner. All MapVHpall sites 
were unmethylated on the active paternal allele but 
methylated on the inactive maternal one. с ют Academie 
Prees 
INTRODUCTION 
Imprinting is a process by which some genes are si­
lenced in a parent-of-origin-dependent manner, re­
sulting in monoallelic expression in the offspring. The 
mechanisms underlying genomic imprinting and by 
which parental alleles are distinguished are largely un­
known. All imprinted genes so far examined in more 
detail contain DNA sequences methylated in a paren­
tal-specific manner, suggesting that this epigenetic 
1 To whom correspondence should be addressed. Telephone. +49-
30-8413-1293. Fax. +49-30-8413-1383. E-Mail: kalscheuer®mpimg-
berhn-dahlem.mpg de. 
process plays an important role in regulating imprinted 
gene expression. 
Recently, the mouse Pegl gene has been identified 
in a systematic screen using subtraction hybridization 
between cDNAs from parthenogenetic and similar 
stage-matched normal control mouse embryos (Ka-
neko-Ishino et al., 1995). Pegl is expressed from the 
paternally derived allele only. Subsequent homology 
search revealed that Pegl is identical to a previously 
identified "mesoderm-specific" cDNA (Mest), which 
maps to the proximal part of chromosome 6, band Bl, 
a region homologous to the long arm of human chromo­
some 7 (Sado et al., 1993). The Pegl/Mest gene codes 
for an enzyme that shows significant similarity to the 
a//3-hydrolase fold family; the precise function is as yet 
unknown. 
Indirect evidence for the existence of at least one 
maternally imprinted gene on the long arm of human 
chromosome 7 came from the study of patients with 
maternal uniparental disomy 7 (mUPD7; Kotzot et al., 
1995). These patients are characterized by intrauterine 
and postnatal growth retardation, indicating that the 
lacking paternal contributions for chromosome 7 may 
account for growth retardation. 
Since imprinting is generally conserved between 
mouse and humans, with the exception of IGF2R and 
MAS, which are oppositely imprinted in the mouse but 
equally expressed from both parental alleles in humans 
(Barlow et al., 1991; Kalscheuer et al., 1993; Ogawa et 
al, 1993; Villar and Pedersen, 1994; Riesewyk et al., 
1996a), human PEG1/MEST was suggested as the first 
candidate imprinted gene located on chromosome 7. In 
the present study, we have isolated and characterized 
the human PEG1/MEST gene, mapped it to chromo­
some 7q32, and found homologous sequences on the 
short arm of human chromosomes 3 and 5. We deter­
mined the imprinting status of PEGl/MESTby making 
use of a newly identified intragenic single nucleotide 
deletion/insertion polymorphism. Sequencing of RT-
PCR products revealed monoallelic expression in all 
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fetal tissues examined. In two informative cases, ex-
pression was found to be confined to the paternally 
derived allele, as in the mouse. Southern blot analysis 
of the 5' CpG island otPEGl/MEST demonstrated par-
ent-of-origin-specific methylation. 
MATERIALS AND METHODS 
Library screening. Arrayed human fetal cDNA libraries (lung and 
liver), a chromosome 7-specifìc cosmid library, and a human PAC 
library were screened with a mouse Pegl/Mest RT-PCR product of 
993 bp amplified with pnmer set Peglf and Peglr (GAGATCGCT-
TGCGCAGGAT, 258-276, AGGAGTTGATGAAGCCCATA, 1250-
1231, Accession No D16262) DNA of the positive clones was pre-
pared according to standard procedures (Sambrook et al, 1989) 
RT-PCR and sequence analysis. All reverse transcription reac-
tions were performed exactly as described previously (Kaischeuer et 
al., 1993). 
For PEG1IMEST polymorphism and expression analysis, reverse 
transenbed cDNAs and genomic DNAs were amplified with pnmer 
set 4 and 10 (TGTGCTATTAGGAAATTCTGA, 1473-1493; GAC-
TCAGCTCTGTGTTGC, 1716-1699, Accession No Y11534) under 
the following conditions initial denaturation for 3 min at 95°C, 1 
mm at 94°C, 1 mm at 57°C, and 1 5 mm at 72°C for 30 cycles, elonga-
tion for 7 nun at 72°C Single-strand conformational polymorphism 
(SSCP) analysis was performed under standard conditions (Onta et 
al, 1989) For each RT-PCR expenment, a control reaction without 
addition of reverse transenptase was performed in parallel Pnor to 
sequencing, PCR and RT-PCR products were cut out of the agarose 
gel and purified using the Quiaquick gel extraction kit (Qiagen) 
Sequencing was performed with pnmer 4. 
PEG1/MEST cDNA clone (ICRFp507M19178Qll) and part of the 
4 3-kb //indili subclone, which contains the genomic 5' region of the 
PEG1/MEST gene, were sequenced with T7, T3, and gene-specific 
pnmers All reactions were performed using the Taq DycDeoxy ter-
minator cycle sequencing kit (Applied Biosystems), and reactions 
were analyzed on an ABl 377 automated sequencer 
Northern blot analysts The Clontech multiple tissue Northern 
blot was hybndized with the PEG1/MEST cDNA clone (ICRFp507-
M19178Q11) according to the GeneScreen Plus protocol Final wash 
was in O.lx SSPE at room temperature for 15 nun 
Southern blot and methylation analysis DNAs were digested 
with the appropnate restnction enzymes, and the fragments were 
separated by agarose gel electrophoresis, transfeiTed to GeneScreen 
Plus membranes, and hybndized under standard conditions Methyl-
ation analysis of genomic DNAs from tissues and blood digested with 
(Hindlll + Mspl) or (HmdHI + Hpall) was performed exactly as 
desenbed previously (Riesewijk et al, 1996b) Uniparental disomy 
was confirmed for all cases included in our study (J Kere et al, 
unpublished, Hdglund et al, 1994, Kotzot et al, 1995) 
The 4 3-kbHindIII fragment containing the 5' region of the PEGU 
MEST gene was subcloned into pT7T318U (Pharmacia) Amplifica-
tion of the 5' region of PEG1/MEST was performed with pnmer set 
15 and 16 (CACCTCCTCTGCGGCAGC, 493-510, ATCTCGGCG-
CACCATGGCC, 693-711; Accession No Y10620) in l x RT-buffer 
(Kalscheuer et al, 1993), 1 mM MgCla, 3 4% formamide, and 10% 
glycerol under the following conditions initial denaturation for 5 
mm at 95°C followed by 35 cycles of 1 mm at 94°C, 2 mm at 60°C, 
and 2 min at 72°C The 3' PEG1IUEST probe was generated by 
RT-PCR on total liver RNA with pnmer set 4 and 6 (TGTGCTATT-
AGGAAATTCTGA, 1473-1493, AAACACTTATTCCAGTTTCAAAG, 
2429-2407, Accession No Y11534) Amplification was earned out 
for 35 cycles in l x RT-buffer, 3 mM MgCl2 at 94°C for 1 min, 57°C 
for 2 mm, and 72°C for 3 mm For Southern hybndizations, DNA 
inserts were labeled by random pnming in the presence of [o>3¿P]-
dCTP (Amersham, England) Hybndizations were performed at 55 
or 65°C Washing was at hybndization temperature in 2x SSC/0 1% 
SDS (2 X 10 mm) followed by l x SSC/0 1% SDS for 15 min and 0 l x 
SSC/0 1% SDS for 15 mm Autoradiograms were exposed for 16 h to 
1 week 
Chromosomal mapping by FISH DOP-PCR (degenerated ohgo-
pnmed PCR) products from PAC DNA were prepared according to 
Telemus et al (1992) FISH expenments were performed as de-
senbed by Suijkerbuijk et al. (1993). 
RESULTS 
Sequence, Homology Analysis, and Mapping of the 
Human PEGU MEST Gene 
A cDNA clone (ICRFp507M19178Qll) of the human 
PEG1IMEST gene was isolated from a fetal cDNA li-
brary, and Northern blot hybridization showed that the 
insert represents the entire mRNA (not shown). Se-
quencing of the 2470-bp insert showed that our clone 
is identical to the PEG1IMEST cDNA described by Ni-
shita et al. (1996; Accession No. D78611), except for 
two thymidine residues in the 5' untranslated region 
(T88 and T98), which were absent in our cDNA se-
quence, and four base changes in the open reading 
frame (Α591-Ό, G593^A, G634-A, and A726-T). 
These changes result in the substitution of two nonho­
mologous amino acids into two residues identical to 
those of the mouse protein. Sequence comparison of the 
human PEG1/MEST cDNA and its mouse counterpart 
with the program BESTFIT displayed 84% homology 
for the entire sequence and 91% for the coding region, 
and amino acid sequence comparison with the program 
BLASTN demonstrated 98% identity. 
To characterize the human PEG1/MEST gene in more 
detail, cosmids were isolated (ICRFcll3M1711Q4, 
K246Q4, and G0353Q4), and restriction digestion with 
ÊcoRI or HmdIII, followed by Southern hybridization 
with cosmid G0353Q4, demonstrated that they mostly 
overlapped. FISH mapping of cosmid G0353Q4 assigned 
the human PEG1IMEST gene to chromosome 7q32, 
thereby confirming the results of Nishita et al. (1996). 
Subsequently, .EcoRI-digested genomic and coemid 
DNAs were subjected to Southern blot hybridization 
with PEG1IMEST cDNA. Surprisingly, eight EcoRl 
fragments (8.7, 6.2, 4.0, 2.65, 2.3, 1.7, 1.05, and 0.6 
kb) were detected in genomic DNA while cosmid DNA 
lacked three of them (6.2, 2.65, and 2.3 kb) (not shown). 
Attempts were therefore made to isolate PAC clones 
from this region. Screening of a PAC library with the 
same PEG1IMEST cDNA revealed 10 individual PAC 
clones, and Southern hybridization of ÊcoRI-digested 
PAC DNA with the PEG1IMEST cDNA resulted in hy-
bridization patterns, allowing us to subgroup the PAC 
clones into three categories. One subgroup of PAC 
clones (LLNLP704G0495Q13, H10144Q13, and M10128-
Q13) showed positive £coRI fragments previously 
found in all cosmids, indicating that these harbor the 
PEG1IMEST gene. These results were confirmed by 
FISH mapping of DOP-PCR products of 1 of these PAC 
clones to chromosome 7q32. Subcloning and sequencing 
7β 
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of EcoRI-digested cosmid fragments that hybridized to 
PCR products generated from the 5' and 3' ends of 
the human PEG1IMEST cDNA demonstrated that the 
cosmids contain the complete human PEG1IMEST 
gene, spanning a genomic region of approximately 13 
kb The presence of additional EcoRl fragments in ge-
nomic DNA that were absent in the PEG1/MEST cos-
mid and PAC clones pointed to the existence of PEGU 
MEST-related sequences elsewhere in the human ge-
nome This is in line with the finding that two groups 
of PAC clones that had been identified with PEGU 
MEST as a probe could not be accomodated within the 
PEG1/MEST cosmid and PAC contig FISH mapping of 
DOP-PCR products of 1 PAC clone from each category 
demonstrated specific signals on the short arm of hu-
man chromosomes 3 and 5, respectively 
To isolate and characterize the 5' end of the human 
PEG1/MEST gene, a PCR product of 219 bp (primer 
set 15 and 16), comprising part of the promoter region 
and exon 1, was hybridized to £coRI-digested cosmid 
DNA A positive fragment of 8 7 kb was identified and 
subcloned following digestion with HmdIII Partial se-
quencing of a 4 3-kb HmdIII clone revealed a high G+C 
content of 72% in the 5' region of the gene and a high 
frequency of CpG dmucleotides, indicating the pres-
ence of a 620-bp-long CpG island, which includes the 
promoter region and exon 1 and extends into intron 1 
(Fig 1) This region contains four SPI binding se-
quences (GGGCGG) but lacks TATA and CCAAT boxes 
Sequence analysis revealed the presence of an imper-
fect direct repeat of 20 bp arranged in tandem (Fig 1A) 
Monoallehc and Biallelic Expression of the Human 
PEGU MEST Gene 
To distinguish between paternally and maternally 
derived alleles and to determine the imprinting status 
of the human PEG1IMEST gene, we searched for a 
polymorphism using SSCP and sequence analysis with 
several sets of primers encompassing the 3' end of the 
gene In a DNA fragment of 244 bp, amplified with 
primer set 4 and 10, a single nucleotide deletion/inser-
tion polymorphism was identified, resulting in a stretch 
of 7 or 8 thymidine nucleotides Of 14 first and second 
trimester fetuses, 4 were found to be heterozygous for 
this polymorphism Subsequently, RT-PCR was per-
formed on total RNA from various tissues of these fe-
tuses, including brain, skeletal muscle, kidney, adre-
nal, tongue, heart, skin, and placenta Sequencing of 
the amplified cDNAs revealed monoallehc expression 
for all fetal RNAs examined (Fig 2A) In two informa-
tive cases, expression of PEG 1 /MEST was shown to be 
confined to the paternally denved allele (Fig 2B) The 
same polymorphism was used to study expression of 
PEGl/MESTm adult blood lymphocytes Interestingly, 
in all three heterozygous samples investigated, tran-
scripts from both parental alleles were found (Fig 2C) 
To explore the possibility of biallelic expression, we 
extended our analysis to total RNA isolated from a 
lymphoblastoid cell line from a patient with mUPD7 
In this cell line PEG1IMEST transcripts were present, 
supporting our previous observation of biallelic expres-
sion in blood All RNAs were treated with DNase I 
prior to reverse transcription To detect possible DNA 
contamination, in each experiment, half of the RNA 
sample was subjected to RT-PCR without the addition 
of reverse transcnptase These controls were negative 
in all samples examined 
Methylation Analysis of the Human PEG11 MEST 
Gene 
To determine the methylation status of the MspV 
Hpall sites in the CpG island of the human PEGU 
MEST gene, we performed Southern hybridizations of 
(HmdIII + Mspl)- and (HmdIII + HpalD-digested ge-
nomic DNAs from adult intestine, cerebellum, stomach, 
liver, lung, and blood lymphocytes with the 4 3-kb 
HmdIII fragment, which encompasses the CpG island, 
exon 1, and part of intron 1 (Fig ЗА) (HmdIII + Mspl)-
digested DNA showed positive fragments of 2 3, 0 65, 
0 45, 0 3, and 0 23 kb Because of their small size, a few 
fragments could not be detected (HmdIII + ΗραΙΙ)-
digested DNA resulted in a similar banding pattern 
with two additional fragments of 4 3 and 2 kb The 
presence of the 4 3-kb fragment, which was observed 
in all DNA samples, indicates that part of the genomic 
DNA is completely methylated in this region and there­
fore undigested by Hpall The fragment of 2 kb, which 
contains the complete CpG island, was prominent in 
lung and blood, much fainter in stomach and liver, and 
nearly undetectable in cerebellum Obviously, the de­
gree of methylation of this particular MspVHpall rec­
ognition site (Fig ЗА, arrow) vanes between tissues 
while all other MspVHpall sites in the CpG island and 
its proximity are completely methylated and therefore 
resistant to digestion (Fig 3C) 
Compared to the Mspl fragments, the Hpall frag­
ments of 0 65,0 45, 0 3, and 0 23 kb were much fainter 
Quantification of the intensities by the program Im-
ageQuant showed that radioactivity was approxi­
mately 50% lower, indicating that 50% of these restric­
tion sites are methylated and resistant to Hpall diges­
tion and 50% are unmethylated and therefore digested 
Southern hybridization of (HmdIII + Mspl)- and 
(HmdIII + HpalD-digested fetal DNA derived from 
brain, liver, chorionic villi, placenta, and control DNA 
from adult blood lymphocytes was performed with a 
Nari probe of 545 bp, encompassing part of the CpG 
island (Fig 1, position 15-561) The hybridization pat­
tern demonstrated that in fetal tissues too, 50% of the 
MspVHpall sites are unmethylated and 50% are meth­
ylated (not shown) 
PEG11 MEST Methylation Is Allele Specific 
Our finding of CpG island methylation in the pro­
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FTC. 1. Sequence and CpG plot of the human PEG1/MEST promoter region, exon 1 (capital letters), and part of intron 1 (A) Sequence 
of the 5' region of PEGIIMEST A tandemly arranged imperfect direct repeat of 20 bp is marked by boxes, and consensus sites for SP1-
binding sites are underlined The putative transcription start, determined from the cDNA sequence, is marked by an arrow, exon 1 is 
written in capital letters, and the 620-bp-long CpG island is marked by a box (B) The CpG plot shows the G+C density (broken line) and 
CpG content (solid line) per 100 bp for this sequence The data are expressed as the observed number of CpGs per 100 bp over the expected 
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FIG. 2. Expression analysis οι PEGl/MEST Arrows point to the newly identified deletion/insertion polymorphism resulting m 7 or 8 thymidine 
residues (A) Sequence analysis of PCR and RT-PCR products of three heterozygous individuals (F6, F7, and Fr3) show that PEGl/MEST is 
monoallehcally expressed (B) Sequence analysis of maternal DNA displaying 8 thymidines, paternal DNA displaying 7 thymidines, heterozygous 
fetal DNA, and corresponding monoallelic RT-PCR product diplaying 7 thymidines, which indicates that PEGl/MEST ш expressed from the paternal 
allele only (C) Sequence analysis of blood DNA from two heterozygous individuals (Blood 4 and 6) and corresponding adult blood lymphocyte RT-
PCR products The presence of 7 and 8 thymidine residues in both RNAs indicates cell-type specific biallehc expression of PEGl/MEST 
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FIG. 3. Methylation analysis of the 5' end of PEG1IMEST. (A) Restriction map of the 4.3-kb HmdIII probe showing the positions of 
the restriction sites analyzed (H, HmdIII; M, MspVHpaW) and the CpG island (box). The arrow refers to the tissue-specific partially 
methylated HpoTI site. (B) Allele-specific methylation of the 4.3-kb HmdIII fragment. The horizontal line represents the chromosome; the 
paternal methylation pattern is depicted above and the maternal pattern below the lines. Unmethylated CpGs are shown as open circles, 
methylated CpGs as black circles. The partially methylated MspVHpaW site of the maternal allele is depicted as dotted circle. (C) Southern 
blot analysis of the promoter region using the 4.3-kb //indili fragment as probe and genomic DNA from adult brain, stomach, liver, lung, 
and blood lymphocytes (the upper part shows a short exposure time and the lower part a longer exposure time of the same blot). A 4.3-kb 
fragment is seen after digestion with //indili and is reduced to 2.3, 0.65, 0.45, 0.3, and 0.23 kb following digestion with Mspl. Because of 
their small size, a few fragments could not be detected. The 4.3-kb //indili fragment was digested to approximately 50^ by the methylation-
sensitive isochizomer //pall, indicating partial or monoparental methylation at these sites. In contrast to the Mspl digestions, a fragment 
of 2 kb, prominent in lung and blood, less intense in stomach and liver, and nearly undetectable in cerebellum DNA, is present, indicating 
tissue-specific methylation of one particular MspVHpaW site (arrow). (D) Southern blot analysis of HmdIII, (HmdIII + Mspl)-, or (HmdIII 
+ HpalD-digested genomic DNA from peripheral blood leukocytes of patients with mUPD7 and pUPD7 and a normal control, probed with 
the 4.3-kb HmdIII fragment. Mspl digests of control and patient DNA show the same banding pattern. Following HpaW digestion, fragments 
of 0.65, 0.45, 0.3, and 0.23 kb are absent in mUPD7 DNA but present in pUPD7 and control DNA. Absence of these fragments in maternal 
DNA and the dosage effect of paternal DNA in comparison to control DNA indicates specific methylation of the maternal allele. 
of allele-specific DNA methylation on the silenced ma­
ternally derived allele. To study this, blood DNA from 
three patients with mUPD7 and one patient with 
pUPD7 was digested with (Hindlll + Mspl) or (Hindlll 
+ Hpall) under the same conditions. Following South­
ern blot analysis with the 4.3-kb Hindl l l probe, Mspl-
digested DNAs showed the same banding pattern as 
control blood DNAs (Fig. 3D). ЯраІІ-digested mUPD7 
DNAs showed fragments of 4.3 and 2 kb. In contrast 
to the control DNAs, the smaller fragments of 0.65, 
0.45, and 0.3 kb were absent in all mUPD7 DNAs and of 
identical intensity compared with the respective Mspl 
fragments in pUPD7 DNA. Our methylation analysis 
clearly demonstrates that the maternal Mspl/Hpall 
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sites of this CpG island are completely methylated and 
therefore not digested by Hpall, whereas the respective 
paternal sites are unmethylated 
In summary, our methylation analysis of the 5' CpG 
island of the human PEG1/MEST gene demonstrates 
parent-of-ongin-specific methylation in fetal and adult 
DNAs with the paternal allele being unmethylated and 
the maternal allele being methylated 
DISCUSSION 
In this study we report that the human PEG1/MEST 
gene is imprinted and contains a CpG island that is 
methylated in a parent-of-ongin-specific manner, with 
the active paternal allele being unmethylated and the 
inactive maternal allele being methylated 
The imprinted mouse Pegl/Mest gene was identified 
in a systematic screen using subtraction hybridization 
with cDNAs from parthenogenetic and control embryos 
(Kaneko-Ishino et al, 1995) Subsequent homology 
search revealed that Pegl was identical to the pre-
viously identified mesoderm-specific cDNA Mest (Sado 
et al, 1993) During our studies, the Pegl/Mest homolo-
gous human cDNA (PEG1/MEST) was isolated and 
mapped to chromosome 7q32 Expression analysis of a 
hydatidiform mole, which is mostly paternal in origin, 
and dermoid cysts, which are mostly maternal in ori-
gin, demonstrated that PEG1IMEST is abundantly ex-
pressed in moles but scarcely in dermoid cysts (Nishita 
et al, 1996) This observation is in good agreement 
with our results which provide clear evidence that the 
human PEG1IMEST gene is imprinted In our ap-
proach to isolate the human PEG1IMEST gene we have 
identified homologous sequences on the short arm of 
human chromosomes 3 and 5 At present it is unknown 
whether these cross hybridizing sequences are ex-
pressed and if so, whether they are subject to im-
printing, too 
A newly identified single nucleotide insertion/dele-
tion polymorphism in the 3' UTR of the human PEGU 
MEST gene enabled us to study allelic expression m 
a series of fetal tissues and adult blood lymphocytes 
Monoallehc expression of PEG1IMEST was observed 
in all fetal tissues examined, including brain, skeletal 
muscle, kidney, adrenal, tongue, heart, skin, and pla-
centa In two informative cases, we could show that 
PEG1/MEST expression is confined to the paternally 
derived allele In contrast to the monoallehc expression 
observed in fetal tissues, biallehc expression was evi-
dent in adult blood lymphocytes of all three heterozy-
gous individuals In addition, we have demonstrated 
the presence of PEG1/MEST transcripts in a lympho-
blastoid cell line of a patient with mUPD7, which is in 
keeping with our finding that this gene is expressed 
in adult blood lymphocytes The imprinting status of 
human PEG1/MEST in fetal blood lymphocytes is cur-
rently unknown, and it remains to be elucidated 
whether in humans the imprint is lost at some time 
during development or whether imprinting is not es-
tablished in these cells Interestingly, it has been 
shown recently that in contrast to the human PEGU 
MEST gene, the mouse gene is only expressed from the 
paternal allele in both fetal and adult blood (M Reule 
and R Fúndele, Berlin, pers comm , March 1997) On 
the basis of this observation, it is most likely that in 
humans, PEG1IMEST imprinting in blood lymphocytes 
is lost during development It is becoming increasingly 
apparent that imprinted genes do not necessarily re-
press one parental locus m all tissues, and our results 
indicate that this is also true for the human PEGU 
MEST gene Tissue-specific escape or relaxation of im-
printing was previously observed for the IGF2 gene in 
adult liver (Kalscheuer et al, 1993), fetal choroid 
plexus, and leptomemnges (Ohlsson et al, 1994) and 
for H19 in placenta Human H19 is biallehcally ex-
pressed in the placenta at an early stage, which con-
trasts with consistent monoallehc expression in the 
mouse placenta (Jinno et al, 1995, Tremblay et al, 
1995) 
The human PEG1/MEST gene spans a genomic re-
gion of approximately 13 kb Sequence analysis of the 
5' end revealed the presence of a CpG island, spanning 
the promoter region, exon 1, and part of intron 1 Three 
imperfect direct repeats of 20 bp, arranged in tandem, 
have been identified upstream from this CpG island 
Direct repeats have been found in most imprinted 
genes analyzed to date and are also evolutionanly con-
served (Neumann et al, 1995), thus, the human PEGU 
MEST gene shares this probably important feature of 
imprinted DNA sequences, too Our methylation stud-
ies of the 5' region ofPEGl/MEST, including the CpG 
island, revealed that it is methylated in a parent-of-
ongin-specific manner with hypomethylation of the pa-
ternal allele and hypermethylation of the maternal al-
lele in all tissues examined We suggest that the ob-
served DNA methylation is involved in the silencing of 
the maternally derived PEG1/MEST allele Interest-
ingly, however, this parent-of-ongin-specific methyla-
tion does not parallel the PEG1IMEST expression pat-
tern in all tissues examined In fetal tissues, PEGU 
MEST is monoallehcally expressed from the paternally 
derived allele Despite the biallehc expression otPEGll 
MEST in adult blood lymphocytes, specific DNA meth-
ylation of the maternally derived allele was identical 
to that of adult and fetal tissues From our results, it 
is most likely that methylation at all Hpall sites in the 
putative promoter region is not sufficient to completely 
silence the maternally derived PEG1IMEST allele in 
blood lymphocytes We cannot determine from the pres-
ent data whether there are specific CpGs, which are 
unmethylated on this allele in blood lymphocytes, or 
whether lymphocyte-specific transcription factors 
allowing transcription of the methylated maternally 
derived allele are involved On the other hand, an alter-
nate promoter that is regulated differently and that 
escapes imprinting in blood lymphocytes could be re-
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sponsible. A well-known example of regulation by im-
printing in development by alternate promoter usage 
is the IGF2 gene. The P I promoter is located more than 
20 kb upstream of the 5' CpG island and appears to 
escape imprinting in several adult tissues (Vu and 
Hoffman, 1994; Ekstrom et al, 1995). 
In summary, the results presented here show that 
the human PEG1/MEST gene is imprinted and that it 
contains a CpG island that is differentially methylated 
on maternally and paternally derived chromosomes. 
Our finding of a paternally expressed gene on human 
chromosome 7q32 is interesting in two respects. First, 
there is strong evidence for the existence of at least one 
maternally imprinted gene on the long arm of chromo-
some 7 that controls intrauterine and postnatal 
growth. Maternal UPD for human chromosome 7 was 
found in 3 patients of short stature (Spence et al, 1989; 
Voss et al, 1989; Spotila et al., 1992), and mllPD for 
the long arm of chromosome 7 and pUPD7 for the short 
arm were found in 1 patient with short stature (Eggerd-
ing et al., 1994). In addition, a sytematic study of pa-
tients with either Silver-Russell syndrome or primor-
dial growth retardation revealed mUPD7 in 4 of the 
35 patients investigated (Kotzot et al., 1995). These 
findings contrast with normal growth observed in 1 
known patient with pUPD7 (Hoglund et al, 1994). 
Hitherto it is unclear whether PEG1IMEST plays a 
role in growth or another yet unidentified paternally 
expressed imprinted gene of chromosome 7 is involved. 
In the mouse, maternal duplication of the proximal re-
gion of chromosome 6 is lethal in embryogenesis, possi-
bly because of deficient PegllMest expression. In con-
trast , paternal duplication of the proximal region of 
chromosome 6 is viable, suggesting that the excess gene 
dosage for PegllMest, or of any other imprinted gene in 
this region, has no detectable influence on development 
(Cattanach and Beechey, 1990; Beechey and Catta-
nach, 1995; Kaneko-Ishino et al, 1995). 
Second, Pérez Jurado et al. (1996) determined the 
parental origin of a deletion found in patients with 
Williams syndrome, a neurodevelopmental disorder in-
volving growth retardation. A significant correlation 
between more severe growth retardation of postnatal 
onset among patients with maternal deletion of part 
of chromosomal band 7ql l .23 compared to those with 
paternal deletion was observed. The authors suggested 
that a yet unidentified paternally imprinted gene 
might be involved. A single patient with paternal ìsodi-
somy for chromosome 7 has been reported to date (Hog-
lund et al, 1994). As this patient has normal stature, 
it is likely that , as in the mouse, paternal disomy for 
chromosome 7 has no phenotypic effect on growth. The 
existence of a paternally imprinted gene on human 
chromosome 7 remains to be elucidated. 
There is good evidence that imprinted genes are clus-
tered in chromosomal regions. Human chromosome 11 
harbors several imprinted genes; some are expressed 
from the same parental allele, others from the opposite 
allele. Similarly, the Prader-Willi syndrome/Angelman 
syndrome region of human chromosome 15 contains a 
cluster of imprinted genes, but in contrast to chromo-
some 11, all yet identified monoallelically expressed 
transcripts are exclusively paternal in origin. In addi-
tion, the region is predicted to contain at least one other 
gene that is only expressed from the maternal allele. In 
this respect, it is tempting to speculate that on human 
chromosome 7 too, imprinted genes may be clustered. 
A systematic search for imprinted genes in the vicinity 
of PEG 1 /MEST is in progress. 
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Silver-Russell syndrome (SRS) is a heterogeneous disorder characterised by intrauterine 
and postnatal growth retardation, with or without additional dysmorphic features Most cases are 
sporadic but a few familial cases have been described A subset of patients exhibit maternal 
uniparental disomy for chromosome 7 (mUPD7) strongly suggesting that genomic imprinting 
plays a role in the aetiology of the disease 
We and others have recently characterised the human PEG1/MEST gene, the first imprinted 
gene known to be located on chromosome 7 Although the function of PEG1/MEST is unknown, 
the paternal-specific expression of this gene and its location at 7q32, render it a promising 
candidate for SRS As a prerequisite for mutation screening in 49 patients with SRS and 9 with 
primordial growth retardation (PGR), we determined the complete genomic structure of the 
PEG1/MEST gene which consists of 12 exons 
Apart from one silent mutation and two novel polymorphisms, nucleotide changes were not 
detected in any of these patients Moreover, methylation patterns of the 5' region of PEG1/MEST 
were found to be normal in 35 SRS and 9 PGR patients and different from the pattern seen in 
patients with mUPD7 These findings strongly argue against a role of PEG1/MEST in the 
majority of Silver-Russell syndrome cases 
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Introduction 
Silver-Russell syndrome (SRS) is characterised by intrauterine as well as postnatal growth 
retardation [1,2,3]. Apart from PGR, most of the SRS patients have a triangular face, delayed 
bone maturation, hemihypertrophy and clinodactyly of the fifth fingers. Other less frequent 
anomalies are hypospadia, café-au-lait spots, syndactyly between second and third toes, male 
hypoplasia and excessive sweating. None of these symptoms is obligatory, however; SRS 
patients may have PGR without any additional features. Most SRS cases are sporadic, but 
familial cases also exist. Both, dominant and recessive inheritance has been reported [4,5,6]. 
The molecular basis of this disorder is unknown but its association with different chromosomal 
aberrations argues for genetic heterogeneity. In particular, two cases with severe SRS and 
balanced translocations disrupting the band 17q25 [7,8], one girl with SRS and a ring 
chromosome 15 involving deletion of the IGF1R gene [9] and one patient with Silver-Russell 
syndrome-like features and an interstitial deletion of 8q11-q13 [10] have been found. Moreover, 
numerous studies have shown that matemal UPD7 is associated with SRS or PGR [11-17] 
whereas patemal UPD7 does not give rise to growth retardation [18]. 
Recently, we and others have isolated the imprinted human PEG1/MEST gene [19,20]. The 
gene has been localised to chromosome 7q32 and in all fetal tissues the expression was 
confined to the paternal allele [19]. The precise function of PEG 1/MEST'is unknown although the 
presence of motifs found in alpha/beta-hydrolase-fold enzymes points to a relationship with this 
family. Three strong lines of evidence have implicated PEG1/MEST as a candidate gene for 
Silver-Russell syndrome. Firstly, PEG1/MEST is the first imprinted gene discovered to date 
which is located on chromosome 7. Secondly, its expression is confined to the paternally derived 
allele and therefore inactive in SRS patients with mUPD7. Thirdly, targeted inactivation of the 
paternally derived mouse Peg1/Mest allele results in viable but growth retarded embryos 
(L.Lefebvre and M.A. Surani, personal communication). 
In this study, we have screened 49 patients with SRS and 9 with PGR, all with confirmed 
biparental inheritance of chromosome 7, for mutations and methylation changes in the 
PEG1/MEST gene in an attempt to substantiate its role in these disorders. 
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Materials and methods 
Patients 
DNA was extracted from blood samples as described by Miller et a l , 1988 [21] Matemal 
UPD7 had been excluded for all patients by simple repeat analysis (own results, [15]) 
Genomic structure of PEG 1/MEST 
EcoR\ fragments of cosmid ICRFc113K246Q4, that was known to contain the complete 
PEG 1/MEST gene, were ligated to pT7T318U (Pharmacia) and sequenced One EcoRI 
fragment of 8 5 kb cloned in both orientations was further subcloned by rehgations of BamH\, 
Hind\\\, Pstt, Sma\ and Xba\ digests Sequencing was performed with standard vector primers 
using either the Taq DyeDeoxy terminator cycle sequencing kit (Applied Biosystems) and 
analysed on ABI 377 automated squencer or the Thermo Sequenase cycle sequencing kit 
(Amersham) with IRD-41 labelled primers and analysed on the Li-Cor (MWG-Biotech) 
automated sequencer 
Single strand conformation analysis 
The primers for PCR analysis were designed to cover the putative promoter region, all exons 
as well as the mtron-exon boundaries of PEG1/MEST as outlined in Table 1 For radioactive 
SSCP analysis the primers were endlabelled with T4 polynucleotide kinase (Gibco BRL) and 
[γ32Ρ]ΑΤΡ in 10xkinase buffer PCR fragments were separated on 5% polyacrylamide-
bisacrylamide (19 1) gels with and without 10% glycerol at 45 W, 4°C Gels were transferred to 
filter paper, dried, and exposed to X-ray film for 10-24 h Part of the exons were analysed by 
non-radioactive SSCP using the Multiphor II system (Pharmacia) 1-2 μΙ of PCR product was 
denatured in 95% formamide, 10mM EDTA and loaded on a 8% Polyacrylamide gel (29 1 or 
49 1 acrylamide bis-acrylamide) containing 2% glycerol Electrophoresis was performed for 3-4 
h at 250 V, 15°C or 20 °C in 1 χ TBE For all exons resolution was optimised by applying both 
running conditions Staining of the gels was performed according to standard technique 
Chromosome 7 markers 
Amplification of the dmucleotide repeats D7S2519 and D7S649 was performed with primer 
sets 5"-GGAGGTTAAGATTTACAGACATG-3·, 5'-TATCCTGTGTTTCCTTGTCC-TG-3' and 5'-
TGCTTTATTATGTCTGTTGTATG-3·, S'-ACTGAGTCAAATTTGTA-GAAGTT-S' Thirty five 
cycles of PCR consisted of denaturation at 94°C, 30 sec , annealing at 56°C, 1 mm and 
elongation at 72°C, 1 mm in the presence of 1 5 mM MgCI2 and [a
32P]dCTP Products were size 
fractionated at 60 W for 3 h on standard 6 6 % denaturing Polyacrylamide gels Exposure was 
for 24-48 h 
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Table 1 PCR primers for human PEG1/MEST exons 
'Amplification of the 5' putative promoter region (#) and exon 1 was performed including 10 % 
glycerol and 3 5 % formamide All primers are shown 5' to 3' Exon 5 was amplified with two sets 
of forward primers, the first forward primer was identical to that of exon 4 The product from this 
reaction was used as template in the second PCR 
Methylation analysis 
For methylation analysis the DNAs were digested with (H/ndlll+Hpall) or (Hindlll+Mspl) and 
transferred onto GeneScreen Plus membrane exactly as described previously [19] The 4 3 kb 
Hmdlll probe containing the 5' portion of the PEG1/MESTgene was labelled by random priming 
in the presence of [a32P]dCTP and hybridisations were performed at 65°C Washing was at 
hybridisation temperature in 2XSSC/0 1%SDS (2x10 mm) followed by 1XSSC/0 1%SDS for 15 




Genomic structure of PEG1/MEST 
As a prerequisite for mutation screening in the PEG1/MEST gene, we have first determined 
the complete exon-intron structure. Following subclonmg of EcoR\ fragments of the cosmid 
ICRFc113K246Q4, which had been isolated from a chromosome 7 specific library previously 
and had been shown to contain the entire gene [19], PEG1/MEST positive fragments were 
sequenced Alignment of the genomic and cDNA sequences revealed that the PEG1/MEST 
gene contains 12 exons and encompasses a genomic region of approximately 13 kb Exon-










































































Table 2: Exon-lntron organization of the PEG1/MEST gene. 
The cDNA positions refer to GenBank accession No Y11534 
1 2 3 4 5 6 7 8 9 10 11 12 
1-1 I III III I 14 
Fig. 1. Genomic organization of the human PEG1/MEST gene. Exons are indicated by filled 
boxes, the 5' and 3' untranslated regions are depicted as open boxes 
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Mutation detection by single strand conformation polymorphism (SSCP) 
SSCP analyses were performed to screen for mutations in the putative promoter region and 
all 12 exons of the PEG1/MEST gene To include exon-mtron junctions, primers were designed 
in the corresponding introns In total, three bandshifts were detected, one in the putative 
promoter region and the others in exon 11 and 12, respectively Sequencing of exon 11 and 
exon 12 fragments revealed a single nucleotide change T1065C which is a silent mutation in 
exon 11 and a G1272C substitution which is located in the 3'UTR of the gene The bandshift in 
the putative promoter region was present in three patient DNAs and was also found in 15% of 
control DNAs No other alterations were detected in the 58 patients tested 
In order to exclude the possibility that the patients are distantly related, we investigated two 
polymorphic CA-dinucleotide repeat markers, D7S2519 (accession No Z54039 [22]) and 
D7S649 (accesssion No Z23771 [23]) which are located in the vicinity of the PEG1/MEST gene 
[24] No evidence for allelic association could be obtained which argues against a monophyletic 
origin of SRS 
Methylation analysis in Silver-Russell syndrome and pnmordial growth retardation 
To search for aberrant methylation patterns in the 5' CpG island of the PEG 1/MEST gene 
resulting from 'imprinting mutations' (see below), we performed Southern blot hybridisations with 
DNA from SRS and PGR patients as target and a 4 3 kb Hmd\\\ fragment as probe DNAs were 
digested with Hind\\\ followed by digestion with either Msp\ or its methylation-sensitive 
isoschizomer Hpall PEG1/MEST alleles derived from the mother give rise to a 4 3 kb fragment 
or to fragments of 4 3, 2 3 and 2 kb due to partial methylation of one Msp\ site in the vicinity of 
the CpG island [19] Paternally-derived alleles are completely unmethylated and therefore 
digested by Hpall which is indicated by the presence of a 2 3 kb fragment and several smaller 
fragments As shown in Fig 2, all patients showed a methylation pattern identical to that of 
normal control DNA and different from the pattern observed in patients with ml)PD7 This 
indicates that the paternal allele is not deleted and that both PEG 1/MEST alleles exhibit normal 
parent-of-ongin specific methylation patterns 
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Fig. 2. Methylation analysis of the 5' region of human PEG1/MEST 
in sporadic SRS patients. 
Southern blot containing genomic DNA of sporadic SRS patients, a normal control and a patient 
with mUPD7 digested with either (H/ndlll + Mspl) or (H/ndlll + Hpall) were hybridized with a 4.3 
kb H/ndlll fragment derived from the 5' end of the PEG1/MEST gene encompassing the 
maternal-specific methylated CpG island. Digestion with Msp\ reduces the 4.3 kb H/ndlll band to 
fragments of 2.3, 0.65, 0.45 and 0.3 kb. Because of their small size a few fragments could not be 
detected. Upon digestion with Hpall the unmethylated paternal allele is completely digested 
giving rise to fragments identical in size to the Mspl derived fragments, whereas the methylated 
maternal allele remains either completely undigested or is digested on a partially methylated 
Mspl site located outside the CpG island giving rise to a 2.3 and a 2.0 kb band. All SRS patients 
show a pattern identical to that of a normal control with both a maternal and a paternal 
methylation profile. In contrast, a mUPD7 patient shows, after digestion with Hpall, only a 
maternal methylation pattern with absence of the smaller paternally derived bands. 
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Discussion 
Recently, we have shown that the human PEG 1/MEST gene is imprinted and expressed from 
the paternally derived allele The gene has been mapped to chromosome 7q32 [19] 
The findings of Kotzot ef al [15], Preece et al [16] and Eggermann ef al [17], demonstrating 
that a subset of patients with SRS and primordial growth retardation carry two maternal 
chromosomes 7 while lacking the paternal counterpart, and the previously described association 
between mUPD7 and short stature, suggest that an imprinted gene on chromosome 7 is 
involved in this disorder PEG1/MEST expression from the patemally-denved allele and its 
location on chromosome 7q, as well as the finding that in the mouse, paternal inheritance of the 
inactivated Peg1/Mest allele leads to fetal growth retardation, render it an excellent candidate 
gene for SRS 
In order to find mutations in the PEG 1/MEST gene, we first determined the genomic structure 
which was found to consist of 12 exons Mutation analysis by SSCP and subsequent 
sequencing revealed two novel polymorphisms and a single nucleotide change resulting in a 
silent mutation in exon 11 Very likely, none of these sequence variants is of functional 
importance and no other mutations were found A monophyletic ongin of the SRS patients is 
most unlikely since no evidence for allelic association could be obtained by analysing two highly 
polymorphic microsatelhtes which are located in the vicinity of PEG1/MEST 
Silver-Russell syndrome patients with mUPD7 lack the paternally expressed PEG1/MEST 
gene product Silencing of the maternally derived PEG1/MEST allele is reflected by maternal-
specific methylation of the CpG island at the 5'portion of the gene During gametogenesis 
parental-specific (methylation) marks have to be reset according to the gender of the individual 
In a minority of cases this resetting fails resulting in a wrong parental methylation profile Such 
so-called 'imprinting mutations' have been identified in patients with imprinted gene disorders 
such as Prader-Willi syndrome (PWS), Angelman-syndrome (AS) and Beckwith-Wiedemann 
syndrome [25,26] In PWS and AS the imprinting mutations arise in the imprinting center which 
regulates imprinted gene expression and methylation over a distance of several hundred 
kilobases [27] In this region, tissue-specific imprinting for UBE3A has been observed with 
expression from the maternally-derived allele in the brain but biallelic expression in other fetal 
tissues and adult lymphocytes and fibroblasts [28,29] The PEG1/MEST gene is also biallelically 
expressed in adult blood cells but parent-specific methylation differences are still present In all 
SRS patients tested, analysis of the critical 5' region of the PEG1/MEST gene revealed 
methylation patterns identical to that of normal control DNAs These findings rule out silencing of 
PEG1/MEST in the SRS by aberrant methylation of the putative promoter region caused by 
'imprinting mutations' Taken together, the absence of mutations in the PEG1/MEST putative 
promoter region and the entire coding region including exon/mtron boundaries and the normal 
methylation patterns of the 5' CpG island, strongly argue against an involvement of the 
PEG1/MEST gene in the majority of SRS cases We cannot, however, completely rule out a role 
for PEG1/MEST in SRS Patients with mUPD7 lack the PEG1/MEST gene product and 
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disruption of the paternal allele is suspected to have a negative effect on growth as deduced 
from the gene targeting experiments in mice. Since SRS is heterogeneous, mutations in any of 
the genes could be present in a relatively small number of SRS cases. 
In mice, maternal duplication of the proximal region of chromosome 6, including Peg1/Mest 
leads to embryonic lethality, whereas paternal duplication of this region is viable [30]. It is not 
understood yet why mice with maternal disomy for this region die in embryogenesis whereas in 
humans mUPD7 is associated with a relatively mild phenotype. The leaky expression of the 
maternal PEG1/MEST gene observed in humans but not in the mouse could be sufficient to 
avoid embryonic lethality [20,31]. In mice, imprinting and X-inactivation processes are, in 
general, more strictly regulated than in humans which might explain the more severe problems 
observed upon parent-specific duplications of imprinted regions. 
Imprinted genes tend to be clustered, as documented for the human and mouse genome. In 
humans, two major clusters, one on chromosome 15q11-q13 and the other on chromosome 
11p15.5, have been identified. It is therefore tempting to speculate that apart from PEG1/MEST, 
the relevant region on chromosome 7 harbors additional imprinted genes one of which may be 
involved in SRS and/or primordial growth retardation. The imprinting status of expressed 
sequences from this region is currently being investigated. 
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8.1 Function and imprint regulation of the Insulin-like growth factor 
type 2 receptor gene 
Functions of the Insulin-like growth factor type 2 receptor gene, IGF2R 
IGF2R is a large gene spanning a genomic region of approximately 93 kb in mouse and 130 
kb in human (Szebenyi and Rotwein, 1994, Riesewijk et a l , 1996) The gene product is identical 
to the cation-independent mannose 6-phosphate receptor (CI-MPR) and has separate binding 
sites for IGF2 and phosphomannosyl residues (Morgan et a l , 1987) IGF2R is expressed 
ubiquitously, 90 % of the receptors are present mtracellularly and the remaining 10 % are 
located in the cell membrane Main functions of the IGF2-receptor include the trafficking of newly 
synthesised lysosomal enzymes from the Golgi apparatus to the lysosomes, and the 
endocytosis of extracellular lysosomal enzymes However, its function in the turnover of IGF2 is 
equally important Binding of IGF2 to the IGF2-receptor leads to mtemalisation and degradation 
of the growth factor within the lysosome (Kornfeld, 1992). 
Igf2r knock-out mice die shortly after birth and are approximately 30 % larger than their 
normal httermates (Lau et a l , 1994, Wang et a l , 1994) Mutant mice missort mannose 6-
phosphate tagged proteins but this defect is at least partly compensated by the cation-
dependent mannose 6-phosphate receptor (Wang et a l , 1994) Both the lethality and the 
overgrowth observed in the Igf2r knock-out mice are thought to be caused by an excess of Igf2 
proteins Indeed, Igf2r mutants are completely rescued by a second mutation eliminating the 
paternal Igf2 allele (Ludwig et a l , 1996, Filson et a l , 1993) Igf2 exhibits its growth promoting 
activities via the Igf1-receptor, and Igf2r mutants are also rescued by a mutation in the Igflr 
gene (Ludwig et a l , 1996, Liu et a l , 1993, Baker et a l , 1993) 
The highest levels of IGF2 proteins are found in the human liver where expression is derived 
from the P1 promoter In contrast to the three imprinted promoters controlling Igf2 expression in 
mice, the P1 promoter, which is present only in humans, gives rise to biallelic IGF2 expression 
This P1 promoter may have become necessary to compensate for the biallelic IGF2R 
expression in humans and to prevent an abnormally high IGF2 turnover in human liver 
Besides IGF2 also other secreted factors, such as proliferili and the latent transforming 
growth factor ß1 (TGFßl ) complex can bind to IGF2R Although binding of these factors will lead 
to mtemalisation and degradation, it is also known that the extracellular activation of the growth 
inhibitor TGFßl is facilitated by the binding of the TGFßl latent complex to IGF2R (Dennis and 
Rifkin, 1991) Thus, IGF2R seems to play an important role in growth control as it is involved in 
both the mactivation of growth promoters and the activation of growth inhibitors 
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IGF2R, a tumour suppressor gene 
In several cancers the expression of imprinted genes is disturbed Biallelic IGF2 expression 
due to loss of imprinting (LOI ) is found in many malignancies and leads to higher IGF2 
concentrations, which is known to be oncogenic However, the IGF2 concentration is not only 
determined by its production but also depends on its degradation which, as described above, is 
mediated by IGF2R In hepatocellular carcinomas (HCC) the expression of IGF2R was found to 
be significantly reduced, and genetic analysis revealed loss of heterozygosity (LOH) at the 
IGF2R locus in 70 % of human hepatocellular tumours (De Souza et a l , 1995a) In 25 % of the 
tumours with LOH, mutations resulting in a truncated receptor or significant amino-acid 
substitutions (De Souza et a l , 1995b) have been identified Furthermore, LOH for the IGF2R 
locus was observed in early stages of liver tumour formation In human as well as in mice (De 
Souza et a l , 1997, Yamada et a l , 1997) These results strongly suggest that IGF2R is a tumour 
suppressor gene Moreover, deletions and LOH of 6q have been observed as recurrent changes 
in breast cancer, and LOH at the IGF2R locus was found in 30 % of the patients (Hankms et a l , 
1996) The finding of missense mutations in 40 % of the patients with LOH firmly establishes a 
tumour suppressor function for the IGF2R gene (Hankms et a l , 1996) 
In mice, the Igf2r gene is expressed from the maternal allele only This means that in mice 
only one single mutation at the maternal allele is required to abolisch IGF2R function whereas in 
humans two mutational events (e g LOH and a mutation in the second allele) are necessary 
Indeed, mice are more sensitive to liver tumour formation (De Souza et a l , 1997) and 
differences in imprinting between mice and human should be taken into account in carcinogen 
risk assessment analysis 
It has been suggested that in humans, imprinting of IGF2R might be a polymorphic trait (Xu 
et a l , 1993) If so, "imprinters" who silence their paternal IGF2R allele would be at a higher risk 
for tumour formation Although Xu et al found that in 7/16 patients with Wilms Tumour (WT) the 
paternal IGF2R allele was markedly repressed in both tumour and normal kidney tissue, the 
frequency of partial IGF2R imprinting in WT appeared to be the same as the percentage of 
"imprinters" they found in fetal kidney and placenta, prior to 20 weeks of fetal age (Xu et a l , 
1997) 
However, debate is still ongoing whether the partial paternal repression observed is really 
caused by genomic imprinting We and others have found biallelic IGF2R expression in all 
tissues tested including several fetal tissues under 20th week of gestation In one fetus with 
complete repression of the paternal allele we were unable to find paternal specific methylation of 
the promoter region, a feature that is characteristic for the silencing of the murine Igf2r gene by 
genomic imprinting (see chapter 4) Moreover, in patients with hepatocellular carcinomas and 
breast cancer, the reduction in IGF2R expression, combined with LOH and mutations found in 
the remaining IGF2R allele suggest a biallelic expression pattern (De Souza et a l , 1995b, 
Hankms et a l , 1996) This indicates that either the percentage of imprinted individuals is very 
low, at least much lower than the 40 % described by Xu et a l , or that the partial repression they 
found is not attributable to genomic imprinting If so, the repression seen could be attributed to 
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allele-specific transcription differences or to diffeculties of the technical procedures used RT-
PCR is known to be very sensitive but may also lead to different amplification of the two alleles 
More studies are required to determine whether or not polymorphic Imprinting of IGF2R in 
humans really exists 
Mechanism of Igf2r imprinting 
Recently, Wutz et al presented a novel mechanism for the imprinting of Igf2r in mice (Wutz 
el a l , 1997) Introduction of a yeast artificial chromosome (YAC) containing the murine Igf2r 
gene m ES cells, followed by the generation of transgenic mice, resulted in monoallelic maternal-
specific expression of the transgene This indicates that the imprinting signal Is located within the 
YAC The maternal-specific methylated CpG island, located in intron 2 of the IGF2R gene, is 
thought to carry the primary imprinting signal since this region is methylated in oocytes but not in 
sperms Moreover, this methylation difference is preserved during early embryogenesis and 
throughout development (Stöger et a l , 1993) Indeed, a deletion of a 3kb region comprising this 
CpG island resulted in loss of imprinting Further research revealed that this intronic CpG island 
is in fact the promoter of an antisense RNA molecule This RNA is transcribed from the paternal 
allele only Transgenes with an inactive Igf2i promoter did not methylate the maternal intronic 
CpG island and had biallehc expression of the antisense RNA, whereas Igf2r was completely 
silenced (Wutz et a l , 1997) Several mechanisms have been proposed to account for the 
imprinted expression of Igf2r The antisense RNA could bind in as to the paternal chromosome 
region, resembling the in as binding of Xist RNA to the inactive X chromosome, and induce the 
formation of inactive chromatin on the paternal allele On the other hand, an enhancer 
competition model as proposed for H19 and Igf2 could be valid for the Igf2r region as well Yet 
another possibility is the clustering of antisense RNA around the paternal Igf2r promoter, thereby 
inhibiting the binding of transcription factors (Wutz et a l , 1997, Reik and Constancia, 1997) 
An intriguing question at the moment is whether or not this antisense IGF2R RNA is 
expressed in humans Although we and others have demonstrated that the intronic CpG island is 
present at a similar location in the human IGF2R gene and that its maternal specific methylation 
pattern is conserved as well (Smrzka et a l , 1995, Riesewijk et a l , 1996), the sequence 
homology between the murine and human CpG islands is limited to a 38 bp region (chapter 3) 
were only 71 % homology was found When considering its function as a tumour suppressor 
gene, transcriptional silencing of the of the paternally expressed antisense RNA, resulting in 
biallelic IGF2R expression, could have become advantageous during evolution It is possible that 
the maternal-specific methylation mark is just an evolutionary remnant and of no functional 
importance Chromatin accessibility experiments showed that the region surrounding the intronic 
CpG island is heterochromatic on both the paternal and the maternal allele (own unpublished 
results) This suggests that this CpG island is not being used as a promoter 
Interestingly, Xu et al found an association between a certain IGF2R allele (called '162') and 
absence of imprinting (Xu et a l , 1997) This 162 allele is the most common IGF2R allele in the 
human population whereas the unprintable alleles are much rarer In combination with certain 
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trans-acting factors a minority of the individuals with a non-162 allele might be able to silence the 
paternal IGF2R allele These individuals should express the antisense RNA found in mice and 
(non)detection of this RNA should end the discussion whether or not IGF2R imprinting exists in 
humans 
The Mas proto-oncogene is closely linked to the Igf2r gene In mice, paternal specific 
expression is found in several fetal tissues (Villar and Pedersen, 1994) In humans, however, 
this gene is biallehcally expressed in all tissues of several first and second trimester fetuses 
tested (see chapter 5) The close association between IGF2R and MAS in both humans and 
mice, combined with the loss of imprinting of both genes in human, suggest that a regional 
imprinting control element might be missing or defunct in humans The identification of the 
antisense RNA molecule regulating Igf2r imprinting in mice may mean that this is the m cis 
regulator and that it induces the imprinting of the Mas gene as well It would be of interest to see 
whether targeted deletion of the 3 kb fragment encompassing the promoter of this RNA results in 
loss of imprinting of Mas too If so, absence of this antisense RNA molecule in humans would 
also explain the biallelic expression of the human MAS gene 
A role for IGF2R in the Beckwrth-Wiedemann syndrome'' 
An important molecular feature of the Beckwith-Wiedemann syndrome (BWS), a fetal 
overgrowth disorder involving several imprinted genes (see general introduction for a 
description), is the biallelic expression of IGF2 Almost 80% of the cytogenetically normal BWS 
patients shows loss of imprinting for IGF2 (Reik and Maher, 1997) Moreover, transgenic mice 
overexpressmg IGF2 show a dosage-dependent appearance of many of the BWS 
characteristics (Sun et a l , 1997) Another overgrowth disorder, the X-lmked Simpson-Golabi-
Behmel syndrome (SGBS) shares many characteristics with BWS Recently, mutations in the 
glypican 3 gene (GPC3) were found in several cases of SGBS (Piha et a l , 1996) Interestingly, 
this protein was shown to bind IGF2 and might function as a co-receptor for IGF2R Thus the 
overgrowth seen in SGBS patients might be due to an excess of IGF2 as well Furthermore, in 4 
out of 6 non-syndromic overgrowth patients relaxation of IGF2 imprinting was observed (Monson 
et a l , 1996) Taken together, these results indicate that IGF2 plays a major role in human 
overgrowth disorders Moreover, different genetic defects leading to an increase of IGF2 can 
result in a similar phenotype The level of IGF2 proteins depends not only on the synthesis of 
new IGF2 molecules but also on the degradation of IGF2, which is regulated by IGF2R 
Therefore, increased IGF2 concentrations leading to overgrowth might result either from 
mutations in IGF2R, or from a reduction in the synthesis of IGF2R protein by LOH or promoter 
mutations It will be interesting to see whether IGF2R mutations occur in patients with BWS or 
other overgrowth syndromes that do not involve biallelic IGF2 expression 
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8.2 Silver-Russell syndrome and the PEG1/MEST gene 
SRS, a genetic heterogeneous growth retardation syndrome 
Silver-Russell syndrome (SRS) is characterised by severe intrauterine and postnatal growth 
retardation (PGR) Most SRS patients also have other minor anomalies such as a triangular 
face, delayed bone maturation, hemihypertrophy and clmodactyly of the fifth fingers The 
incidence of SRS is not Known In the literature, more than 380 patients have been described, 
but the syncrome might be underdiagnosed since SRS patients may have PGR without any 
additional features (Wollmann et a l , 1995) The molecular basis of the disorder is unknown and 
both recessive and autosomal dominant transmission has been reported although most cases 
are sporadic (Al Fifi et a l , 1996, Teebi, 1992, Duncan et a l , 1990) In familial cases, male-to-
male transmission is very rare which is compatible with an X-lmked form of SRS Moreover, 
chromosomal abnormalities involving chromosome 8, 15, and 17 have been associated with 
SRS, arguing for genetic heterogeneity of the disorder (Schinzel et al., 1994, Ramirez Dueñas et 
a l , 1992, Midro et a l , 1993, Tamura et a l , 1993) In particular, distal 15q deletions or ring 
chromosomes 15 including LOH for the IGF1R gene region have been observed However, LOH 
or mutations in the two important domains of IGF1R were not found in 33 sporadic, 
cytogenetically normal SRS patients arguing against a role of IGF1R in SRS (Abu-Amero et a l , 
1997) 
About 10 % of the SRS patients have two maternal but no paternal chromosome 7 (Kotzot et 
a l , 1995, Preece et a l , 1997, Eggermann et a l , 1997) Maternal uniparental disomy (mUPD) for 
chromosome 7 (mUPD7) is the most frequent abnormality found in SRS Maternal UPD7 has 
also been observed in patients with PGR, whereas patemal UPD 7 has no effect on growth 
(Höglund et a l , 1994) Presumably, a maternally imprinted gene on chromosome 7 is 
responsible for growth retardation in at least a subset of SRS patients At present only one 
imprinted gene has been identified on chromosome 7, the Paternally Expressed Gene 1 (PEG1), 
also called Mesodermal Specific Transcript (MEST) 
PEG1/MEST, a candidate gene for SRS 
The PEG 1/MEST gene maps to 7q32 and is paternally expressed in all fetal tissues tested 
whereas it is biallelically expressed in adult lymphocytes indicating tissue or stage specific 
imprinting (Kobayashi et a l , 1997, Nishita et a l , 1996) (chapter 6) We identified a maternal-
specific methylation mark of the promoter associated CpG island of PEG1/MEST, which most 
likely silences the maternal allele (Riesewijk et a l , 1997) In the mouse Peg1/Mest gene, 
Lefebvre et al have recently found an identical methylation mark which is absent in sperm DNA 
(Lefebvre et a l , 1997) Furthermore, they identified a 122 bp G-rich region containing 24 tandem 
repeats, an apparently characteristic feature of imprinted genes, in a region just preceding exon 
2 It is not clear yet whether the human PEG 1/MEST gene contains this repeat region too 
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Surprisingly, the methylation profile in adult blood cells, which have biallelic PEG1/MEST 
expression, Is identical to that of fetal cells where the maternal allele is silent (chapter 6) With 
methylation sensitive restriction enzymes, differences in the methylation level of individual CpG 
sites between adult lymphocytes and fetal tissues could not be excluded Preliminary results 
using sodium bisulphite analysis to determine the methylation state of every individual CpG site 
within the promoter region did not reveal any methylation differences (Blagitko et a l , 
unpublished results) Alternatively, the biallelic expression in lymphocytes could be under the 
control of a tissue specific promoter and/or transcnption factors In contrast to human 
lymphocytes were PEG1/MEST is biallehcally expressed, both fetal and adult mouse 
lymphocytes show monoallelic, paternal-specific expression of this gene (Reule and Fúndele, 
Berlin, pers comm , March 1997) 
PEG1/MEST is highly expressed in early embryonic stages but expression decreases from 
late embryonic stages onwards (Kobayashi et a l , 1997) Leaky expression from the maternal 
allele was demonstrated in embryonic and chorion RNA from 6 to 9 week old human fetuses 
Since at these stages PEG1/MEST expression is high, leaky expression might result from an 
increased transcriptional pressure However, leaky expression was never observed in mouse 
samples of any age PEG 1/MEST transcripts are easily detectable in lymphoblastoid cell lines of 
mUPD7 patients and normal controls Furthermore, although not tested by quantitative RT-PCR, 
the expression levels of paternal and maternal PEG 1/MEST alleles seemed equivalent in adult 
blood (chapter 6) 
Tissue specific imprinting differences between mice and human have been reported for at 
least two other imprinted genes The human IGF2 gene Is biallehcally expressed in human liver 
whereas in the mouse, monoallelic expression is maintained (Kalscheuer et a l , 1993) 
Moreover, in human placentae biallelic expression of the H19 gene has been found (Jmno et a l , 
1995) In all three cases (ι e IGF2, H19 and PEG1/MEST) it is the human gene which displays a 
biallelic expression pattern Since imprinting and X-inactivation processes are in general more 
strictly regulated in mice than in humans this might explain the more severe problems observed 
upon parent-specific duplications of imprinted regions in mice Maternal disomy for chromosome 
17 in mice is lethal whereas maternal disomy for chromosome 6, the homologous region in 
humans, leads to a normal phenotype (Welch et a l , 1990, Abramowicz et a l , 1994, Cattanach 
and Beechey, 1990) Furthermore, mUPD7 leads to growth retardation whereas mUPD for the 
proximal part of murine chromosome 6, containing the imprinted Peg1/Mest gene, is lethal 
(Kotzot et a l , 1995, Beechey and Cattanach, 1989) The same is true for pUPD11 in humans, 
which leads to BWS but is not lethal whereas mice with paternal disomy for the homologous 
region on chromosome 7 die in early embryogenesis (Henry et a l , 1991, Beechey and 
Cattanach, 1997) 
At least three lines of evidence support the notion that PEG1/MEST plays a role in the growth 
retardation observed in SRS patients Firstly, PEG1/MEST is the only imprinted gene identified 
on chromosome 7 Moreover, it is located on the long arm of chromosome 7 which, based on the 
description of a patient with postnatal growth retardation and mUPD7q/pUPD7p, is expected to 
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contain an imprinted growth controlling gene (Eggerdmg et a l , 1994) Secondly, PEG1/MEST 
expression is confined to the paternal allele which means that S RS patients with mUPD7 lack 
this gene product Thirdly, a knock-out mouse for the Peg1/Mest gene is growth retarded but 
exhibits no other abnormalities Thus the case for this knock-out strain being a mouse model for 
SRS, and for PEG i/MEST and SRS genes being identical is quite strong Therefore, our inability 
to detect PEG 1/MEST mutations in a large cohort of unrelated SRS patients is quite surprising 
Methylation and mutation analysis of the promoter region, of all exons and the exon-mtron 
boundaries in 49 sporadic SRS patients and 9 patients with PGR did not reveal any mutation, 
except for a silent T1065C substitution in exon 11 and two polymorphisms (chapter 7) These 
results indicate that in the majority of SRS patients PEG 1 /MEST abnormalities are not involved 
However, we did not look at expression differences or abnormal splicing of the RNA Moreover, 
changes in the expression level of PEG1/MEST in fetal tissues could not be examined since, for 
obvious reasons, RNA from fetuses with SRS was not available It would be of interest to see 
whether the tandem repeats preceding the murine Pegl/Mest exon 2 are present in human as 
well If so, sequence variations in these repeats might be present in SRS patients SRS is a 
genetically heterogeneous disorder and mutations in any of the SRS genes are expected in only 
a portion of the patients Still a group of 49 patients as analysed in this thesis should be large 
enough to identify mutations in PEG1/MEST were this gene to play a major role in the aetiology 
of SRS 
In order to determine the methylation profile of the promoter associated CpG island we have 
established a test which identifies the parental specific methylation differences This test is also 
useful for the identification of rnUPD7 patients, especially in those cases were no parental 
material is available There are no clinical differences between SRS patients with and without 
mUPD7 Since 10 % of the SRS patients exhibit mUPD7, this test might be used in the 
diagnostic evaluation of any patients with unexplained growth retardation and features 
suggestive of the Silver-Russell syndrome 
Other imprinted genes on chromosome T> 
Although no other imprinted genes have been identified in the vicinity of Peg1/Mest yet, the 
differences in phenotype between maternal disomy for the proximal region of chromosome 6 
(which is lethal) and the Peg1/Mest knock-out mouse (which is small but viable), as well as the 
general tendency of imprinted genes to form clusters, suggest the presence of other imprinted 
gene(s) in this region Possibly, one of them plays a role in the aetiology of SRS To identify 
these genes we employed different strategies eg by making use of cDNA 
subtraction/hybridisation methods and differential display techniques to identify genes that are 
differentially expressed in mUPD7 patients and normal controls In parallel, we used standard 
cloning techniques to identify expressed sequences in the vicinity of PEG1/MEST 
None of the clones identified with the cDNA subtraction/hybridisation method mapped to 
chromosome 7 The characterisation of clones derived by differential display is under way, but 
so far none of these clones mapped to chromosome 7 either For our studies we used RNA 
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isolated from Epstein-Barr virus (EBV) transformed lymphoblastoid cell lines In these cells 
PEG1/MEST is biallehcally expressed as we found dunng the course of our investigations The 
expression of clustered imprinted genes is often regulated in a co-ordinate way, for example the 
spatial and temporal expression patterns of H19 and IGF2 are quite similar (Ohlsson et a l , 
1994) Therefore it is possible that in lymphoblasts other imprinted genes in the PEG1/MEST 
region are also biallehcally expressed, or maybe silenced Likewise, it is possible that they are 
not expressed in adult cells but only in fetal stages or that their expression is confined to specific 
cell types 
In order to establish a detailed map of the PEG1/MEST region we constructed a YAC, PAC 
and cosmid contig surrounding PEG1/MEST Within this contig we now map, characterise and 
analyse the expression of known and new expressed sequences Any gene from this region 
showing an imprinted expression pattern will be a promising new candidate for SRS 
6.3 Mechanism and function of genomic imprinting; 
still more questions than answers 
Gene silencing mechanisms in genomic impnnting 
It is not known whether all imprinted genes are silenced in a similar manner Accumulating 
data suggest that differential methylation is involved in most of the imprinted genes Promoter 
methylation is associated with silencing of the imprinted allele but in many cases, this 
methylation is secondary to the silencing of the gene Methylation of specific CpG sites is 
associated with the marking of one parental allele, which can either be the active or the inactive 
one, and could function as the primary imprint However, other silencing mechanisms are 
involved as well In many imprinted gene clusters ORF-less RNAs have been identified and 
these RNAs could, in analogy with Xist, bind to the DNA from which they are expressed and 
introduce an inactive chromatin structure (Clemson et a l , 1996, Wevrick et a l , 1994, Bartolomei 
et a l , 1991, Dittnch et a l , 1996, Wutz et a l , 1997, Reik and Constancia, 1997) Chromatin 
inactivation may then spread into neighbouring DNA which could provide an explanation for the 
clustering of imprinted genes 
Silencing mechanisms used by imprinted genes may operate in organisms which do not 
exhibit imprinting In Drosophila the 5' region of the H19 gene which is necessary for H19 
imprinting in mice, functions as a silencing element (Lyko et a l , 1997) The silencing observed 
was parent independent, bidirectional and did not involve DNA methylation These results 
suggest that an evolutionary conserved mechanism, which does not involve DNA methylation is 
responsible for both gene silencing in Drosophila and imprinting in mice 
The elucidation of the silencing mechanisms used by imprinted genes remains a major task 
for the future The various imprinted regions of the human chromosomes may have developed 
different strategies for gene silencing Depending on their need for specific cis-actmg factors 
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silencing might be induced by enhancer competition or by heterochromatinization due to the in 
as binding of ORF-less RNAs Furthermore, the importance of the direct repeats In the 
acquisition of a primary methylation mark needs to be investigated, as well as the involvement of 
other factors implicated in chromatin structure and gene silencing such as histon deacetylases 
and heterochromatic proteins 
Function of genomic impnntmg 
The process of genomic imprinting is restricted to mammals suggesting that it plays a role in 
a mammal-specific aspect of reproduction One of the hallmarks of mammalian development is 
the formation of the placenta, an organ which mediates the interaction between embryo and 
mother during intrauterine growth Most imprinted genes identified do have a function in 
embryonic and placental growth control In general paternally expressed genes enhance growth 
whereas maternally expressed genes reduce growth and control development 
Conflicting interests between paternal and maternal genes are the basis for the "parental 
war" hypothesis (Moore and Haig, 1991) For the mother it is important to balance the need of 
the fetus and her own nutritional requirements by promoting genes that control growth and 
development However, a larger embryo will have a better fitness, and since future pregnancies 
can be sired by other males the father's interests are best served by providing his offspring with 
genes promoting embryonic and placental growth Interestingly, the elimination of Igf2 and Igf2r, 
two reciprocally imprinted genes acting in the same pathway, leads to a normal development 
and it may very well be that pairs of imprinted genes have developed during evolution (Ludwig et 
a l , 1996. Filsonetal,1993) 
Other theories propose that control of placental growth and protection of the mother from the 
invasive trophoblast are the mam causes of genomic imprinting Malignant trophoblast disease, 
which is caused by pregnancy, is a very invasive and often lethal disorder In contrast, ovarian 
tumours derived from parthenogenetically activated oocytes are benign Varmuza and Mann 
(1994) suggested that genomic imprinting is used to shut off the genes involved in trophoblast 
formation in the oocyte, and that the absence of imprinting would lead to an aggressive and 
invasive nature of the ovarian tumours resulting in a higher death rate for females 
Yet another theory suggests that imprinting may have originated from a proposed host 
defence mechanism involving methylation of foreign DNA sequences (Barlow, 1993, Jaenisch, 
1997) Specific features of foreign DNA, such as specific integration structures or the presence 
of repeated sequences, could attract DNA methyltransferase Short repetitive sequences are 
often found in the vicinity of differential methylated regions of imprinted genes They might form 
specific structures triggering the de novo methylation in the male or female germlme, or during 
early postfertilization development The imprinted murine U2af1-rs1 gene is most likely a 
retroposon of the non-imprinted U2af1-rs2 gene (Nabetani et a l , 1997) In contrast to its non 
imprinted counterpart, U2af1-rs1 contains some unique repeats in the 5' untranslated region 
(UTR) which might represent the modification needed for the maternal-specific methylation and 
silencing of this gene The imprinting of U2af1-rs1 may be related to that of transgene imprinting 
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which is also characterised by maternal-specific methylation 
At present it is not possible to distinguish between the different theories The isolation of 
other imprinted genes, and the elucidation of their functions has to be awaited However, the 
observation that most imprinted genes are involved in embryonic growth control combined with 
the absence of imprinting in oviparous vertebrates, suggests that genomic imprinting has 
originated as a means to control intrauterine growth The recent observation that p73, a 
homologue of the tumour suppressor gene p53, is imprinted provides a direct link between 
imprinting and tumongenesis (Kaghad et a l , 1997) Like p53, overexpression of p73 results in 
the inhibition of cell growth and apoptosis (Jost et a l , 1997) One of the genes activated by p73 
is the cell-cycle inhibitor p21waf1 which binds to the proliferating cell nuclear antigen (PCNA) 
PCNA is involved in DNA replication and co-ordinates the activity of the DNA methylase 
enzyme DNA methylation is negatively regulated by the association of p21waf1 to PCNA which 
prohibits the binding of PCNA to the DNA methylase enzyme (Chuang et a l , 1997, Baylin, 
1997) Processes as diverse as DNA replication and methylation as well as imprinting and 
tumongenesis are linked by the activity and gene regulation of p73 Like many other imprinted 
genes p73 remains imprinted during postnatal development and throughout adulthood This 
indicates the relevance of genomic imprinting as a means to control cell differentiation and 
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Genomic imprinting is an epigenetic mechanism resulting in the parental-specific expression 
of genes Only a small portion of mammalian genes are subject to genomic imprinting Yet, 
these imprinted genes play an important role in various genetic disorders and in tumongenesis 
In this thesis we have focussed on the identification of new human imprinted genes and and on 
the mechanisms by which a cell recognises and silences a specific parental allele 
Most genes that are imprinted in mice are also imprinted in humans However, this is not the 
case for the IGF2R gene which, in contrast to its imprinted murine homologue, is biallelically 
expressed in humans This is corroborated by the observation that neither paternal nor maternal 
UPD6 patients are associated with clinical symptoms that are due to altered IGF2R expression 
(see chapter 2) Comparison of the murine and human IGF2R genes provides a model system 
to identify regions or sequences that are important for imprinted gene expression We found that 
similar to the murine Igf2r gene, the human IGF2R gene contains two CpG islands, one 
surrounding the promoter region and one in intron 2 The maternal hypermethylation of the 
mtronic CpG island is conserved between humans and mice In contrast, the promoter-associated 
CpG island is completely unmethylated on both parental chromosomes in humans whereas in mice 
the paternal allele is hypermethylated (chapter 3) It has been proposed that in humans imprinting 
of the IGF2R gene might be a polymorphic trait However, our analysis of one fetus showing 
maternal-specific IGF2R expression suggests that silencing of the paternal allele is not due to 
genomic imprinting (chapter 4) 
The munne Mas proto-oncogene was recently shown to be imprinted and closely linked to 
the Igf2r gene As most imprinted genes are found in clusters the identification of a second 
imprinted gene in the vicinity of Igf2r was not unexpected We isolated the human homologue 
(MAS) and assigned this gene to chromosomal bands 6q25 3-q26 in close proximity to the IGF2R 
gene By making use of an novel intragenic polymorphism we demonstrated that the MAS gene is 
biallelically expressed in all tissues examined Hence both MAS and the neighbouring IGF2R gene 
are not imprinted in humans (chapter 5) This suggests that in the human IGF2R gene cluster, a 
regional control on imprinted gene expression is lost or defunct Recently, a paternally 
expressed Igf2r antisense RNA molecule was identified in the mouse This RNA uses the 
intronic CpG island as a promoter and absence of this CpG island leads to silencing of the Igf2r 
transgene Possibly the transcription of this antisense RNA in humans is suppressed which 
would explain the biallelic expression of IGF2R, and maybe also of MAS 
To identify new imprinted genes in the human genome we isolated the human homologue of 
Peg1/Mest, an imprinted gene identified in the mouse by subtraction hybridisation Expression 
analysis, using a newly identified intragenic polymorphism, revealed that PEG1/MEST is 
monoallehcally transcribed in all fetal tissues examined In two informative cases, expression 
was shown to be confined to the paternally derived allele In contrast to the monoallelic 
expression observed in fetal tissues, biallelic expression was evident in adult blood 
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lymphocytes A maternal-specific methylation mark was identified at a CpG island surrounding 
the 5' end of the PEG 1/MEST gene (chapter 6) 
The human PEG1/MEST gene maps to chromosome 7q32 Patients with mUPD7 are 
affected by the Silver-Russell syndrome (SRS), a growth retardation disorder, indicating that an 
imprinted gene on chromosome 7 is involved in this disease The localisation of PEGI/MESTto 
7q32 combined with its paternal specific expression and the phenotype of a Р ді/Mest knock­
out mouse, render PEG1/MESTar\ excellent candidate gene for this disorder As a prerequisite 
for mutation screening we determined the complete genomic structure of the PEG1/MEST gene 
which consists of 12 exons Apart from one silent mutation and two novel polymorphisms, 
nucleotide changes were not detected in any of the 49 SRS patients tested with SSCP 
Moreover, methylation patterns of the 5' region of PEG1/MEST were found to be normal in 35 
SRS patients and different from the pattern seen in patients with mUPD7 (chapter 7) These 
findings strongly argue against a role of PEG1/MEST in the majority of SRS patients, suggesting 
that yet another impnnted gene on chromosome 7 is involved in growth retardation and SRS 
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In de kern van elke cel in ons lichaam bevinden zich de chromosomen, de dragers van ons 
erfelijk materiaal leder chromosoom maakt deel uit van een paar waarvan één chromosoom 
afkomstig is van de moeder en één van de vader Op de chromosomen liggen de genen Van 
elk gen zijn er dus twee kopieën De meeste genen zijn zo gereguleerd dat de matemale en de 
patemale genkopie op hetzelfde moment aktief of inactief zijn Dit is echter niet het geval bij 
genen die aan genomische imprinting onderhevig zijn Voor deze genen wordt het al dan niet 
doen gelden van hun eigenschappen bepaald door het feit of ze van de vader of van de moeder 
afkomstig zijn Van sommige genen is alleen de matemale genkopie aktief terwijl de patemale 
genkopie is uitgeschakeld Voor weer andere genen geldt de tegenovergestelde situatie Het 
bestaan van deze ouderafhankelijke regulatie impliceert dat gelmprmte genen een markering 
(imprint) dragen om te onthouden van welke ouder ze afkomstig zijn BIJ bepaalde erfelijke 
ziekten en ook bij kanker spelen geimpnnte genen en hun regulatie een belangrijke rol Het 
ouderafhankelijke gedrag van geimprmte genen wordt zichtbaar in de overerving van deze 
ziekten Indien het gen voor ziekte X door genomische imprinting uitgeschakeld wordt als het 
van de vader komt, kan deze ziekte alleen optreden als het betreffende gen via de moeder is 
verkregen Immers, de patemale genkopie is niet aktief en eventuele mutaties daarin zullen dus 
zonder gevolgen blijven In dit proefschrift is gezocht naar nieuwe geimprmte genen in de mens, 
en aan de hand van de resultaten is getracht het mechanisme van genomische imprinting te 
doorgronden 
In de muis zijn een aantal genen bekend die door genomische imprinting gereguleerd 
worden Aangezien de muis en de mens genetisch gezien veel op elkaar lijken is het 
waarschijnlijk dat in de muis geimpnnte genen ook in de mens geimpnnt zijn Dit is echter niet 
het geval bij het insulme-achtige groeifactor type 2 receptor gen (IGF2R) In de muis is van dit 
gen alleen de matemale kopie aktief terwijl in de mens zowel de matemale als de paternale 
genkopie aktief zijn Door het humane en het muizen IGF2R gen met elkaar te vergelijken is een 
beter begrip opgebouwd van de sequenties en structuren die belangrijk zijn voor de regulatie 
van genomische imprinting 
In geimpnnte genen komen vaak ouderafhankelijke verschillen in methylatiepatronen voor 
Hierbij gaat het met name om de methylermg van CpG eilanden, dit zijn stukjes DNA die uit veel 
С en G nucleotiden bestaan Het muizen IGF2R gen bevat twee CpG eilanden, één aan het 
begin van het gen, het zogenoemde promoter-geassocieerde CpG eiland, en één in intron 2 Uit 
ons onderzoek bleek dat in het humane, niet geimpnnte, gen deze twee CpG eilanden ook 
aanwezig zijn en bovendien op identieke posities in het IGF2R gen liggen Verder bleek het 
CpG eiland in het humane intron 2, net als in de muis, specifiek gemethyleerd op de matemale 
genkopie In tegenstelling tot de paternaal-specifieke methylatie van het promoter-
geassocieerde CpG eiland in de muis werd in de mens geen methylatie van dit CpG eiland 
gevonden Methylatie van promoter-geassocieerde CpG eilanden resulteert meestal in de 
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inactivatie van het betreffende gen De afwezigheid van promoter-methylatie in mensen is in 
overeenstemming met het feit dat in mensen beide IGF2R genkopiën aktief zijn 
Resultaten van een onderzoeksgroep uit Canada suggereerden dat in sommige mensen het 
IGF2R gen misschien wèl gelmprint is WIJ hebben één door deze groep onderzocht foetus, met 
maternaal-specifieke IGF2R expressie, nader bestudeerd Methylatie-analyse wees uit dat het 
promoter-geassocieerde CpG eiland in dit foetus met gemethyleerd is Dit betekent dat de 
patemale inactivatie waarschijnlijk niet veroorzaakt wordt door genomische imprinting maar door 
een nog onbekende mutatie 
Gelmprinte genen liggen vaak in clusters, en het is daarom niet verwonderlijk dat het dicht bij 
Igf2r liggende Mas proto-oncogen in de muis ook geimpnnt is Om de situatie In de mens te 
bestuderen hebben WIJ het humane MAS gen gekloneerd Dit gen bleek ook in de mens dicht bij 
IGF2R te liggen en expressie-analyse toonde aan dat in de mens beide genkopiën van het MAS 
gen tot expressie komen Er zijn dus tenminste twee dicht bij elkaar liggende genen, IGF2R en 
MAS, die in de muis wèl maar in de mens niet aan genomische imprinting onderhevig zijn Het 
Is onwaarschijnlijk dat mutaties in beide genen de oorzaak zijn van dit imprinting verlies 
Waarschijnlijk is in de mens een centrale factor die de imprinting van beide genen regelt niet 
meer functioneel of zelfs afwezig Een mogelijke kandidaat voor deze factor is een recentelijk in 
de muis gevonden RNA molecuul met anti-sense IGF2R sequenties Dit RNA komt alleen van 
de paternale genkopie tot expressie Indien dit anti-sense RNA niet meer tot expressie kan 
komen dan verdwijnt de imprinting van het Igf2r gen in de muis Mogelijk is afwezigheid van dit 
anti-sense RNA in mensen een verklaring voor de biallelische expressie van IGF2R, en MAS 
Om nieuwe geimpnnte genen in de mens op te sporen is de humane homoloog van het 
muizen Peg1/Mest gen, geïsoleerd Het humane PEG1/MEST gen ligt op chromosoom 7 en 
expressie-analyse wees uit dat in de mens, net als in de muis, alleen de patemale PEG1/MEST 
genkopie aktief is Het PEG1/MEST gen bleek een promoter-geassocieerd CpG eiland te 
hebben waarvan alleen het maternale CpG eiland gemethyleerd is Ook bij de muis is deze 
maternaal-specifieke methylatie aanwezig 
Er zijn mensen die twee chromosomen 7 van hun moeder hebben gekregen en geen 
chromosoom 7 van hun vader Dit wordt maternale uniparental disomie 7 genoemd (mUPD7) 
Patienten met ml)PD7 zijn kleiner dan normale mensen en veel van hen hebben het Silver-
Russell syndroom (SRS) Omdat van het PEG1/MEST gen alleen het paternale allei tot 
expressie komt hebben patiënten met maternale UPD7 geen aktief PEG1/MEST allei Muizen 
zonder het Peg1/Mest gen zijn net als de mUPD7 patiënten kleiner dan normaal Een logische 
veronderstelling is dat de afwezigheid van een goed functionerend PEG1/MEST gen deze 
groeiachterstand, en ook SRS veroorzaakt Er zijn SRS patiënten die wel een paternaal, en dus 
aktief, PEG1/MEST gen hebben In deze patiënten zouden mutaties in, of abnormale methylatie 
van, het paternale PEG1/MEST gen, het ontstaan van SRS kunnen verklaren Echter, in 49 
onderzochte SRS patiënten zijn geen mutaties in het PEG1/MEST gen gevonden en ook de 
methylatie van het promoter-geassocieerde CpG eiland was bij deze patiënten normaal Dit 
betekent dat het Silver-Russell syndroom en de groeiachterstand in maternale UPD7 patiënten 
116 
SAMENVATTING 
wellicht veroorzaakt worden door een ander op chromosoom 7 liggend geimprmt gen 
Concluderend kunnen we zeggen dat, hoewel de meeste gelmpnnte genen in de muis ook in 
de mens geimpnnt zijn, dit niet het geval is voor twee van de drie hier onderzochte genen De 
dicht bij elkaar liggende IGF2R en MAS genen zijn beiden in de muis wel, en in de mens niet, 
geimpnnt Het derde onderzochte gen, PEG1/MEST, is zowel in de mens als in de muis 
geimpnnt De CpG eilanden van het IGF2R gen, liggen in mens en muis op identieke posities en 
ook de maternale melhylatie van het intron 2 CpG eiland is geconserveerd Toch verschilt de 
genomische imprinting van IGF2R tussen mens en muis In mensen komt het IGF2R gen 
biallehsch tot expressie terwijl het in muizen gelmprmt is Mogelijk biedt biallelische IGF2R 
expressie betere bescherming tegen de vorming van bepaalde tumoren Dit wordt bevestigd 
door het feit dat verlies van IGF2R expressie, met name in levertumoren, een veel voorkomend 
fenomeen is Bovendien is de muis, die door imprinting maar één aktief Igf2r gen bezit, 
gevoeliger voor het ontstaan van levertumoren dan de mens Net als het overgrote deel van de 
geimprinte genen, is de genomische imprinting van het PEG1/MEST gen wel geconserveerd 
tussen mens en muis Dit is een aanwijzing voor de belangrijke rol die geimpnnte genen spelen 
bij de regulatie van groei en ontwikkeling in zoogdieren Het vergelijken van humane en 
muizengenen die aan imprinting onderhevig zijn vormt een belangrijke strategie om het 
















































BWS critical region 
cystic fibrosis 
deoxyribonucleic acid 
DNA methyl transferase 
embryonic stem cells 
fluorescence in situ hybridisation 
human Achaete-Scute homologue 2 
hepato cellular carcinoma 
impnnting centre 
insulin-like growth factor type-1 
insulin-like growth factor type-1 receptor 
insulin-like growth factor type-2 
insulin-like growth factor type-2 receptor 
insulin 
impnnted in Prader Willi 
intrauterine growth retardation 
potassium channel involved in Long Q-T 
loss of heterozygozity 
loss of impnnting 
maternal/paternal uniparental disomy 
mesodermal specific transcript 
open reading frame 
pseudo autosomal region 
proliferating cell nuclear antigen 
polymerase chain reaction 
paternally expressed gene 
paragangliomas gene 





small nuclear nbonucleotide particle N 
Silver-Russell syndrome 
transforming growth factor p i 
E6-AP ubiquitin protein ligase ЗА 
untranslated region 
Wilms tumor 
X mactivation centre 
X-inactive specific transcnpt 
yeast artificial chromosome 
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Dankwoord 
Het schrijven van een proefschrift is de afsluiting van een periode van bijzondere 
persoonlijke en wetenschappelijke ontwikkeling Tijdens deze periode hebben vele mensen mij, 
elk op hun eigen persoonlijke wijze, geholpen en gestimuleerd 
Vera, gedurende de gehele tijd van dit promotie onderzoek ben JIJ er zeer intensief bij 
betrokken geweest Jij zette, met succes, het impnntingsonderzoek op in Nijmegen en 
vervolgens Berlijn De afstand Nijmegen-Berlijn werd met behulp van mailtjes, videoconferenties 
en vele telefoontjes overbrugd tot het moment dat ik zelf voor een jaar in jouw groep in Berlijn 
kwam werken Ik heb genoten van deze tijd en wil je graag bedanken voor je enthousiaste 
begeleiding en je gastvrijheid die niet ophield bij de laboratoriumdeur 
Hans-Hilger Ropers, mijn promoter, ik wil jou graag bedanken voor het initiëren van het 
impnntingsonderzoek in Nijmegen Nadat ik gedurende een stage zeer geïnteresseerd was 
geraakt in het bijzonder boeiende fenomeen "genomic imprinting" heb ik bij jou de mogelijkheid 
gekregen om mij hierin 4 jaar lang te verdiepen Halverwege mijn promotie besloot je een baan 
als directeur bij het Max Planck Instituut voor Molculaire Genetica in Berlijn te combineren met 
het hoogleraarschap in Nijmegen Hierdoor kreeg ik de mogelijkheid om een jaar in Berlijn te 
werken Ik kijk met veel plezier terug op dat jaar waarin ik veel geleerd heb Ik zou je graag 
willen bedanken voor de tijd en energie die je in mijn promotie hebt gestoken 
Vooral in de beginfase van het onderzoek hebben de ideeën van Edwin Manman 
meegeholpen het onderzoek op de rails te zetten Bedankt voor de vele stimulerende 
discussies 
Voor de gezellige sfeer op het lab in Nijmegen, iets waarvan de belanrijkheid nogal eens 
over het hoofd wordt gezien, zou ik graag alle medelabbewoners willen bedanken Marga, jou 
wil ik bedanken voor alle proeven die de basis van dit boekje vormen Misschien dat na jou 
schaatscursus 50 mini's niet meer voor 50 km toerschaatstocht gaan Donen, Sylvia, Yvette, 
Gerard, Liesbeth, Saskia en Ineke wil ik graag bedanken voor het dagelijkse reilen en zeilen van 
lab en secretariaat 
Weiter möchte ich mich ganz herzlich bei allen Mitarbeitern des MPI Abteilung Ropers 
bedanken Ich habe sehr gute Erinnerungen an Euch Insbesondere möchte ich mich bei der 
Arbeitsgruppe Kaischeuer, Ute, Landlan, Bodo und Nadya bedanken für die angenehme 
Zusammenarbeit 
Buiten het lab waren er mijn vrienden, Yvonne, Romke, Evert, Elles, René, 
Wendelmoet, en Antoine, die alle problemen relativeerden met hun eigen, maar wel 
vergelijkbare verhalen, weekendjes weg, schaatstochten, oud en nieuw vieringen, etc Hiervan 
heb ik altijd zeer genoten Verder zou ik Leo, Margriet, Kristel en Sander willen bedanken voor 
de gezelligheid bij hen thuis en tijdens kampeer, kano, langlauf en (berg)wandel 
vakantie/weekendjes Mijn ouders hebben mij altijd sterk gestimuleerd door het vetrouwen en de 
vrijheid die ze me hebben gegeven Aan hen wil ik dan ook graag dit boekje opdragen 
Lieve Luc, nu is ook mijn boekje af Bedankt voor al je steun, geduld en vertrouwen, en alles wat 
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